Bioprocess Design Considerations for the Large Scale Manufacture of Pluripotent Stem Cell Derived Retinal Pigment Epithelium by Lane, ARR
  
 
Bioprocess design considerations for the 
manufacture of pluripotent stem cell derived retinal 
pigment epithelium for the treatment of age-related 
macular degeneration 
 
 
 
 
 
 
Thesis submitted for the degree of 
 
Doctor of Engineering In 
Biochemical Engineering 
 
 
 
Amelia Ronnaug Rose Lane 
 
 
The Advanced Centre for Biochemical Engineering  
Department of Biochemical Engineering  
University College London 
1 
  
 
Declaration 
 
I, Amelia Ronnaug Rose Lane, confirm that the work presented in this thesis is 
my own. Where information has been derived from other sources, I confirm 
that this has been indicated in the thesis. 
2 
Acknowledgements 
 
Thank you to my supervisors, Professor Chris Mason for recruiting me to this 
exciting project and for his enthusiasm and advice, and Professor Pete Coffey for his 
knowledge, wisdom and support throughout. 
 
Thanks to everyone at the London project - your knowledge, dedication, hard work 
and enthusiasm for the project has been inspiring. Particularly Mayaan, Shazeen, 
LiLi,, Amanda, Matt, Ant, Carlos and Jean for patiently teaching me new techniques 
and for all the interesting conversations and insights both in and out of the Eagle.  
 
In the UCL RegenMed lab I sincerely thank Ludmilla Ruban for training me in 
HESC culture and for looking out for me. To Dae, for unselfishly sharing his 
knowledge and for being an inspiringly hard worker and truly excellent friend.  To 
Diana again for sharing her knowledge and insight at the most critical moments.  
Thank you to Kate for being such a kind and supportive friend as we went through 
the good and bad times together. Thanks to Iwan for all your optimism and help at 
the end with thesis reading. And to TPM, Guillia, Vishal, Owen, Shaz, Nat, John and 
Yemisi for being the finest office buddies, friends and colleagues. I am also very 
grateful for the help of Martin Town in the biochemical engineering for designing 
and making our imaging system. Thank you also to my masters student Lissa Philip. 
 
Thank you to my very good friends and flat mates Sioned and Sarah for their proof 
reading help, LYMTLI and my sis Freya for listening to me moan and always 
coming up with constructive solutions.  Thank you to the Meek-O’connor family for 
very kindly having me to stay with them many times during the completion of this 
thesis, for many delicious meals and interesting conversations.  Thank you to the 
wonderful Elbaz family and my amazing grandmother Bestemor for having me to 
stay for the last months of writing up, it has been such a pleasure to sit round your 
table, thank you for your kindness. Thank you to my parents and brother Oliver, for 
your proof reading, financial and emotional support from across the world. Your 
wise words helped me to maintain perspective and I will always be grateful. Lastly to 
Innes, thank you for supporting me and encouraging me always - your patience, 
kindness and optimism make everything possible. 
 
Finally I want to thank my sponsors the Rosetrees trust and the engineering and 
physical sciences research council for their support. 
 
 
 
 
 
 
 
 
3 
Abstract  
 
 
Human embryonic stem cells (HESC) are a promising source of retinal pigment 
epithelium (RPE) for the treatment of common and incurable forms of blindness such 
as age-related macular degeneration (AMD). Whilst most HESC lines will produce 
some pigmented RPE cells when allowed to overgrow and spontaneously 
differentiate for 30-60 days, the efficiency of this process is highly variable and the 
critical factors which determine target cell yield remain largely uncharacterised. This 
will prove problematic in the large-scale production of RPE cells needed for cell 
therapy. In this project the aim was to identify and minimise sources of variability 
during differentiation and to develop an efficient and scalable HESC-RPE 
differentiation protocol. 
 
Using a novel imaging platform in combination with quantitative gene expression 
analysis and immunocytochemistry, the relative differentiation efficiency in two new 
cell lines, Shef6 and Shef3 was characterised. It was found that the age of the starting 
HESC population, the cell seeding density and the passaging method used have a 
strong influence on RPE yields. It was also demonstrated that RPE can be generated 
from HESC following single cell dissociation and in the absence of feeder cells, 
thereby significantly simplifying cell culture logistics and reducing variability.  In 
addition it was shown that the lower yielding cell line, Shef3, has a reduced innate 
propensity for neuroectoderm conversion and that by directing this process with a 
small molecule, dorsomorphin, efficiency can be significantly improved. Overall this 
novel protocol increased RPE foci yields per cm2 by 5 fold in Shef6 and 4 fold in 
Shef3 compared to traditional mouse embryonic fibroblast (MEFs) co-culture 
systems. Since HESC-derived RPE are now entering clinical trials, it has become 
increasingly important to optimise manufacturing; this study identifies several 
critical parameters that could help develop a robust, scalable and cost-effective 
strategy for HESC-RPE manufacturing. 
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1.1 Introduction 
 
Human embryonic stem cells (HESC) have enormous potential as a limitless source 
of human cells that could be used in the treatment of degenerative diseases where 
replacement of aged or defective cells could restore function to damaged tissues. 
Age-related macular degeneration is an incurable form of blindness that is estimated 
to affect over two million people in the USA and UK alone, with incidence predicted 
to double over the next decade (Owen et al., 2012, Friedman et al., 2004). The 
disease is caused by the degeneration of a specific cell type found in the retina, the 
retinal pigment epithelium, which can be derived from HESC (Young et al., 1987, 
Vugler et al., 2007). Autologous RPE transplants in humans have shown that 
replacement of the defective retinal pigment epithelium can lead to re-establishment 
of the critical photoreceptor–RPE interaction and at least partial restoration of visual 
function (Da cruz et al., 2007). The eye is believed to be a highly suitable target 
organ for transplantation therapies due to its accessibility, immunologically 
privileged status and the ease with which grafts can be viewed (Da Cruz et al., 2007). 
Multicentre clinical trials using HESC derived RPE to treat dry AMD and Stargardt 
disease (so called ‘juvenile macular degeneration’) are currently underway (Schwartz 
et al., 2012). 
 
HESC are derived from the inner cell masses of human blastocyst stage embryos 
(Thomson et al., 1998). Despite an increasing understanding of the mechanisms that 
control pluripotency, maintaining undifferentiated HESC in culture continues to be 
laborious and unpredictable, often generating heterogeneous cultures with variable 
growth rates and differentiation capacity (Akopian et al., 2010, Adewumi et al., 
2007).  Never the less, differentiation of HESC into putative RPE cells occurs 
robustly in many HESC and induced pluripotent stem cell (IPSC) lines. Pigmented 
cells expressing the characteristic gene and protein expression, pigmentation, and 
morphology of adult retinal pigment epithelium (RPE) cells have been reported by 
several groups (Rowland et al., 2012). Why this phenomenon occurs so readily in 
many HESC lines is not completely understood, though it has been suggested that 
standard culture conditions including components of the growth media and secretions 
from the inactivated mouse feeder layer contribute significantly, perhaps by 
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mimicking aspects of the highly conserved retinal development pathway (Vugler et 
al., 2008, Shi et al., 2008, Hongisto et al., 2012).  
 
Reviewing the published accounts of HESC-RPE differentiation reveals significant 
variability in the reported timing and yields of RPE cells following HESC 
differentiation (table 1.1). This suggests that there are process critical variables 
which have not yet been identified, or are not routinely controlled, which have a 
profound impact of the productivity of HESC-RPE differentiation. Directed 
differentiation protocols based on our knowledge of in-vivo eye development have 
been used to generate photoreceoptor progentiors and RPE, in many of these 
protocols however it is not convincingly demonstrated that directed strategies are 
superior to so called ‘spontaneous’ methods in terms of overall cells in vs. cells out 
yield or in terms of reproducibility.  Identification and optimisation of the variables 
that control the differentiation efficiency will be critical to overall process 
efficiencies and may ultimately determine the economic feasibility of HESC-RPE to 
treat AMD.  
  
1.2 The Retina and Macular Degeneration 
 
1.2.1 Anatomy and Physiology of the RPE 
 
 
Light enters the eye through the window of the pupil and is focused by the lens onto 
a region of the retina known as the macula. The macula is an area around 3mm in 
radius centred around the fovea; it confers the greatest visual acuity and has a 
particularly high concentration of cone type photoreceptors (Curico et al., 1990). The 
retina consists of four physiologically distinct layers (Fig. 1.1): the photoreceptors, 
the retinal pigment epithelium (RPE), the Bruch’s membrane and the choroid blood 
supply.  
 
 
 
    
 
 
Figure 1.1 Schematic of the human retina.  The retina consists of physiologically distinct layers. 
The basolateral side of the RPE forms part of the Bruch’s membrane that separates the retina from the 
choroid blood supply. The RPE and photoreceptors are intimately connected via long microvilli 
20 
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extending from the RPE around the photoreceptor outer segments. Diagram adapted from Kolb et al., 
1995. 
 
The first of these layers to be reached by incoming light contains the photoreceptors. 
Incident photons react with the light sensitive opsins which are abundant in the 
membranous stacks of the photoreceptor outer segments (Hall et al., 1973). 
Photoreceptors are constantly exposed to, and damaged by light. In order to preserve 
function, each photoreceptor undergoes a process of continual destruction and 
renewal of the light-processing outer segment. Stacks of visual pigment containing 
molecules in the outer segments are added at the base of the outer segment whilst old 
stacks are pinched off the other end and phagocytosed by the adjacent retinal 
pigment epithelium (Young et al., 1969).  
 
The RPE cells lie directly behind the photoreceptors. Approximately twenty-three 
photoreceptors are supplied by one RPE in the fovea (Gao, 1992). The RPE possess 
long microvilli on their apical side which surround the rod and cone outer segments 
and engulf the shed outer segment discs. There is a burst of outer segment shedding 
and phagocytosis by the RPE at first light in the morning (Young et al., 1971). The 
basolateral side of the RPE forms part of the Bruch’s membrane that lies between the 
fenestrated capillaries of the choroid and the retina. The cells have many important 
functions in the nourishment and maintenance of the photoreceptors. A critical role 
of the RPE, which is used to demonstrate the functionality of cells grown in culture, 
is in the phagocytosis of shed photoreceptor’s outer segments (Carr et al., 2009). 
Shed segments bind to the RPE surface and are internalised a process in which the 
MerTK receptor is implicated (D’cruz et al., 2000). In the macular there are more 
photoreceptors per RPE cell and the RPE here are adapted to a higher turnover rate 
of shed outer segments (Weiter et al., 1986). 
 
The RPE are highly susceptible to photo-oxidative damage; the environment of high 
intensity light exposure, rich oxygen supply and the abundance of polyunsaturated 
fatty acids together with continuous phagocytic activities lead to the generation of 
significant amounts of potentially toxic reactive oxygen intermediates (ROI) (Weiter 
et al., 1987).  The RPE cells employ various protective strategies to minimise the 
toxicity of their environment (Straus et al., 2005). A large number of melanin 
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containing melanosomes which absorb light and reduce the photodynamic production 
of potentially toxic ROI are found in the RPE (Beatty et al., 2000). In addition the 
RPE accumulate anti-oxidative substances that sequester damaging free radicals 
(Boulton et al, 2001), including the antioxidant enzymes superoxide dismutase, 
catalase and peroxidase (which have micronutrient components of zinc, selenium and 
copper) antioxidant nutrients vitamin C (ascorbate), E (α-tocopherol), β-carotene and 
the caretenoides lutein and zeaxanthin (Micele et al., 1994). 
 
The polarised RPE monolayer forms the retinal-blood barrier with tight junctions 
across the epithelium separating the subretinal space from the choriocapillaris and 
controlling the trans-epithelial transport of nutrients and waste products (Hughes et 
al., 1998). A large amount of water is produced in the retina and the RPE is 
responsible for removing it from the sub-retinal space and transporting it to the 
choriocapillaris.  The apical side of the RPE membrane contain Na+ / K+ ATPases 
(Marmorstein et al., 2001) which supply the energy required for transepithelial 
transport and are important in setting up the ion gradients that enable the transport of 
chloride ions and water, the removal of photoreceptor metabolic end products, such 
as lactic acid and in maintaining pH (Strauss et al., 2005).  These transport 
mechanisms are critical to homeostasis of the extra-photoreceptor matrix (Wimmers 
et al. 2007). Transport of glucose and supplementary Vitamin A (for use in the 
retinal cycle) from the choroid to the photoreceptors is also achieved by the RPE via 
specialised, receptor mediated processes (Pfeffer et al., 1986).  
 
The RPE also has important functions in the retinoid cycle, the process by which 11-
cis-retinal is regenerated from all-trans-retinol following light induced 
photoisomerization. The photoreceptors themselves lack the cis-trans isomerase 
enzyme required for this conversion. The transportation of the reduced form of all-
trans-retinal (all–trans-retinol) from the intradiscal space of the photoreceptors, to 
the RPE is achieved in a process involving transporter protein ABCA4 and carrier 
protein IRBP. The regeneration of 11-trans-retinol  is then carried out by enzymes 
(LRAT, RPE65,CRALBP,RDH5,) residing in the RPE cells as they recycle parts of 
the phagocytosed photoreceptor outer segments, before transporting the regenerated 
molecules back to the photoreceptors (Purves et al., 2001, Strauss et al., 2005).  
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Mutations in ABCA4 have been associated with Stargardt disease and age-related 
macular degeneration (Allikmets et al., 2000). 
 
RPE exhibit polarised secretion of growth factors. In healthy eyes PEDF in secreted 
from the apical side of the epithelium, this growth factor has anti-angiogenic and 
neuroprotectant properties and reduces hypoxia induced apoptosis (Dawson et al., 
1999). On the basal side of the RPE, small quantities of VEGF are secreted. This 
growth factor helps to prevent endothelial cell apoptosis and maintains the 
fenestrations in the choriocapillaris (Roberts et al., 1995). In response to injury the 
RPE have been shown to upregulate the secretion of additional neurotrophic factors 
bFGF and CNTF (Wen et al., 1995). In the diseased retina inappropriate secretions of 
these growth factors contributes to aberrant neovascularisation, as seen in ‘Wet’ 
AMD (Wada et al., 1999, Ishibashi et al., 1997). 
 
In summary the high metabolic activity of the photoreceptors coupled with the 
intensity of incoming light is conducive to cellular damage in the adult human retina. 
The RPE are specially adapted to minimise this damage and protect the 
photoreceptors via a variety of mechanisms. In addition the RPE carry out vital 
functions in the digestion of photoreceptor outer segments, regeneration of molecules 
critical to the visual cycle, transportation of nutrients and waste products across the 
retinal blood barrier and the secretion of growth factors critical to retina and choroid 
health and function.  
 
 
1.2.2 Embryonic development of the retina 
  
The stages that mark the transformation from pluripotent inner cell mass to the 
formation of a differentiated, multilayered retina have been studied extensively in 
animal models including amphibians, chick, mouse and fish.  The eye develops from 
multiple embryonic tissue layers, whilst the neuroectoderm forms the RPE and 
neural retina, the mesoderm contributes to the cornea and choroid layer, neural crest 
cells contribute to the cornea, cilary muscles, sclera and choroid layer and the 
ectoderm forms part of the lens and cornea (Schoenwolf et al., 2009).  This section 
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focuses on embryonic development of the retina from the neuroectoderm. The 
process of retinal development is categorised into the following stages: neural 
induction  and specification of the anterior neural plate, establishment of the eye field 
and optic vesicles and formation of the optic cup. 
 
Neural Induction and specification of the anterior neural plate: Neural induction is 
triggered by the inhibition of BMP signalling by Chordin, Noggin and Follistatin 
which are released from the Spemann’s organizer (Kessler et al., 1994, Wilson et al., 
2004). Anteriorisation of the neural plate and formation of the forebrain is the default 
fate for neural induced tissue and at this stage FGFs, Retinoic acid and canonical 
Wnt signalling suppress anteriorization and induce posteriorization of the neural 
plate (Niehrs et al., 2004, Villanueva et al., 2002). The secreted proteins IGF and 
Cerberus specifically induce the expression of anterior neural plate transcription 
factor Otx2 (Pera et al., 2001). 
 
Establishment of the eye field: The eye field forms in a region of the anterior neural 
plate surrounded by telencephalic precursors and cells that go on to form the 
hypothalamus (Esteve et al., 2006). Otx2 expression in the prospective forebrain 
region of the anterior neural plate primes this area for eye field formation, inducing 
the expression of a network of self-regulating eye field transcription factors (EFTFs) 
including Pax6, Six3, Lhx2 Rx1 and Six6 (Zuber et al., 2003). The EFTFs work 
together and in some cases mutually induce the expression of one another (Zuber et 
al., 2003). Rx is essential to optic vesicle invagination and its overexpression leads to 
excessive proliferation of both the RPE and neural retina (Bailey et al., 2004). Pax6 
is also critical to optic cup formation, null mutants do not develop an optic cup and 
its ectopic expression has been shown to induce eye formation in Xenopus (Chow et 
al., 1999). 
 
The optic vesicles are first morphologically distinguishable as lateral bulges 
evaginating from the forebrain region of the neural tube towards the surface 
ectoderm.  Shh signalling suppresses the expression of eye field transcription factors 
down the midline of the neural tube thereby producing two distinct eye fields (Yang 
et al., 2004). As the vesicles grow outwards they become surrounded by 
mesenchyme derived from neural crest cells and head mesenchyme.  This extraocular 
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mesenchyme starts to form on post-ovulatory day 24 and surrounds the entire vesicle 
by day 26 (Schoenwolf et al., 2009).   Initially all regions of the optic cup are tri-
potent and can form neural retina, RPE or optic stalk; the patterning and subsequent 
differentiation is induced by surrounding tissues (Slack et al., 2006). Signalling from 
the adjacent surface ectoderm, mediated by FGFs, induces neural retina via the 
homeobox transcription factor Chx10 (Zhao et al., 2001), whereas BMP or activin 
like signalling originating in the extraocular mesenchyme induces expression of the 
basic helix loop helix (bHLH) transcription factor, MitF, which specifies RPE and 
induces pigmentation as well as suppressing Chx10 (Fuhrmann et al. 2000, Nguyen 
et al., 2000). The combined expression of Otx2 and Wnt/βcatenin has been shown to 
induce MitF expression and drive the conversion of retinal progenitor cells into 
presumptive RPE in chick optic explants (Westenskow et al., 2010). The 
presumptive neural retina and the RPE express FGFs and BMPs respectively which 
help to consolidate their respective identities and define the boundary between these 
phenotypically distinct retinal layers (Vogel-Hopker et al., 2000, Zhao et al., 2001). 
As the optic vesicle continues to expand the distal portion comes into contact with 
the overlying surface ectoderm causing the optic vesicle and the ectoderm to 
invaginate in a process that requires the transcription factors Pax6, Lhx2 and Hes1 
(Canto-Soler et al., 2006, Chow et al., 2001), (Fig.1.2). 
 
Optic cup formation: Pigmentation (the production of melanin) in the presumptive 
RPE first occurs midway through the fifth post-ovulatory week, whereas neural 
retinal differentiation begins at the end of the sixth week (Schoenwolf et al., 2009).  
Oxt2 and MitF activate melanin synthesis genes Tyrosinase, Trp1, Trp2 and QNR71 
(Martinez-Morales et al., 2003), at this stage Shh and Wnt play key roles in RPE 
maintenance (Shi et al., 2008).  The basal lamina of the RPE goes on to form the 
Bruch’s membrane shortly after pigmentation begins. By the sixth week the neural 
retina is patterned into an outer and inner neuroblastic cell layer. Subsequently, six 
classes of neurons and one glial cell type are formed in an evolutionarily conserved 
order; ganglion cells, cone photoreceptors, horizontal cells then amacrine and rod 
photoreceptors followed by biopolar cells and muller glia (Slack et al., 2006) (Fig. 
1.1). 
 
 
  
 
 
 
Figure 1.2 Schematic of human eye development. (A) The optic vesicles are first morphologically 
distinguishable as lateral bulges evaginating from the forebrain towards the surface ectoderm. Otx2 
drives the expression of a network of eye field transcription factors Six3, Lhx2, Rx, Pax6 and Six6.  
(B) Extraocular tissues pattern the optic vesicle. Adjacent surface ectoderm secretes FGFs which 
induce Chx10 expression and formation of presumptive neural retina and BMP or activin like signals 
from the extraocular mesenchyme drive MitF expression and presumptive RPE. (C) The optic vesicle 
and thickened surface ectoderm invaginate to form a bilayered optic cup in which the outer layer 
becomes the pigmented RPE.  Drawings adapted from Adler et al., 2007. 
 
 
In summary understanding the developmental cues that lead to the specification of 
RPE cell fate in vivo is an important starting point in deciphering how RPE might be 
derived in HESC culture, although it is feasible that the in vitro derivation routes 
may differ in some details. Understanding of in vivo eye development is also critical 
in facilitating the characterisation of the stages of HESC differentiation enabling 
more targeted manipulation of differentiating cells in culture. 
 
1.2.3 Pathophysiology of dry age-related macular degeneration 
 
Age-related macula degeneration (AMD) is currently the leading cause of blindness 
in the western world (Chopdar et al., 2008).  Incidence is strongly correlated with 
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age: pooled data from 15000 individuals across 3 continents found the incidence of 
AMD (all types) to be 0.2% in people aged 55-64 years old, rising to 13% of the 
population over 85 years (Smith et al. 1999). Continuing advances in technology and 
medicine are resulting in an ever increasing elderly population; this will lead to an 
inevitable increase in the incidence of age related illnesses such as AMD.  
 
Patients afflicted with AMD suffer from a gradually diminished ability to carry out 
essential daily activities like driving, reading and recognizing faces often leading to 
complete loss of central vision. Impaired vision is a consequence of degeneration of 
the retinal pigment epithelium and Bruch’s membrane specifically in the macula. 
With advancing age the RPE become less efficient at carrying out the essential 
functions outlined in section 1.2.1, partially due to what is now recognised as 
chronic, low grade inflammation in the central outer retina (Jager et al., 2008). 
Damaged RPE develop imperfections in their digestive functions leading to the 
gradual accumulation of toxic metabolic waste products such as lipofuscin which 
increasingly interfere with other cell functions (Young et al., 1987) and may induce 
apoptosis in the RPE (Strauss et al., 2004). The homeostatic environment of the 
retina thus becomes disturbed and undigested waste material termed ‘drusen’ begins 
to accumulate between the RPE and Bruch’s membrane. Apoptosing or poorly 
functioning RPE cannot support the overlying photoreceptors leading to the 
photoreceptor cell death and loss of vision (Young et al., 1987).   
 
The Bruch’s membrane also undergoes significant changes with age, particularly in 
the submacular region. These changes include the deposition of extracellular matrix, 
lipids, collagen and advanced glycation end products (Gullapalli et al., 2005). The 
hydraulic conductance of the membrane also decreases with age, leading to the 
accumulation of fluid in the subretinal space (Bird et al., 1986). If the integrity of the 
Bruch’s membrane is broken, new blood vessels may begin to form and invade the 
sub-retinal space.  This is known as ‘wet’ or exudative AMD. These blood vessels 
are often leaky and result is a dense fibrovascular scar that may cover the whole 
macula area. Visual acuity usually declines more rapidly in Wet AMD (Chopdar et 
al., 2009).   
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1.2.4 Animal models of AMD  
 
AMD is a complex and heterogeneous disease and no one animal model recapitulates 
all of its features. Rodent models with defects in the complement factor pathway, 
glucose and lipid metabolism, oxidative stress, inflammation responses and 
accelerated ageing have all been useful in elucidating the causative role of these 
various factors in disease pathology (reviewed in Pennesi et al., 2012).  A major 
draw back of these rodent models is the absence of a cone-rich macular in  the rodent 
retina. Rodents do display a higher concentration of photoreceptors in their central 
retina’s relative to the periphery however, and the major anatomy (RPE, Burch’s 
membrane, Choroid), is preserved across species (Zeiss et al., 2010).    
 
The Royal College of Surgeons (RCS) rat is frequently used to investigate changes in 
the retina and the efficacy of potential treatments. The RCS rat possesses a 
recessively inherited retinal degeneration caused by an inability of the RPE to 
phagocytose photoreceptor outer segments. This is attributed to a deletion in a gene 
encoding the receptor tyrosine kinase (MerTK), which is involved in phagocytosis of 
shed outer segments (D’Cruz et al., 2000).  In the RCS rat, shed outer segments build 
up in the sub-retinal space over time leading to the degeneration of the outer nuclear 
layer of the photoreceptors and blindness over the course of three months (Coffey et 
al., 2001). The RCS rat is particularly useful for investigating the possibility of 
photoreceptor rescue. The RCS rat has limitations as a model of AMD however as 
their Bruch’s membranes do not deteriorate as seen in AMD, making the rats a poor 
model for graft integration (D’Cruz et al., 2000).   
 
Polymorphisms in the gene encoding complement factor H (CFH) are implicated in 
being at risk for AMD (Edwards et al., 2005). With at least 50% of AMD cases 
associated with Y402H polymorphisms in the CFH gene, this is the single largest 
genetic risk factor.  Genetically engineered CFH-/- double knock out mice display 
some retinal abnormalities similar to those seen in AMD (Coffey et al., 2007). These 
include accumulation of drusen like material, a re-organisation of organelles within 
the retinal pigment epithelium, disorganisation of the photoreceptor outer segments 
and thinning of the Bruch’s membrane (Coffey et al., 2007). Thinning of the Bruch’s 
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membrane is unique among AMD animal models, and this is thought to result from 
increased phagocytic activity as a result of the deregulated complement pathway. 
 
The ELOVL4 transgenic mouse is used as a model for Stargardt macular 
degeneration, a form of early onset AMD characterised by photoreceptor 
degeneration and atrophy of the retinal pigment epithelium (RPE) in the central 
retina (Karan et al., 2005). ELOVL4 mice have a mutated form of a protein involved 
in long chain fatty acid synthesis in photoreceptor outer segments.  This leads to the 
accumulation of improperly digested outer segments in the RPE, lipofuscin and 
phagosomes and subsequent RPE degeneration, primarily in the central retina. 
 
Visual acuity in rodent models can be assessed using head-tracking experiments 
where animals are placed in the centre of a revolving drum lined with wave gratings 
of a particular width (Coffey et al., 2002) or in optomotry testing apparatus 
comprising four computer screens projecting a 3D rotating cyclinder  (Lu et al., 
2009).  Rodents are unable to resolve the lines past a certain age as their vision 
deteriorates and therefore do not move their heads to track the lines. Optokinetic 
head-tracking has been shown to correlate well with photoreceptor preservation and 
is a sensitive method for assessing visual function (Haruta et al., 2004, Coffey et al., 
2002, Lawrence et al., 2000).  
 
 
1.2.5 Risk Factors and Treatment 
 
AMD is caused by chronic, low grade inflammation in the central retina, the causes 
of which are multifactorial (Jager et al., 2008). Age dependent reduction in 
pigmentation of the RPE cells and in their secretion of an important antioxidant α-
tocopherol (vitamin E) has been reported in AMD (Friedrichson 1995) and 
insufficient dietary intake of antioxidant rich foods may have a role to play (Evans et 
al., 2001), smoking also results in an increased risk of AMD. Other studies have 
linked hypertension, cardiovascular disease, alcohol consumption, oestrogen 
replacement and diet to AMD incidence, though this evidence is less consistent 
(Evans et al., 2001). Age and genetic makeup are currently the most important 
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known risk factors. Linkage analysis has revealed a particular area of chromosome 1 
as a susceptibility locus for AMD (Hageman et al., 2005) this region harbours the 
complement factor H gene (Alternative pathway regulator factor H). Further studies 
have found that individuals who are homozygous for this ‘at risk allele’ are 7.4 times 
more likely to develop AMD (Klien et al., 2005). Individuals with the at-risk allele 
have a reduced capacity to down-regulate inflammation in response to infection or 
injury which fits with the theory of an inflammatory event being the initial cause of 
RPE deterioration in AMD (Hagemen et al 2005).  In addition a smaller fraction of 
AMD cases have been linked to mutations in the gene encoding a ABCA4 
transporter protein (see section 1.2.1) and Fibulin-5 which encodes a protein found 
on the Bruch’s membrane (Allikmets et al., 2000, Stone et al., 2004, Tuo et al., 
2004). 
 
Therapies that target aberrant neovascularisation in the sub-retinal space have proven 
effective in the treatment of wet AMD. Photodynamic therapy involves a 
combination of drugs and laser treatment and can induce the destruction of new 
blood vessels (Bressler et al., 2000). Injection of VEGF-inhibitor based drugs 
Lucentis or Avastin (Genentech, CA, USA) are also routinely used to target new 
blood vessel formation (Csaky et al., 2003). None of these therapies are targeted at 
repairing the damaged RPE or photoreceptors and thus have a limited capacity to 
improve vision and are not applicable to patients with dry AMD. The cost of these 
treatments is significant: the dosing regime for Lucentis involves monthly intravitreal 
injections costing 2000 USD each, whereas photodynamic therapy is reported to cost 
1800 USD per treatment (Meads et al. 2003). 
 
Patients suffering from dry AMD do not have many treatment options. Randomised 
controlled trials have been undertaken to investigate the effects of antioxidant 
supplementation on AMD. These have included vitamins C, E, Zinc Sulphate, β-
carotene and Lutein (Evans et. al., 2001).  So far a positive effect has been seen in 
the case of lutein supplementation especially in combination with other antioxidants 
(Richer et al. 2002). In addition studies into the supplementation with Zinc oxide 
(Newsome et al. 1988) and a combination of Vitamin C, E, β-Carotene, Zinc and 
copper have been suggestive of a reduced risk of disease progression (Bartlett 2003). 
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1.3 Cell Therapy in the Treatment of AMD 
 
Whilst the events occurring within the retina that lead to deteriorating vision in dry 
AMD are well documented, there is as yet no pharmaceutical means by which to halt 
the process.  The retinal pigment epithelium has a pivotal role in the functioning of 
the photoreceptors and in maintaining homeostasis in the retinal environment. If 
follows that one approach to halting the deterioration has been to transplant healthy 
RPE cells into the subretinal space in an attempt to halt the disease progression. The 
potential benefit of RPE cell replacement has been investigated extensively in 
animals and more recently in humans (Reviewed in Da cruz et al., 2007).  
 
1.3.1 Autologous RPE Grafts 
 
RPE degeneration in AMD occurs specifically in the macula and the RPE, the 
choroid and Bruch’s membrane in the periphery remain largely healthy.  Thus the 
peripheral retina is an autologous source of RPE cells. Macular translocation surgery 
involves the surgical separation of the neural retina in the macular region and its 
subsequent rotation by 45 degrees and reattachment to a healthy region of RPE-
choroid (Da Cruz et al., 2007). This technique has been used to treat patients with 
wet and dry AMD who do not respond to photodynamic therapy or anti VEGF drugs 
(Treumer et al., 2006, Joussen et al., 2006). An average follow up of three years on 
40 patients receiving macular translocation surgery revealed a sustained 
improvement in visual acuity with 25% of patients maintaining a 3 line gain in best 
corrected visual acuity (Chen et al., 2010).  In another variation, full thickness RPE -
choroid patches are excised from the peripheral retina using a specially developed 
knife (Treumer et al. 2006, Joussen et al. 2006). The neurosensory retina in the 
macular region is first detached by the infusion of liquid into the subretinal space. 
The contiguous patch graft is then transferred to the sub-macular location using 
subretinal forceps where it is flattened and held in place by the injection of heavy 
silicon oil. This approach has been successful in improving visual function, and 
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adherence and vascularisation of the graft has been reported up to two years post 
transplant (Stagna et al., 2002, Joussen  et al., 2006).   
 
Retinal patch-graft and macular translocation surgeries are very complex and require 
great technical expertise. Thus far there has been a high rate of surgical 
complications including retinal detachment and macular oedema (Da Cruz et al., 
2007, Gelisken et al., 2007, Maclaren et al., 2007). Despite their clinical benefit, the 
prolonged surgical time, significant trauma to the eye and difficulty in placing the 
graft in the correct location reduces the feasibility of these surgeries becoming a 
routine clinical procedure for AMD.  In addition a number of AMD cases experience 
peripheral reticular degeneration (Lewis et al., 1985, Sunness et al., 1999) making 
translocation/harvesting of cells from the periphery potentially futile. 
 
1.3.2 RPE sources for Allogeneic Transplant  
 
Using healthy RPE from an external source reduces the surgery time and complexity 
as well as inflicting minimal trauma to the afflicted eye. Implanted cells or grafts 
made from outside sources have the additional advantage that they can be pre-made 
and standardized in terms of quality control, safety and efficacy. For these reasons an 
allogeneic cell graft is a more feasible option for large scale and routine clinical 
application.  
 
Human RPE cells derived from donor eyes are in limited supply and harvested cells 
can only be kept in culture for a restricted number of passages making availability a 
problem for wide scale clinical use (Engelhardt et al., 2005). The difficulty in 
expanding the cells means that the capacity to do extensive safety and quality testing 
is also severely restricted. 
 
Investigations into the therapeutic value of a spontaneously immortalised human 
RPE cell line ARPE19 and a genetically engineered human RPE line H1RPE7 have 
been performed in RCS rats (Coffey et al. 2002, Lund et al 2001). The cells in 
suspension were injected into the sub-retinal space of immunosuppressed rats. In 
both cases the injected cells preserved photoreceptors, visual responses and cortically 
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mediated vision compared to sham injected controls.  These immortalised cell lines 
lose critical functionality after repeated passaging in culture however (Alge et al., 
2003) and their therapeutic value is thought to come from their ability to deliver 
growth factors as appose to carrying out the full range of normal RPE functions 
(Wang et al. 2005).  
 
The potential of human foetal derived RPE to replace diseased RPE in humans with 
AMD has also been investigated in a small scale clinical study (Algvere et al.,1994). 
The retina containing posterior segment of the eye was isolated from 15-17 week old 
foetuses and the choroid dissected away leaving the RPE cell sheets to grow on a 
culture dish. When patients were ready for surgery, an optimal patch was selected, 
the outer edge (where ‘new growth’ could be seen) was cut away and a specialised 
cannula-pipette device was used to pick up the patch and place it in the sub-foveal 
location. Only five subjects were trialled in this study. Whilst the RPE cells grew and 
integrated effectively into the space, the new RPE supported visual function for only 
a month. After this an accumulation of fluid in the sub-retinal space began to impair 
vision. It has been hypothesized that this is a slow form of a-cellular host-graft 
rejection (Algvere et al., 1999). These studies indicate potential for foetal stem cells 
and especially the advantages of transplanting the cells as patches. However it is 
unlikely to provide sufficient material for wide scale clinical use; foetal human RPE 
begin to show morphological abnormalities after 5-6 passages and are therefore not 
suitable as a universal donor source (Gullapalli et al., 2008).  Creating the grafts 
relies on a supply of developing eyes from aborted foetuses which has both ethical 
and logistical problems. 
 
In addition to RPE transplantation, clinical trials using non-differentiated stem cells 
derived from umbilical chords are being conducted in patients with dry AMD 
(http://clinicaltrials.gov, number NCT01226628). The undifferentiated cells were 
shown to improve visual parameters when injected subretinally into RCS rats, 
probably via the secretion of neural survival promoting growth factor such as brain 
derived neurotrophic factor (Lund et al., 2007, Ramsden et al., 2013).  Similarly bone 
marrow derived mesenchymal stem cells (BMMSCs) have been shown to reverse the 
decline in visual parameters when injected into RCS rats (Lu et al., 2010), and bone 
marrow derived haematopoietic stem cells (BMHSCs) have been shown to migrate to 
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site of a damaged retina and express RPE65 in mice.  No improvements in visual 
parameters were seen when these cells were injected into three patients with retinitis 
pigmentosa (Siqueira et al., 2011, Ramsden et al., 2013). 
 
The main drawback of allogeneic transplants is their potential to illicit adverse 
immune responses. The ocular environment has been described as 
immunosuppressive and anti-inflammatory or ‘immunologically privileged’ 
(Niederkorn et al., 1990), however an AMD afflicted eye with a deteriorated Bruch’s 
and reduced numbers of immunosuppressive RPE may no longer be such a benign 
environment for transplantation.  After several studies of foetal RPE grafts in 
humans, it was concluded that rejection is common but not inevitable and risk factors 
include transplanting the graft close to the area of retinotomy, near to the fovea or 
transplanting large number of cells (Da Cruz et al. 2007).  In the case of allogenic 
bone marrow derived mesenchymal stem cells, immunosuppression may not be as 
important, but early studies in rats indicated that their functionality is inferior to that 
of differentiation RPE cells (Ramsden et al., 2013). 
 
In summary it is desirable to identify a source of RPE suitable for wide scale clinical 
use. The cells would ideally be fast to expand from an unlimited/abundant source, 
stable over indefinite passages and easy to assemble into a form that can be 
implanted in a simple and fast procedure.  In addition the cells for therapy must be 
amenable in all aspects to the various regulatory authorities. A number of RPE cell 
sources have been trialled for their therapeutic value in the treatment of AMD in both 
RCS rats, and humans (Ramsden et al., 2013). In most cases some level of improved 
visual acuity or attenuation of deterioration was observed. The spontaneously 
immortalised ARPE19 cell line provides an abundant source of material but the cells 
do not possess all the key attributes of native RPE, foetal RPE on the other hand may 
function well but are scarcely available and thus not suitable for wide scale clinical 
application.  
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1.4 Pluripotent stem cells as a source of RPE 
 
Pluripotent stem cells (human embryonic stem cells (HESC) and induced pluripotent 
stem cells (IPSC)) have the potential to differentiate into all cell types in the body, 
including RPE. The spontaneous formation of RPE was first described in primate 
embryonic stem cells in 2002 (Kawasaki et al., 2002). Pigmented areas appeared in 
primate ESC colonies after three weeks of co-culture with PA6 stromal cells. The  
phenomenon was subsequently reported two years later, this time using several 
human embryonic stem cell (HESC) lines including H1, H7 and H9 (Klimanskaya et 
al. 2004). The pigmented ‘HESC-RPE’ cells were at this time characterised using 
transcriptomics and found to compare favourably with primary RPE tissue.  
Following the discovery in 2007 of effective methods to reprogram adult somatic 
cells into a pluripotent state (Takahashi et al., 2007, Yu et al., 2007), so called 
induced pluripotent stem cells (IPSC) derived RPE have been produced from several 
lines and shown to have similar characteristics to HESC-RPE and foetal RPE 
(Buchholz et al., 2009, Carr et al., 2009, Kokkinaki et al., 2011 ). Since the start of 
this project in 2008 there have been over thirty independent accounts of deriving 
RPE cells from HESC and IPSC. The cell lines, techniques, timings and RPE yields 
(when known) from these various studies are summarised in at the end of this chapter 
in table 1.1. 
 
The advantages of using HESC or IPSC as a source of RPE are multiple; their ability 
to self-renew indefinitely in culture makes for a theoretically unlimited source of 
clinical material and extensive characterisation has revealed their superior 
functionality relative to adult RPE lines (Klimanskaya et al., 2004, Vugler et al., 
2008). Pluripotent stem cells are amongst the most biologically complex materials 
ever to be proposed for clinical use however and the mechanisms by which they 
differentiate into RPE are challenging to pick apart and control.   In this section the 
origins and characteristics of HESC and IPSC are reviewed as are the methods for 
generating HESC-RPE.  
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1.4.1 Origins and characteristics of human embryonic stem cells 
 
The isolation and establishment of human embryonic stem cell (HESC) lines was 
first described in 1998 (Thomson et al., 1998). The essential characteristics of human 
embryonic stem cells were defined in that report as follows: 1.derivation from the 
pre-implantation or peri-implantation embryo, 2. stable developmental potential to 
form derivatives of all three embryonic germ layers even after prolonged culture 
(pluripotency) and 3. prolonged undifferentiated proliferation (Thomson et al., 1998).  
 
Derivation: Fertilised embryos donated by couples undergoing IVF are cultured to 
the blastocyst stage (6 days). The inner cell mass (ICM) is then isolated by 
immunosurgery before culturing in medium containing bovine serum albumin (BSA) 
on mitomycin C inactivated mouse embryonic fibroblasts (MEFs) (Thomson et al., 
1998, Reubinoff et al., 2000).  The BSA containing media and MEFs are materials 
originally developed in 1954 for the cultivation of HeLa cells (Puck et al., 1954). A 
number of improvements to the derivation methods have been made since the 
original study including the generation of HESC lines without destruction of the 
embryo (Chung et al., 2008) and the derivation of clinical-grade cGMP cell lines 
(Crook et al., 2007). These lines were derived on FDA approved clinical grade 
human foreskin fibroblasts, in cGMP manufactured BSA-based serum replacement 
medium.  Isolation of the ICM was carried out manually to avoid the requirement for 
cGMP grade antibodies. These developments significantly reduced the obstacles in 
establishing HESC derived products suitable for clinical practice. 
 
Pluripotency: Unlike mouse embryonic stem cells it is not ethically feasible to test 
the full developmental potential of a human ES cell by implantation into an intact 
embryo; thus it can only be hypothesised that human ES cells would be able to 
contribute to all adult tissues including germ cells. The most stringent means for 
assessing pluripotency in HESC are currently teratoma assays in which 
undifferentiated HESC are transplanted into immunodeficient mice. After 3 weeks 
solid teratomas form which are excised and dissected in order to detect the presence 
of organised differentiated cells or tissues derived from each of the three 
developmental germ layers (Muller et al., 2010, Amit et al., 2002, Damjanov et al., 
1993). Alternatively HESC can be differentiated as suspended aggregates allowing 
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the formation of embryoid bodies (EBs) in which the early development of the three 
germ layers is re-capitulated (Sheridan et al., 2011). Analysis by gene expression, 
histology and immunohistochemistry has demonstrated the presences of ectoderm, 
endoderm and mesoderm derivatives in HESC derived EBs (Itskovitz-Eldor et al., 
2000, Hopfl et al., 2004). 
  
Longer term directed differentiation protocols have been successful in generating 
more functionally mature cell types originating from all three germ layers including 
insulin secreting pancreatic islet cells (Lumelsky et al., 2001), cardiomyocytes (Xu et 
al., 2002a), and dopaminergic neurons (Chambers et al., 2009) amongst many others. 
Directed protocols for generating these cells types generally involve supplementing 
the media with relatively small range of growth factors including 
TGFβ/activin/nodal, BMP, Wnt and FGF agonists/antagonists, during specific time 
windows. 
 
Mechanisms of pluripotency:  The mechanisms by which HESC remain in an 
undifferentiated state remain under investigation; it is clear that transcriptional 
regulation, epigenetic regulation and regulatory miRNAs have important roles to 
play. Homeodmain transcription factors Oct4, Nanog, and HMG transcription factor 
Sox2 have been identified as key transcription factors in the pluripotency network 
(Chen et al., 2008). These transcription factors share target genes and regulate each 
others expression in feedback and feed forward loops (Boyer et al., 2005) as well as 
regulating the expression of genes involved in histone and chromatin remodelling 
complexes (Gan et al., 2007), and genes encoding transcription factors key to early 
development and differentiation (Chickarmane et al., 2006, Chen et al., 2008). The 
chromatin in HESC cells is found in a unique, hyperdynamic and permissive state 
(Gan et al., 2007). This is thought to facilitate the rapid changes in gene expression 
required to initiate differentiation, a process which is facilitated by the combined 
action of pluripotency factors and miRNAs (Chen et al., 2008).  
 
 HESC pluripotency in culture requires the external stimulation by factors which 
mediate elements of the pluripotency network including Oct4, Nanog and Sox2. 
activin/nodal, FGF, IGF and Wnt/β catenin signalling pathways have variously been 
implicated either alone or in combination with one another (Vallier et al., 2005, Ding 
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et al., 2010, Bendall et al., 2007). In standard culture conditions these signalling 
pathways are stimulated by growth factors secreted by MEFs and by the exogenous 
addition of recombinant FGF (Chin et al., 2007). Activin/nodal is thought to act via 
SMAD2/3 to maintain the expression of Nanog which then acts as a co-factor in 
maintaining SMAD2/3 induced transcriptional activity (Brown et al., 2011). The 
activin/nodal pathway is critical to the maintenance of pluripotency but external 
stimulation of this pathway alone is insufficient to maintain pluripotency in defined 
medium and it appears to act through a mechanism in which FGF acts as a 
competence factor (Vallier et al., 2005). The mechanisms by which FGF acts to 
maintain pluripotency also remain under investigation. In one study FGF was shown 
to act indirectly on HESC pluripotency by stimulating IGFII production in a subset 
of partially differentiated Oct4 negative HESC derived feeder cells that become 
established adjacent to Oct4 positive undifferentiated HESC cells as part of a 
regulatory niche that establishes itself in culture (Bendall et al., 2007). Other studies 
have demonstrated a more direct role of FGF in mediating pluripotency gene 
expression via MAPK and PI3K signalling pathways (Ding et al., 2010).  
 
Despite the inconvenience of MEFs co-culture, its reliability and relative cost 
efficiency has meant that it remains the most common method for deriving and 
sustaining HESC as well as IPSC. An increasing body of knowledge on how these 
pluripotency networks are regulated has in recent years facilitated the design of 
defined culture for HESC maintenance (Xiao et al., 2006, Chin et al., 2010). None of 
these systems entirely prevent spontaneous differentiation however and as a result 
cultures are heterogeneous, containing both undifferentiated and spontaneously 
differentiating cells (Narkilahti et al., 2007, Chin et al., 2010). Thus it remains 
common practice to continually observe HESC cultures and manually ‘weed out’ 
colonies with differentiated morphology (Loring et al., 2007). 
 
Prolonged undifferentiated proliferation:  HESC are often described as immortal due 
to their prolonged proliferative potential (Carpenter et al., 2003). HESC population 
doubling times are between 30-40 hrs (Amit et al., 2000) and pluripotent, 
karyotypically normal HESC have been maintained in culture for longer than one 
year or over one hundred and forty passages (Carpenter et al., 2003, Narva et al., 
2010). This property is key to their potential wide scale clinical value as it enables 
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scaled up cell production. Similar to other cell types with extensive replicative 
capacity (e.g. germ cells, tumour cells) telomerase activity is relatively high in HESC 
compared to somatic cells, as is the expression of its catalytic component hTERT 
(Amit et al., 2000, Lebkowski et al., 2001, Thomson et al., 1998). Telomerase 
reduces and stabilises the telomere shortening which contributes to senescence in 
somatic cells.  Upon differentiation, hTERT expression is down regulated as 
differentiated HESC derivatives become senescent (Lebkowski et al., 2001). In spite 
of their proliferative potential there is compelling evidence that HESC populations 
change over time in culture (Enver et al., 2005, Baker et al., 2007, Harrison et al., 
2007, Narva et al., 2010). Although the incidence of gross karyotypic re-
arrangements are not necessarily correlated with time in culture (Adewumi et al., 
2007, Brimble et al., 2004) more subtle epigenetic adaptations that favour survival 
and rapid growth are selected for over successive passages (Rossler et al., 2004, 
Enver et al., 2005). The extent to which these changes occur is not predictable and 
differences in passaging methods, seeding density, general exposure to stress and 
individual properties of the cell line may have an impact (Draper et al., 2004, 
Brimble et al., 2004, Baker et al., 2007). With increasing passage number changes in 
growth rates and a reduced tendency for early stage spontaneous differentiation have 
been reported (Enver et al., 2005, Herszfeld et al., 2006). The effects of such changes 
on long term differentiation yields are yet to be determined. 
 
1.4.2 Origins and characteristics of induced pluripotent stem cells 
 
In 2007 Yamanaka’s group and Jamie Thompson’s group showed that adult human 
fibroblasts could be successfully reprogrammed into an embryonic like state by the 
addition of four transcription factors (Takahashi et al., 2007, Yu et al., 2007). Since 
then a variety of functional and mature cell types have been differentiated from IPSC 
including RPE  (Meyer et al., 2009, Buchholz et al., 2009, Carr et al., 2009, Hirami 
et al., 2009).  IPSC have both advantages and disadvantages as a cell source over 
HESC. IPSC share the majority of the critical characteristics of HESC – they retain 
the ability to differentiate into all cell types over prolonged periods of time in culture, 
and yet do not require the destruction of a human embryo and can be derived from 
many kinds of somatic adult tissue. In this way IPSC circumvent the ethical concerns 
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and limited supply problems associated with HESC. IPSC technology theoretically 
enables the generation of patient specific, autologous cell lines for cell therapy, as 
well as providing a unique opportunity to study cellular phenotypes from patients 
with genetic disorders (Merkle et al., 2013). Some important questions about the 
differences between HESC and IPSC remain unanswered however. Although the 
work in this thesis is carried out in HESC, given the rising prominence of IPSC as an 
alternative source of retinal and RPE cells, some background on IPSC and the recent 
efforts to differentiate IPSC-RPE and to test their functional/ therapeutic equivalence 
have been included in this literature review. 
 
Derivation: Induced pluripotent stem cells were originally derived by ectopic 
expression of a combination of transcription factors OCT4, SOX2, KLF4 and C-
MYC by retroviral delivery first into mouse fibroblasts (Takahashi et al., 2006) and 
then into human fibroblasts (Takahashi et al., 2007) or OCT4, NANOG, SOX2 and 
LIN28 (Yu et al., 2007). IPSC have since been derived from adult human cell types 
as diverse as terminally differentiated lymphocytes (Loh et al., 2010) and post 
mitotic neurons (Kim et al., 2011), although dermal fibroblast obtained from skin 
biopsies remain the most common source. The choice of donor cell is important as 
some cell types such as blood (Ohmine et al., 2011) and urine (Zhou et al., 2012) are 
less invasive to sample, but may have poor reprogramming efficiencies due to their 
capacity for expansion in culture and/or differentiation status (Eminli et al., 2009). 
Currently the best quoted efficiencies of human somatic cell to IPSC conversion, 
using retroviral integration methods remains low at between 0.1-1% (Sommer et al., 
2013). The technology is advancing quickly however and efficiencies are improving 
due to new methods for gene delivery, the discovery of small molecules which 
enhance reprogramming efficiency (e.g. valporic acid, sodium butyrate) and in some 
cases transferral to hypoxic conditions (Warren et al., 2010).  Of particular interest 
for therapeutic application are non-integrative reprogramming methods that do not 
risk insertional mutagenesis or leaky transgene expression which can result in 
partially reprogrammed cells and/or enhanced tumorigenicity. Integration free 
methods including episomally maintained plasmids, adenoviral vectors, recombinant 
DNA, mRNA, and recombinant proteins have proven successful at generating human 
IPSC lines (reviewed in Stadtfeld et al., 2013) although conversion efficiencies are 
generally several orders of magnitude lower than with integrating methods (Sommer 
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et al., 2013). IPSC lines are also being derived in accordance with GMP regulations 
(Ohmine et al., 2011). 
 
Pluripotency, HESC equivalence: The first IPSC to be derived were found to be 
similar to HESC in terms of morphology, surface marker expression, methylation 
status in promoter regions associated with pluripotency and in-vitro differentiation 
(Takahashi et al., 2007, Yu et al. 2007). Similar to HESC it is not ethically feasible to 
test the pluripotency of human IPSC by implantation into embryos, however this 
experiment has been performed in mouse demonstrating the potency of 
reprogrammed cells. Injection of IPSC into tetraploid blastocycts has been shown to 
produced chimeric mice and in some cases ‘all-IPSC’ mice (Boland et al., 2009). 
IPSCs meet the most stringent criteria of HESC pluripotency in that they form 
teratomas containing derivatives of all three germ layers when injected into 
immunodeficient mice (Park et al., 2008). More detailed studies into the equivalence 
of HESC and IPSC have looked at global gene expression profiles and histone 
modificiation patterns and found a high degree of similarity between the two 
(Maherali et al., 2007, Mikkelsen et al., 2008).  Reported differences between the 
two cell types have included less efficient and more variable neuronal differentiation 
in IPSC (Hu et al., 2010a), premature senescence in IPSC derived cells (Feng et al., 
2010, Kokkinaki et al., 2011) and epigenetic memory of the cell type of origin in 
IPSC (Kim et al., 2010). One report found that IPSC deviate from ES in a recurrent 
gene expression signature (Chin et al., 2009). Despite these differences, a huge range 
of functionally mature cell types have been derived from IPSC.  
 
Prolonged undifferentiated proliferation: The formation of IPSC from mature 
somatic cells requires epigenetic re-programming which is triggered by the transient 
expression of the reprogramming transcription factors (Takahashi et al., 2007).  A 
recent study comparing the DNA methylation profiles of 22 IPSC lines over long 
term culture found that continuous passaging reduced the differences between IPSC 
lines, with multiple appearances and disappearances of hyper-methylation throughout 
the reprogramming process (Nishino et al., 2011).  This is thought to reflect a process 
of cell lines losing the characteristics derived from their parental cell type and 
adapting a more embryonic like character. Reprogramming of somatic cells induces 
telomere length extension and a reactivation of the enzymatic complex telomerase 
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(Takahashi et al., 2007, Park et al., 2008). Thus reprogrammed cells from donors of 
any age do not undergo replicative senescence. Whether or not these cells undergo 
the same process of culture adaptation seen in HESC remains an open question.  The 
identical culturing practices used to maintain IPSC and HESC would suggest that a 
similar phenomenon is likely to occur. 
 
 
1.4.3 Embryonic retinal development is mimicked in HESC and IPSC 
Spontaneous differentiation into RPE appears to occur reliably in the majority of 
HESC and, more recently, IPSC lines in standard culture conditions (MEFs, DMEM, 
20% KOSR) without the requirement of exogenous growth factors (Odorico et al., 
2001, Klimanskaya et al., 2004, Lund et al., 2006, Vugler et al., 2008, Buchholz et 
al., 2009, Hu et al., 2010, Vaajassari 2011 – see table 1.1). It is generally assumed 
that the differentiation of HESC into RPE and other retinal phenotypes faithfully 
mimics the well defined and evolutionarily conserved development program that 
occurs during human retinogenesis (Vugler et al., 2007). This assertion is based on 
three lines of evidence in the case of RPE differentiation: 1. the coordinated 
sequence of gene/protein expression and timing of pigmentation, 2. stage specific 
responses of differentiating HESC to exogenous growth factors and 3. in vitro 
observations of structural aspects of optic vesicle morphogenesis in HESC. The 
melanocytes that make up the retinal pigment epithelium (RPE) have a distinct 
developmental origin to those which are found in the iris, choroid, inner ear and skin 
(Nakayama et al., 1997). The RPE cells are uniquely derived from anterior neural 
plate (Bharti et al., 2006) whereas the other pigmented cells are neural crest derived. 
Thus the epithelial melanocytes (RPE) derived from long term HESC culture differ 
from other pigmented cells not only in their terminal morphology and marker 
expression, but in the developmental stages through which they progress (Fig.1.3) 
  
Figure 1.3 Embryonic retinal development is mimicked in HESC. Pigmented RPE emerging in 
HESC culture have been shown to undergo the same developmental stages seen in vivo. Pluripotent 
HESC differentiate into derivatives of all three germ layers but under the right conditions a significant 
proportion adopt an anterior neuroectodermal fate. Some of these cells adopt eye field and 
subsequently a pigmented, RPE phenotype (boxes).  Directed differentiation with appropriately timed 
external cues can also yield Sox10 and Pax3 positive melanocytes. derived from a neural crest 
progenitor type cell (chambers et al., 2009), (TF= transcription factor). 
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Coordinated sequence of gene/protein expression: Using a non-interventionist 
approach Meyer et al., demonstrated the step wise differentiation of the H9 cell line 
toward RPE and early retinal progenitors in minimal media (Meyer et al., 2009).  
Time course experiments revealed a steady increase in Pax6 and Rx gene expression 
from day 3 and 5 of differentiation respectively, accompanied by a steady increase in 
the abundance of cells immunopositive for these markers. The expression of other 
eye field transcription factors (Six3, Six6, Lhx2) was first detectable from days 6-10. 
Importantly these markers are not detected in undifferentiated HESC from days 0-4 
post seeding. In longer time course experiments MitF expression was found to peak 
at day 37 and Chx10 expression later at day 60 in line with the sequence of these 
events in vivo (Nguyen et al., 2000). Endogenous expression of BMP and Wnt 
antagonists Noggin and DKK1 has also been show to increase during early 
differentiation (Meyer et al., 2009) and Shh and Nodal expression to increase from 
day 45 onwards (Mellough et al., 2013).  
 
There is considerable variation in the reported timings of pigmentation appearance 
during spontaneous differentiation ranging from 40-60 days (Meyer et al., 2011, 
Rowland et al., 2012) to 10-17 days (Vaajassari  et al., 2011) (See table 1.1 for 
timings of all HESC-RPE differentiation protocols published to date). This is likely 
due to differences in differentiation propensity between cell lines as well as methods 
for pigmented cell detection.  A crude assessment of the published timings (table 1.1) 
yields a median time to pigmentation of 28 days ± 12 STDEV (N=35) post cell 
seeding. Pigmentation of the prospective RPE occurs in humans at post ovulatory 
weeks five to six (days 35-42) and given that HESC are derived from post 
implantation embryos at day 5-7, the average timing of HESC-RPE emergence falls 
within the shorter end of the predicted range.  A number of protocols employ a cell 
expansion step in HESC maintenance media during which supposedly 
undifferentiated HESC proliferation occurs (Vugler et al., 2008, Buchholz et al., 
2009, Maruottie et al., 2013) this is often 7-10 days in length. In such cases the 
spontaneous differentiation of pluripotent cells to pigmented RPE cells occurs more 
rapidly than in vivo (~18 days).   A very recent study has reported the derivation of 
Pmel17 positive, pigmented RPE in a significantly shorter time period (2 weeks post 
seeding) by inducing differentiation with several growth factors and small molecules 
(Buchholz et al., 2013). 
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Responses to exogenous growth factors: Early addition of BMP4 and Wnt3a to the 
culture medium prevents the formation of Pax6 and Rx positive neural rosettes 
(Meyer et al., 2009) affirming the role of inhibition of these pathways in the in vitro 
equivalent of anterior neural plate formation (Villanueva et al., 2002, Wilson et al. 
2004). Similarly IGF1, which is secreted by MEFs (Bendall et al., 2009) and is 
present in Matrigel and N2/B27 supplement (www.bdbioscences.com), has been 
shown to be critical to Pax6, Rx and Otx2 expression during early HESC 
differentiation, and its pharmacological inhibition prevents the formation of stratified 
retinal neuroepithelium during spontaneous differentiation (Zhu et al., 2012). This is 
in line with the role of IGF1 in inducing Otx2 expression during specification of the 
anterior neural plate and eye field (Pera et al., 2001). In another example, the 
addition of small molecule Wnt agonist CHIR99021 at a later time point in the 
differentiation (days 18-21) significantly enhances the formation of RPE cells 
(Nakano et al., 2012), in agreement with the key role of Wnt/βcatenin (in 
combination with Otx2) in driving MitF expression at the optic vesicle/early optic 
cup stage in vivo (Westenskow et al., 2010).   Finally activin A/TGFβ has been 
shown to stimulate RPE differentiation when added from day 14 onwards (Idelson et 
al., 2009, Meyer et al., 2011) as seen in chick optic explants (Furhmann et al., 2000).  
 
Structural aspect of eye morphogenesis: Recently the spontaneous emergence of 
optic vesicle like structures in HESC differentiating as floating aggregates has been 
described (Nakano et al., 2012). Using an Rx::Venus HESC reporter line, the 
formation Rx expressing hollow bulbs was shown following early treatment of 
HESC aggregates with a Wnt inhibitor. These bulbs developed into Chx10 +ve 
neural retinal epithelium. Subsequent addition of a Wnt agonist induced the 
formation of thin MitF expressing epithelium next to the Chx10 positive cells.  The 
Chx10, MitF expressing bulbs then spontaneously invaginated to form a double 
walled optic cup structure 550µM in diameter in which pigmented RPE and stratified 
layers of the neural retina could be clearly identified within 24 days of differentiation 
(Nakano et al., 2012). The size of the optic cup structure is similar to observations in 
human foetal eye development, and the time taken is only a few days shorter 
(O’Rahilly et al., 1999). Similar experiments in mouse embryonic stem cells 
generated a significantly smaller optic cup (~280µM) in a shorter time (9 days) as 
predicted by observation in mouse foetal development (Nguyen et al., 2000). 
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1.4.3 Characterisation of HESC and IPSC derived RPE 
 
Pigmentation and distinctive cobblestone morphology enables the identification of 
HESC-RPE among a background of other cell types in culture.  Given that HESC are 
theoretically capable of producing any cell type including other pigmented cells such 
as melanocytes, it is necessary to employ assays that eliminate the possibility that the 
cells have other identities.  A number of assays have been developed in order to test 
the functionality of HESC derived RPE. An important point for investigation has 
been to establish the equivalent developmental stage which HESC derived RPE most 
closely resemble.  
 
Gene expression: HESC-RPE expression profiles have been characterised 
extensively, they express known RPE transcription factors (Otx2, MitF), genes 
involved in pigment synthesis (Tyrosinase, Pmel17, Tyrp1/2), the visual cycle 
(CRALBP, RPE65, LRAT), membrane associated protiens (Bestrophin, EMMPRIN) 
as well as early eye field genes (Pax6, Rx, Six3) (Vugler et al., 2008, Meyer et al., 
2009, Buchholz et al., 2009, Vaajasaari et al., 2010). Global gene expression analysis 
has demonstrated the similarity between HESC derived RPE and foetal RPE 
(Klimanskaya et al., 2004, Liao et al., 2010). HESC-RPE were found to be more 
similar to foetal RPE than to the spontaneously immortalised cell line ARPE19.  This 
is in line with observations that ARPE19 cell lines tend to lose expression of critical 
functional genes such as RPE65, Bestrophin, CRALBP and PEDF over time in 
culture (Alge et al., 2003). 
 
Newly differentiated HESC-RPE are thought to be in a developmentally immature 
state. This has implications in terms of the expansion capacity of the HESC derived 
RPE. The immature status may also be advantageous in terms of their ability to 
integrate into the degenerating retina; the fundamental importance of controlling the 
developmental staging of ES derived retinal cells for successful integration has been 
shown in the degenerating mouse retina (Maclaren et al., 2006, Lamba et al., 2009). 
Observations that HESC-RPE express early developmental markers in addition to 
mature markers suggests some heterogeneity within these populations (Liao et al., 
2010). 
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Protein Expression: Shef1 derived HESC-RPE cells stain positively for important 
RPE proteins involved in the visual cycle  (CRALBP), membrane associated channel 
proteins (Bestrophin), RPE transcription factors (MitF, Otx2), pigment synthesis 
(Pmel17),  tight junction protiens (ZO1, Occludin and Claudin-1) and polarised ion 
transporters (Na+/K+ ATPase) (Vugler et al., 2008). A number of these markers 
have since been found in HESC-RPE and IPSC-RPE derived from other cell lines 
(Ideslon et al., 2009; Meyer et al., 2009; Buchholz et al.,2009; Vjasaari et al., 2010; 
Kokinakki et al. 2011). The expression of RPE65 protein by HESC-RPE has also 
been verified by immunohistochemistry and western blot, a protein is usually 
undetectable in ARPE19 (Vugler et al., 2008, Alge et al., 2003).  
 
Morphological features: In vivo RPE form a highly polarised monolayer.  Electron 
micrographs of RPE expanding on Matrigel clearly show the presence of polarised 
features such as apical microvilli and basal nuclei (Vugler et al., 2008, Idelson et al. 
2009).  Mature HESC-RPE feature a basally located nucleus, tight junctions and 
apically distributed melanosomes with the morphologies indicative of the various 
stages of melanogenesis (Vugler et al., 2008, Carr et al., 2009, Zhu et al., 2013).   
 
Growth factor secretion:  When cultured on transwell plates ESC and IPSC derived 
RPE demonstrate polarised growth factor secretion as seen in vivo (Maminishkis et 
al., 2006).  A range of growth factors are secreted by HESC-RPE including VEGF, 
PEDF, BDNF and TGFβ (Sugino et al., 2011). Media samples taken from the upper 
and lower reservoirs of HESC-RPE seeded on transwell plates show that VEGF is 
mainly secreted on the basal side, and PEDF mainly on the apical side as seen in vivo 
in healthy RPE (Kokkinaki et al. 2011; Vjasaari et al., 2011).  The secretion of 
specific growth factors may be critical to the therapeutic benefit of cells transplanted 
into the ocular environment (Lawerence et al., 2000) and it has been shown that the 
levels of secretion correlate with the degree of RPE differentiation in cultured human 
RPE cells with more mature RPE secreting larger quantities (Ohno-Matsui et al., 
2001). 
 
Phagocytosis: As detailed in section 1.2.1, an important function of RPE in the retina 
is to phagocytose rod and cone outer segments. In an attempt to demonstrate this 
capacity several groups have used a latex bead assay, in which the ability of the cells 
48 
to internalise fluorescently labelled latex beads is demonstrated (Klimanskaya et al., 
2004; Idelson et al., 2009, Osakada et al., 2008). Carr et al. have subsequently 
demonstrated the full functionality of Shef1 derived RPE by showing their ability to 
phagocytose fluorescently labelled outer segments from porcine eyes. The latter is 
more relevant as defective RPE are not able to phagocytose photoreceptor outer 
segments but can ingest inert polystyrene/latex beads (Carr et al., 2009b). 
 
Attachment and survival assays: Attachment and survival of the HESC-RPE cells in 
the ocular environment will be critical to their function in transplantation therapies.  
Transplantation strategies differ with some favouring direct injection of a cell 
suspension into the sub-retinal space (Lu et al., 2009, Schwartz et al., 2012) and 
others seeding cells onto an artificial substrate generating a differentiated RPE 
monolayer prior to transplantation (Hu et al., 2012 (c), Kearns et al., 2012, Subrizi et 
al., 2012 – see section 1.5.2-1.5.3). In the former strategy, characterising the ability 
of the cells to attach and survive in the ocular environment is critical. Sugino et al. 
compared the ability of HESC-RPE with different degrees of pigmentation to attach 
and survive on aged human Bruch’s membranes. It was found that more pigmented 
and differentiated HESC-RPE (5 or 10-11 weeks in culture) had improved survival 
over 21 days relative to less pigmented HESC-RPE (1 week in culture) (Sugino et 
al., 2011). Conversely, another study determined that less pigmented HESC-RPE had 
improved survival on gelatine relative to heavily pigmented differentiated cells 
(Schwartz et al., 2012). 
 
IPSC-HESC RPE equivalence:  Several induced pluripotent stem cell lines have been 
successfully differentiated into RPE cells (Meyer et al., 2009, Buchholz et al., 2009, 
Hu et al., 2010, Carr et al., 2009, Kokkinaki et al., 2011 – see table 1.1).  
Differentiating IPSC generate RPE foci within the typical time frames and 
efficiencies that have been described in HESC (see table 1.1). Significant variability 
in RPE yields are seen between IPSC lines with one study implicating the 
reprogrammed cell of origin, and the ‘epigenetic memory’ of the cells in the relative 
differentiation efficiency (Hu et al., 2010). In the most extensive study of gene 
expression profiles to date, purified, first passage IPSC-RPE have been shown to 
have equivalent expression of 59/89 signature genes (Strunnikova et al., 2010) 
compared to native RPE by QPCR (Kokkinaki et al., 2011).  RPE derived from the 
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fibroblast IPSC line IMR90, adopt the polarised morphological characteristics typical 
of native and HESC-RPE including apical mircovilli, basal nuclei, melanosomes, 
basal lamina and adherens junctions (Carr et al., 2009) as well as expressing 
appropriately localised proteins such as collagen IV  and Na+/K+ ATPase ATP1B1 
and RPE proteins MitF, Otx2, Bestrophin, CRALBP and RPE65 (Buchholz et al., 
2009, Carr et al., 2009). In another study, IPSC-RPE were shown to have equivalent 
polarised growth factor secretion, ion transport and membrane potential to an adult 
human retina. These differentiated RPE were also shown to have rapid telomere 
shortening and DNA chromosomal damage which may have implications for their 
expansion capacity and survival post transplantation, this property therefore warrants 
further investigation (Kokkinaki et al., 2011).  The ability of IPSC-RPE to 
phagocytose fluorescently labelled bovine and porcine photoreceptor outer segments 
was found to be equivalent to  HESC-RPE and foetal-RPE (Buchholz et al., 2009, 
Carr et al., 2009). 
 
 
1.4.3 Directed differentiation strategies 
 
In addition to spontaneous differentiation strategies, commonly used cell lines such 
as H7 and H9 (Thomson et all., 1998) as well as others, have been used in a variety 
of so called ‘directed’ retinal differentiation protocols that often aim to mimic the 
developmental cues that direct eye development in vivo (see section 1.2.2) by the 
addition of growth factors.  In spite of the huge range of methods and reported yields, 
pigmented cells possessing the typical RPE characteristics described in the previous 
section are consistently derived.  
 
These ‘directed’ strategies employ a range of media formulations including growth 
factors and small molecules in attempts to enhance differentiation yields, reduce the 
time required to generate the required cell, encourage differentiation into more 
mature retinal cell types and/or to investigate the synergies with human eye 
development (section 1.2.2). The number of distinct methods has risen rapidly over 
the last 4 years since the start of this project, the basic methodologies and findings 
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are summarised in table 1.1. Here we will discuss in general terms the relative 
success of these differentiation strategies. 
 
Growth factors and small molecules that are known to enhance early neural 
specification and specify the anterior neural fate in vivo by interfering with major 
signalling pathways have been used extensively at the early stages of HESC 
differentiation protocols. These have included Wnt antagonists (DKK1, CKI7),  
Nodal antagonists (LeftyA, SB431542) and BMP antagonists (Noggin) as well as 
Insulin growth factor (IGF) which is thought to specify anterior neural specification 
(see section 1.2.2). Growth factors DKK1, LeftyA and IGF reportedly increase MitF 
positive cell yields by 3-5 fold following embryoid body differentiation (Osakada et 
al., 2008). Their small molecule equivalents (CK17, S431542) have comparable 
efficacy at a significantly reduced cost (Osakada et al., 2009).  
 
N2 and B-27 supplements are also common to many of the protocols listed in table 
1.1. These supplements contain high concentrations of insulin and have been shown 
to promote neuralization as well as enhancing neural progenitor proliferation 
(Schuldiner  et al., 2000). Mellough et al., found the retinal differentiation promoting 
effect of these supplements was significantly greater than that of the recombinant 
growth factors DKK1, LeftyA, IGF1 (Mellough et al., 2013).  
 
Nicotinamide (NIC) is an example of a small molecule shown to robustly enhance 
RPE yield without directly interfering with RPE specification pathways (Idelson et 
al., 2009). Idelson et al., found that 10mM NIC added to standard culture medium 
(14% KOSR, -bFGF) enhanced the number of embryoid bodies containing 
pigmented cells between 2 and 5.6 fold, dependent on the cell line.   This study 
concluded that the mechanism of Nicotinamide’s RPE promoting action was by 
reducing apoptosis in cells differentiating towards the neuroectoderm lineage. Large 
scale transcriptional analysis found that NIC specifically enhanced the expression of 
genes involved in anterior neural specification as apposed to midbrain or caudal 
markers (Idelson et al., 2009). 
 
At later time points, factors that interfere with neural-retina vs. RPE fate decision at 
the optic vesicle/optic cup stage are frequently added in an effort to enhance RPE 
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differentiation.  In the study described above, NIC treated cells are further treated 
with TGFβ superfamily growth factors including activin A and TGFβ (Idelson et al., 
2009). When added to standard medium between weeks 3-4 activin A enhanced 
pigmentation in three cell lines (3- 5 fold increase relative to NIC only). Activin A 
has been shown to improve RPE yields in optic vesicle like structures (Meyer et al.,. 
2011, Zhu et al.. 2013), although in other cell lines it has been reported it to have 
little effect on pigmentation or RPE gene expression (Buchholz et al., 2013, Zhu et 
al., 2013), and thus the wide-scale efficacy of activin A in differentiating HESC 
remains somewhat controversial. As discussed in section 1.2.2, FGF signalling 
emanating from the surface ectoderm during optic cup formation down regulates 
MitF and enhances Chx10 expression thereby specifying neural retinal fate 
(Fuhrmann et al., 2000). The addition of the FGF inhibitor SU5402 from days 16-40 
have been shown to increase MitF expression ~12 fold (Meyer et al., 2009).    Aside 
from the TGFβ/FGF signalling pathways, Wnt agonists (days 18-21, Nakano et al., 
2012) and Shh agonists (days 15-18, Nakano et al., 2012, days 18-30 Zahabi et al., 
2012) have been used to induce pigmentation as well as a small molecule vasoactive 
intestinal peptide (VIP) (days 6-10, Buchholz et al., 2012) which has been shown to 
speed up the maturation of cultured primary RPE (Koh et al., 2000). 
 
Apart from the addition or removal of growth factors innovative strategies have been 
devised to purify cells predicted to be destined to undergo retinal/RPE 
differentiation. Meyer et al., generated aggregates from neuroepithelial rosettes and 
were able to identify and manually isolate ‘optic-vesicle like’ aggregates (~20%) 
from a mixed population by virtue of their unique morphology (phase bright ‘outer 
mantel’ of cells) (Meyer et al., 2011). Interestingly these optic vesicle like aggregates 
adopted a Chx10 positive neural retinal identity by default; the addition of activin A 
from days 20-40 induced pigmentation in some of these aggregates. 
 
Many HESC-RPE/retinal differentiation protocols employ an embryoid body (EB) 
stage in which cells are cultured in suspension for time periods ranging from 7 to 56 
days.  Protocols for the generation of RPE most commonly feature a subsequent 
adherent stage where EBs are plated onto various substrates including Laminin, 
Matrigel, Poly D lysine/laminin/Fibronectin and defined substrates such as 
Synthemax.  Rowland et al., have shown that the choice of substrate is critical to 
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RPE differentiation and maturation with Matrigel and mouse laminin supporting the 
highest levels of pigmentation (Rowland et al., 2012). 
 
A commonly cited problem with EB based methods are the losses incurred during the 
aggregate formation stage (Dang et al., 2002,), this is thought to lead to reduced 
overall efficiency (Vugler et al., 2008), though to our knowledge this has not been 
systematically investigated. The tightly connected epithelial cells that form on the 
surface of EBs presents a limitation to the transfer of growth factors and small 
molecules generating a gradient of concentrations that causes heterogeneous cell 
populations (Van winkle et al., 2012). It is also a challenge to derive EBs of equal 
size, a parameter which affects early lineage specification (Bauwens et al., 2008, 
Bratt-Leal et al., 2009). Innovative methods to control EB sizes, such as forced 
aggregation of single cells in defined numbers using AggrewellTM plates 
(STEMCELL Technologies) have recently been developed. In addition to these 
problems it is challenging to monitor differentiating cell morphology and to quantify 
relative RPE yields in EBs; % pigmented aggregates is often cited (Idelson et al., 
2009, Vaajasaari et al., 2011) a parameter which gives no indication as to the number 
of pigmented cells per aggregate.  The lack of reliable methods for quantifying 
pigmented cell yields have led to a variety of parameters being used to assess relative 
yields; % MitF positive cells, % pigmented colonies, % PMEL17 positive cells and 
quantitative PCR for RPE genes are the most commonly used. 
 
Aside from the protocols that rely of spontaneous differentiation on MEFs, relatively 
few methods have been published using directed, continuous adherent differentiation 
(Rowland et al., 2012). Zahabi et al., achieved high yields (40% RPE65 positive) 
from HESC and IPSCs in feeder-free adherent differentiation using inhibition of 
BMP signalling (Noggin) and subsequent treatment with retinoic acid and Shh 
(Zahabi et al., 2011).  Two additional very recently published studies have used 
continuous adherent differentiation as an alternative to EB based methods (Maruottie 
et al, 2013, Buchholz et al., 2013), with the latter employing directed differentiation 
strategies involving Noggin, DKK1, IGF1, NIC, activin A and VIP and the former 
relying on spontaneous differentiation but in feeder-free conditions. 
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In summary an ever increasing number of HESC-RPE differentiation strategies are 
being published using a large number of HESC and IPSC cell lines.  Their ability to 
generate morphologically indistinguishable pigmented RPE cells underlines the 
robustness of this spontaneous phenomenon.  Despite the many complex 
differentiation strategies, protocols employing neuroectodermal cell survival factors 
such as NIC, N2 and B27 may be the most efficacious at improving over all yields.  
The large variability in timings and methods used to assess relative yields, the 
absence of quoted yields in untreated controls and the varying responses between cell 
lines makes it challenging to compare protocols and determine which strategy is the 
most effective. From a bioprocessing perspective, it will be important to consider not 
only the yield but the efficiency, cost, reproducibility and scalability of 
differentiation strategies. 
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1.5  Clinical  trials in  HESC/IPSC-RPE therapy for AMD 
 
Given the unlimited expansion capacity of the HESC and the superior functional 
properties of HESC-RPE, these cells are a promising source for wide scale cell 
therapy. Their efficacy has been tested extensively in the RCS rat and a 
safety/tolerability trial is currently underway in patients with dry AMD and Stargardt 
disease (Schwartz et al., 2012).  HESC are a biologically complex source for a 
therapeutic and their potential tumorigenicity is a concern to regulatory bodies (Blum 
et al., 2008). One HESC derived therapy consisting of Oligodendricyte progenitor 
cells for the treatment of spinal cord injury was granted clinical approval in 2011 
with five patients enrolled in a 15 year clinical trial carried out by Geron Corp 
(Menlo Park CA, USA). This trial is currently on hold however due to financial 
restrictions from the parent company. Thus in spite of significant pre-clinical 
evidence it was not until 2012 that HESC derived RPE were first injected into 
patients in a trial operated by Advanced Cell Technologies (ACT). Here we will 
review the published pre-clinical evidence for efficacy and early reports from phase I 
trials by ACT as well as upcoming trials by the London Project to Cure Blindness, 
the Riken institute, Japan and the California project to cure blindness. 
 
1.5.1 HESC/IPSC-RPE in AMD animal models 
 
The ability of the HESC derived RPE to rescue visual function has been tested by 
several groups in the RCS rat (Lund et al., 2006, Vugler et al., 2008, Lu et al., 2009, 
Idelson et al., 2009,  Zhu et al., 2013).  In the first demonstration of HESC-RPE 
transplantation, batches of 2x104 cells HESC-RPE cells were injected per rat eye. 
The cells were injected into the sub-retinal space at post-natal day 21 when 
photoreceptor degeneration was yet to develop. Photoreceptor rescue was 
demonstrated by improvements in electro-retinography, head tracking experiments 
and luminance threshold recordings relative to sham injected controls (Lund et al., 
2006).  These results have since been repeated using a range of dosages (5K-
100K/eye) and pigmentation levels (Lu et al., 2009). Injected HESC-RPE have been 
shown to maintain pigmentation and expression of RPE specific markers (CRALBP, 
RPE65, Vimentin, Bestrophin) up to 19 weeks post transplantation  (Vugler et al., 
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2008, Idelson et al., 2009). Transplanted HESC-RPE successfully phagocytose 
Rhodopsin positive debris in the RCS rat retina, confirming their functionality 
beyond growth factor secretion (Vugler et al., 2008, Idelson et al., 2009).  In all 
studies, preservation of the photoreceptors outer nuclear layer adjacent to the HESC-
RPE graft was seen (up to 19 weeks) and no reported evidence of tumour formation 
has been found (Lund et al., 2006, Vugler et al., 2008, Idelson et al., 2009).  
 
 
1.5.2 ACT clinical trial 
 
ACT (Malborough, MA, USA) are in the process of carrying out an early stage 
clinical trial using HESC-RPE to treat dry AMD and Stargardt disease 
(Clinicaltrials.gov numbers NCT01345006, NCT01344993).  At the time of writing, 
12 patients with Stargardt disease and 6 patients with dry AMD have had HESC-RPE 
transplanted, a preliminary report published 4 months post implantation, details the 
surgical procedure (Schwartz et al., 2012). Fifty thousand viable RPE cells 
suspended in a 150µL of balanced salt solution were injected into in the subretinal 
space in a specific site in the pericentral macular in two patients. Prior to 
transplantation, batches of RPE cells were assessed according to their overall 
melanin content and ability to attach to gelatine coated plates following extrusion 
through the injection cannula to be used in surgery. It was found that lightly 
pigmented RPE were better able to survive and attach to the surface following 
extrusion and thus lightly pigmented cells were chosen for transplantation. No 
abnormal growth or hyper-proliferation has thus far been observed, there were no 
surgical complications, injected RPE cells were not found outside of the subretinal 
space and no signs of inflammation have been detected.  It is too early to determine 
whether or not the cells will affect any clinical benefit, as the reported improvement 
in visual acuity was within the repeatability limits of the visual acuity test used 
(Huang et al.,  2012). 
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1.5.3 Upcoming clinical trials 
 
Injection of cell suspensions has thus far been the most commonly used method to 
administer HESC-RPE into the subretinal space in animal models (Lund et al., 2006, 
Vugler et al., 2008, Lu et al., 2009, Schwartz et al., 2012). This technique, whilst 
convenient, can result in the formation of isolated cell clumps which fail to form a 
polarised monolayer and do no function as normal RPE. An alternative approach 
involves seeding RPE cells on a transplantable scaffold, allowing them to form a 
polarised monolayer prior to administration (Hu et al., 2012). This approach has 
several potential advantages in terms of cell survival and functionality and may act as 
a replacement to the damaged Bruch’s membrane (Ramsden et al., 2013).  However 
the transplantation of polarised patches is a more complicated surgical procedure 
than injection of a cell suspension and requires the use of specially developed tools 
(Gosh et al., 2002, Thumann et al., 2006, Stanzel et al., 2012).  A clinical trial 
application submitted by the London Project to Cure Blindness 
(www.thelondonproject.org), using Shef1 derived HESC-RPE cultured on a 3mm by 
6mm polyester membrane has been submitted to the UK medicines and Healthcare 
Regulatory Agency for approval (Carr et al., 2013). 
 
The California project to cure blindness, currently in the pre-clinical stage, plans to 
use a similar strategy of transplanting sheets of HESC-RPE, this time derived from 
the H9 HESC line on a vitronectin coated parylene substrate.  IPSC derived RPE are 
also being developed into a trial therapy for dry AMD. The project is being carried 
out at the RIKEN Centre for Developmental Biology in Kobe, Japan and is expected 
to gain approval to begin clinical trials in the near future.   
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1.6 Summary  
 
Age-Related Macular degeneration is the most common form of blindness in the 
western world and yet there are precious few treatment options for those afflicted.  
The disease is caused by an age associated break down of the retinal pigment 
epithelium in the macular region of the retina which may be brought about by 
chronic, low grade inflammation. Replacing these cells with healthy cells from the 
periphery or other allogeneic sources has proven to be an effective treatment 
however the extreme technical complexity of autologous patch graft translocation 
means there is a high complication rate and the surgery could not at present be a 
routine treatment option. 
 
With the advent of human embryonic stem cells a potentially unlimited source of 
highly functional retinal pigment epithelium cells has become available making the 
wide spread production of allogeneic ‘off the shelf’ RPE patches for transplantation a 
possibility.   
 
RPE cells form in confluent HESC culture with minimal intervention.  Since the 
beginning of this project there has been a rapid increase in the number of reports of 
new methods for deriving RPE, these have been comprehensively reviewed in table 
1.1. The methods range from straight forward spontaneous differentiation protocols 
to complex sequences of growth factor and small molecule additions and 
withdrawals. In addition many methods include steps to mechanically isolate cells 
with favourable morphologies..  
 
There are major challenges in garnering widely applicable outcomes from these 
studies; clearly there are major differences in the behaviour of cell lines – potentially 
due to genetic makeup, or the methods used to isolate the inner cell mass and 
establish lines.  There are also major differences within cell lines which are cultured 
in different laboratories. It has been suggested that this may result from individual 
passaging techniques and culturing practices (feeding regimes, passaging frequency, 
colony dissection) and in the MEFs feeder cells on which they are grown. Thus in 
addition to improving differentiation efficiency, a major goal of this thesis will be to 
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establish and characterise a differentiation protocol that minimizes these obvious 
sources of variability, with a view to improving reproducibility. 
 
Clinical trials utilizing HESC-RPE commenced last year, and more centres are 
scheduled to begin their own trials in 2013. Currently the process for generating RPE 
by spontaneous differentiation is robust within certain cell lines but also highly 
inefficient.  HESC are amongst the most complex biological entities to be proposed 
as a source of a therapeutic. The wide spread clinical application of HESC derived 
therapies will depend not only on the of efficacy of the eventual therapy but also on 
the economic feasibility of said product and the efficiency of the manufacturing 
process is likely to be a major cost determinant.
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Reference Cell Line Timing of 
Pigmentation 
(days) 
Expansion/differ
entiation 
media/Substrate 
Cell 
Seeding 
Density 
‘Treatment’  RPE yield 
before 
treatment 
RPE yield 
after 
treatment 
Purpose 
Odorico et al., 
2001 
H9  EBs (8-14 days) 
Gelatin 
    Multilineage 
differentiation 
Kawasaki et al., 
2002 
Primate ES 
(CMK 6,9) 
21 days Collagen  SDIA (surface molecule 
derived from PA6)  
None 8 ± 4% of 
colonies 
Accidental RPE 
MEFs 
(7-10 days)  
 Klimanskaya et 
al., 2004 
H1,H7, H9,  
MA01,3,4,9,14,40,J1 
42-56 days 
EBs 
 -bFGF, -LIF (day 7-10) 
 
 
<1% EBs 
Transciptional 
comparison to 
RPE 
MEFs 
 
 Lund et al., 
2006 
H1,H7, H9,  
MA01,3,4,9,14,40,J1 
42-56 days 
EBs 
   
<1% EBs 
Multiple lines 
made for HLA 
match 
Vugler et al., 
2008 
Shef1, Shef7 17-24 days MEFs  -bFGF 
10 days confluent 
  Ontogenesis 
Day 13 Pax6 +ve neural 
progenitors on:  
 
 
Matrigel 
None None 
Laminin None None 
Gong et al., 
2008 
 17-28 days PA6 cells 
  
2000/cm2 
Human Bruch’s None Best + 
CRALBP 
expression 
Bruch’s 
membrane 
facilitates  RPE 
differentiation 
ES (Monkey) 
 
 
10% MitF 
+ve 
colonies 
55% MitF 
+ve colonies 
Osakada et al., 
2008 
KhES1  
60 days SFEB (21 days) 
Poly D 
lysine/laminin/ 
Fibronectin 
 Days 0-21 DKK1  (Wnt 
inhibitor) 100ng/.ml 
LeftyA (Nodal inhibitor) 
500ng/ml  37% MitF 
+ve colonies 
Generate 
photoreceptors 
from HESC 
KhES1 
235G1, 201B7 (IPSC) 
8% MitF 
+ve 
colonies 
28-32% 
MitF +ve 
pigmented 
colonies 
Osakada et al., 
2009 
201B6 (IPSC) 
40 days SFEB (21 days) 
 
Poly D 
lysine/laminin/ 
fibronectin 
880 
clumps/
ml  
 
Days 0-25 
CKI7 (Wnt inhibitor) 5µM  
SB 431542 (Nodal 
inhibitor )5µM. 
None None 
Using small 
moleules in place 
of growth factors 
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Reference Cell Line Timing of 
Pigmentation 
(days) 
Expansion/differ
entiation 
media/Substrate 
Cell 
Seeding 
Density 
‘Treatment’  RPE yield 
before 
treatment 
RPE yield 
after 
treatment 
Purpose 
Lu et al., 2009 H1 
H9 
- EBs (7 days) 
Gelatine 
MDKB serum 
free media + 1x  
B-27 
    cGMP 
manufacture 
  25% MitF 
Cells 
 
Meyer et al., 
2009 
H9 
IMR90 (IPSC) 
30 days EBs (6 days) 
Laminin +  
 
1% B-27, 1% N2, 
2 µg/ml Heparin  
2%B-27 (Days 4-
6) 
 
SU5402 (FGF inhibitor) 
(day s 16-40)   
 
1 fold MitF 
mRNA 
11.8 Fold 
MitF mRNA 
Modelling retinal 
development 
iPS (foreskin)-1 (IPSC) 
iPS (foreskin)-2 (IPSC) 
21-28 days 
IMR90-3 (IPSC) 
IMR90-4 (IPSC) 
20-35 days 
MEFs  or 
Matrigel 
+100ng/ml 
bFGF (7-10 
days) 
Buchholz et al., 
2009 
H9  20-35 days HFFs (7-10 
days) 
    Functional RPE 
from IPSC 
201B7 (IPSC) 
253G1 (IPSC) 
 
39% 
Pigmented 
colonies 
Hirami et al., 
2009 
201B6 (IPSC) 
40 days SFEB (21 days) 
Poly D 
lysine/laminin/ 
fibronectin 
 DKK1  (Wnt inhibitor) 
100ng/.ml 
LeftyA (Nodal inhibitor) 
500ng/ml (days 0-21) 
 
None 
Retinal cells from 
IPSC 
HES1 
 
28 days 0%EBs 
pigmented  
10% EBs 
pigmented 
(6% of each 
EB) 
HES4 10%  35% of EBs 
H7 
10mM Nicotinamide 
(vitamin B)day 0 -28  
3%  6%  of EBs 
HES1 18% 55% of EBs 
HES4 35% 60% of EBs 
Idelson et al., 
2009 
H7 
28-35 days 
EBs, 14% KOSR 
 
 
10mM Nicotinamide + 
100ng/ml Activin A (days 
14-28) 6% 32% of EBs 
Directed 
differentiation 
with 
Nicotinamide and 
TGFβ 
superfamily 
members  
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Reference Cell Line Timing of 
Pigmentation 
(days) 
Expansion/differ
entiation 
media/Substrate 
Cell 
Seeding 
Density 
‘Treatment’  RPE yield 
before 
treatment 
RPE yield 
after 
treatment 
Purpose 
Carr et al., 2009 IMR90-3 (IPSC) 28 days MEFs + 
100ng/ml bFGF 
 -bFGF 
7-10 days confluent 
  IPSC-RPE in 
vivo model 
Nistor  et al. 
2010 
H7 42 days Matrigel + Mefs 
conditioned 
medium  
 
EBs (day 21-28) 
 
Collagen/ laminin 
(days 28-35) 
 B27, Insulin–Selenite–
Transferrin (IST), 
triiodothyronine (T3), 
Taurine 2.5 g/l; Hyaluronic 
Acid (HA) 250mg/l, Dkk1 
 25ng/ml, LeftyA 50ng/ml, 
FGF 5ng/ml  (days 14-21) 
 
 
 
  3D RPE/neural 
progenitor 
construct created 
Yue et al., 2010 Primate ES cells 21 days Co-culture with 
Sertoli Cells 
    Use inactivated 
RPE as a feeder 
layer for 
differentiating 
photoreceptors 
H1, H9 20 foci /cm2 
 
HUES12, HUES15, 
HSF1 
15  foci /cm2 
Liao et al., 2010 
HSF6 
21-28 days MEFs  -bFGF 
7-10 days confluent 
 
<10  foci 
/cm2 
Determine RPE 
‘molecular 
signature’ 
H14 32 days  12% 
colonies 
pigmented 
IMR90-3 (foetal lung 
IPSC) 
22 days  7%   
IPS (foreskin)-2  (IPSC) None  0%  
A3 (Foetal RPE IPSC) 19 days  72%   
A4 (Foetal RPE IPSC 19 days  60%   
Hu et al., 2010 
A6  (Foetal RPE IPSC) 30 days 
EBs (8 days) 
Seeded onto 
0.1% gelatine 
 -bFGF 
 2% 
Epigenetic 
memory in foetal 
RPE derived 
IPSCs. 
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Reference Cell Line Timing of 
Pigmentation 
(days) 
Expansion/differ
entiation 
media/Substrate 
Cell 
Seeding 
Density 
‘Treatment’  RPE yield 
before 
treatment 
RPE yield 
after 
treatment 
Purpose 
Separate phase bright optic 
vesicle like EBs (days 20-
25) 
 
 
Pigmentati
on observe 
‘rarely 
observed’ 
WA09 
WA01 
IPS-12 (IPSC) 
IPS-12.4 (IPSC) 
 
Activin A  100ng/ml (days 
20-40) 
Rarely 
observed 
Pigmented 
subsets 
observed. 
8 Fold 
increase in 
MitF mRNA 
5 fold 
RPE65, 19 
fold 
Bestrophin 
Meyer 2011 
Lenti IPSC2 (IPSC) 
40-60 days EBs (7 days),  
N2 (1%), Heparin 
(2 µg/ml), B-27 
(2%) (Days 4-6) 
 
Neural rosettes 
isolated at day 16 
and grown in 
suspension  
 DKK1(100ng/ml) + 
Noggin  (days 2-4) 
 
27% Pax6 
+ve 
5.1% 
Chx10 +ve 
72% Pax6 
+ve 
34% Chx10 
+ve  
Separation of 
retinal progenitor 
cells from early 
forebrain 
populations 
Regea 08/013,  
 
21 ± 3 days  Day 28,10% 
pigmented 
aggregates 
 
Regea 08/017, 12 ± 7  days 
 
 6% 
Regea 08/023, 12 ± 5 days 
 
 23% 
Regea 08/056,  10 ± 2  days 
 
 22% 
Vaajassari  et al., 
2011 
FiPS 5-7 (IPSC) 
 
 
11 ± 5  days 
 
–bFGF(1-7 days) 
EBs  (days 7-30) 
 -bFGF 
 24% 
 
Screen multiple 
lines on human 
feeders (HFFs) 
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Reference Cell Line Timing of 
Pigmentation 
(days) 
Expansion/differ
entiation 
media/Substrate 
Cell 
Seeding 
Density 
‘Treatment’  RPE yield 
before 
treatment 
RPE yield 
after 
treatment 
Purpose 
K11 (Retinitis 
Pigmentosa  (RP) IPSC) 
 
 At day 60, 
16% 
pigmented 
area: 
K21 (RP- IPSC) 
 
 24% 
K10 (RP- IPSC) 
 
 18% 
K101 (RP- IPSC) 
 
 23% 
Jin et al., 2011 
P59 (RP- IPSC) 
40-60 days SFEB  
Poly D 
lysine/laminin/ 
Fibronectin (21 
days) 
15-20 
aggregate
s per 
slide 
DKK1  (Wnt inhibitor) 
100ng/.ml 
LeftyA (Nodal inhibitor) 
500ng/ml (Days 0-21) 
 
 20% 
Modelling 
Retinitis 
Pigmentosa 
Sugino et al. 
2011 
MA01 (H1) 28-30 days EBs 7-10 days in 
MDKB media + 
1x B27 
supplement,  
Seeded onto 1% 
gelatine 
    Attachment and 
survival on aged 
Bruch’s 
membranes 
Kokkinaki et al, 
2011 
IMR90-4 (IPSC) 28 days EBs of defined 
size in 
AggrewellsTM 
1000-
2000 cell 
EBs 
10µM NIC (day 1-28),  
140ng/ml Activin A +  
SB431542 (days 21-28) 
 37% 
pigmented 
clusters 
Comparison of 
IPSC and HESC 
derived RPE. 
Zahabi et al., 
2011 
Royan H6 
hiPSC1 (IPSC) 
25 days 5% KOSR,  N2 
 
 250ng/ml noggin 
10ng/ml bFGF (day 0-6) 
 
bFGF 10ng/ml 
Retinoi acid 0.2-0.6µM 
only (day 6-12) 
 
25ng/ml Shh, 25 ng/ml 
bFGF (days 12-18) 
 
18-25 5% KOSR only 
(days 18-40) 
 40% 
RPE65 + 
ve,   
40% 
Bestrophin 
+ve  
(Day 40) 
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Reference Cell Line Timing of 
Pigmentation 
(days) 
Expansion/differ
entiation 
media/Substrate 
Cell 
Seeding 
Density 
‘Treatment’  RPE yield 
before 
treatment 
RPE yield 
after 
treatment 
Purpose 
35 days MEFs cells  Clarke et al., 
2012 
H9 
28 days PA6 cells  
-bFGF (days 10-35)  Day 28, 9% 
pigmented 
surface 
area 
Clonal isolation 
(FACS) and 
characterisation 
Hongisto et al., 
2012 
Regea 06/040 
FiPS5-7 (IPSC) 
15-17 days EBs  Activin A 10ng/ml (day 0 
onwards) 
Day 28 
30% 
pigmented 
aggregates 
Day 28 70% 
pigmented 
aggregates 
Activin A mimics 
RPE promoting 
action of MEFs  
IWR1e (Wnt inhibitor) 
(3µM)(days 0-12) 
FBS (10%), SAG 
(Hedgehog /smoothened 
agonist) (100Nm) (days 12-
18) 
 
 No pigment Nakano et al., 
2012 
Khes1 21 days SFEB 
G-MEM 
20% KOSR 
1mM Pyruvate 
10µM Y-27632 
 
Embedded in 
Matrigel (1%) 
(days 2-18) 
 
9000 
cells/well
/EB 
CHIR99021 (GSKβ 
inhibitor) (days 18-21) 
No 
pigment 
Pigmented + 
3.5  increase 
in MitF 
mRNA 
3D optic cup 
formation and 
cryopreservation 
HS27 feeders Day 51,  
~4.2/cm2 
Matrigel ~2.3/cm2 
H9 
 
51 days 
Mouse Laminin ~2.1 /cm2 
MEFs 0mm2 / well 
Matrigel 0.28mm2  
Rowland et al., 
2012 
IMR90-3  (IPSC) 35 days 
Mouse Laminin 
 -bFGF (day 7-10)  
0.30 mm2  
Effect of 
substrate on 
RPE 
differentiation 
yield 
Singh et al., 
2012 
A416K, N296H (Best 
disease IPSC lines), 
30-40 days EBs (6 days) 
Laminin + 1% 
B-27,N2, 2µg/ml 
Heparin, 2%B-27 
(Days 4-6) 
    Characterising 
Best disease 
patient derived 
IPSC-RPE. 
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Reference Cell Line Timing of 
Pigmentation 
(days) 
Expansion/differ
entiation 
media/Substrate 
Cell 
Seeding 
Density 
‘Treatment’  RPE yield 
before 
treatment 
RPE yield 
after 
treatment 
Purpose 
-B27 
-N2 
~49% 
RPE65 +ve 
day 30 
 
~30% 
RPE65 +ve 
day 60 
 
~10% 
RPE65 +ve 
day 30 
 
~30% 
RPE65 +ve 
day 60 
 
Mellough et al., 
2013 
H9 
hIPSC-NHDF (IPSC) 
20-30 days EBs 30 days,10% 
KOSR + B27 
(1:50) 
  
Poly-L-
ornithine/laminin 
coated slides (30 
days) N2 (1:100), 
B27 (1:50)  
(day 30-60) 
 
Noggin (1ng/ml), Dkk1 
(1ng/ml), IGF (5ng/ml), 
LeftyA (500ng/ml), Shh 
(30nM) (Day 0-37) 
 
Noggin (10ng/ml ), DKK1 
(10ng/ml), IGF1 (10ng/ml), 
FGF (5ng/ml), Retinoic 
acid (500nM), T3 
(40ng/ml), Taurine (2µM), 
Shh (12nM) (day 37-60) 
~49% 
RPE65 +ve 
day 30 
 
~30% 
RPE65 +ve 
day 60 
 
~59% 
RPE65 +ve 
day 30 
 
~30% 
RPE65 +ve 
day 60 
 
Screen of staged 
growth factor 
addition for 
retinal 
differentiation. 
Krohne et al. 
2013 
IMR-90 (IPSC), 4F 
IPSC, (2F) IPSC, (1F) 
IPSC 
 EBs  10mM NIC,  
62ng/ml Activin A (day 0-
28) 
 ‘More rapid 
and 
efficient’ –  
Characterising in 
vivo functionality 
of 1 factor (1F) 
reprogrammed 
IPSC. 
 
Maruottie et al., 
2013 
H7 HESC,  
IPSC (IMR90-4) 
32-38 days 8 Days in 
mTesR1(single 
cell seeding)   
 
Matrigel  or VN-
PAS Synthemax 
DMEM/F12 
20k/cm2 Day 50 passage as single 
cells, seed at 100K/cm2 
(P1), grow for 15-20 days, 
Passage again seed at 
100K/cm2 (P2) for 30 
days. 
16 % RPE 
65 +VE  
97-99% 
MitF +ve 
RPE65 +ve 
(115 days 
total) 
Serial passaging 
of mixed 
cultures 
eventually 
generates pure 
RPE  
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Reference Cell Line Timing of 
Pigmentation 
(days) 
Expansion/differ
entiation 
media/Substrate 
Cell 
Seeding 
Density 
‘Treatment’  RPE yield 
before 
treatment 
RPE yield 
after 
treatment 
Purpose 
Buchholz et al., 
2013 
H9 14 days B27, N2 
Matrigel 
 50ng/mlNoggin, DKK1, 
IGF1, NIC (days 0-2)   
 
10ng/.ml Noggin, Dkk1, 
IGF1, NIC +bFGF (day 
2-4)  
 
10ngml DKK1,10ng/ml 
IGF1 (days 4-6) 
 
100ng/ml activin a, 10µM 
SU5402,  1mM VIP (days 
10-16) 
25 %± 
2%, 
PMEL17  
79% ±1 % 
PMEL17  
High yields in 
short time 
Sridhar et al., 
2013 
IPSC (IMR90-4) 30 days EBs (7 days) 
 
Synthemax  
 1% N2, (days 7-17) 
2% B-27 (up to 60 days) 
  Completely xeno 
free. 
H9 
O27-08 (IPSC) 
Isolated 
pigmented 
foci 
96% 
pigmented 
cells (day 
30) 
Transplantation 
of whole RPE 
aggregates with 
no selection or 
purification. 
100ng/ml Activin A (+20% 
KOSR) (days 6-25)  
 
 
 No effect  
Zhu et al., 2013 
H1 
18-30 days EBs embedded in 
150-300µL 
matrigel in 
N2/B27 neural 
induction 
medium (5 days) 
 
Dissociated into 
single cells 
seeded onto 
matrigel coated 
transwells 
9.6 cm2 
confluent 
cells into 
300µL of 
matrigel. 
 
 2-4 x105  
differenti
ated cells 
per 
6.5mm 
well 
8µM SB435142  (+20% 
KOSR) (days 6-25) 
Pigmented 
(~80-90%) 
No 
pigmentatio
n 
 
 
 
68 
 
 
 
 
 
Table 1.1  A history of pluripotent stem cells to RPE differentiation  Methods used to derive RPE from HESC and IPSC.  All cell lines listed are human embryonic stem 
cell lines unless stated otherwise in brackets. Protocols that use continuous adherent differentiation methods that do not employ a cell detachments and suspension culture step 
are highlighted in bold. The cell seeding density column is left blank where no information about density is given. Like wise the yield before/after treatment is blank where 
this information was not recorded, as appose to the word ‘none’ when the absence of pigment/immunopositive cells is noted. ‘Purpose’ column summarises the main theme of 
the study as indicated by the paper’s title. ‘RPE yield’ is assessed by different studies in a variety ways which are denoted (eg. ‘%MitF +ve’  is the percentage of cells which 
are immunopositive for the early RPE marker MitF). Note ‘% pigmented aggregates’, referring to the relative number of differentiating embryoid bodies that contain 
pigmented patches of any size, is not equal to ‘% pigmented cells’.  Expansion and differentiation media is standard HESC media (knock out DMEM/F12 + 20% knock out 
serum, NEAA, glutamine and β mercaptoethanol and bFGF, and any deviations from this are noted (e.g. 5% KOSR). In the ‘treatment’ section, the ‘-’ prefix signifies the 
removal of growth factor(s) from the expansion medium to induce differentiation at the specified time.  
 
SFEB = Serum free embryoid body method (Watanabe et al., 2005), cells are cultured in clumps of 5-10 cells in decreasing serum concentrations in G-MEM media (Gibco, Invitrogen) and a final concentration of 5% 
KOSR. MEFs= mitotically inactivated mouse embryonic fibroblasts. HFFs = human foreskin fibroblasts EBs = embryoid bodies. PA6 are murine, bone marrow derived stromal cells used as an alternative feeder layer to 
induce neuralization.  ‘Time to pigmentation’ is quoted as the total time since cells are seeded (includes expansion steps). ‘Aggrewell’ plates are conical bottomed 96 well plates provided by STEMCELL Technologies.
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1.6 Summary  
 
Age-Related Macular degeneration is the most common form of blindness in the 
western world and yet there are precious few treatment options for those afflicted.  
The disease is caused by an age associated break down of the retinal pigment 
epithelium in the macular region of the retina which may be brought about by 
chronic, low grade inflammation. Replacing these cells with healthy cells from the 
periphery or other allogeneic sources has proven to be an affective treatment 
however the extreme technical complexity of autologous patch graft translocation 
means there is a low success rate and the surgery could not at present be a routine 
treatment option. 
 
With the advent of human embryonic stem cells a potentially unlimited source of 
highly functional retinal pigment epithelium cells has become available making the 
wide spread production of allogeneic ‘off the shelf’ RPE patches for transplantation a 
possibility.   
 
RPE cells form in confluent HESC culture with minimal intervention.  Since the 
beginning of this project there has been a rapid increase in the number of reports of 
new methods for deriving RPE, these have been comprehensively reviewed in table 
1.1. The methods range from straight forward spontaneous differentiation protocols 
to complex sequences of growth factor and small molecule additions and 
withdrawals. In addition many methods include steps to mechanically isolate cells 
with favourable morphologies. Perhaps unsurprisingly, given the demonstrable 
importance of the interplay with adjacent tissues, no reports have described close to 
100% HESC-RPE conversion efficiencies.  
 
There are major challenges in garnering widely applicable outcomes from these 
studies; clearly there are major differences in the behaviour of cell lines – potentially 
due to genetic makeup, or the methods used to isolate the inner cell mass and 
establish lines.  There are also major differences within cell lines which are cultured 
in different laboratories. It has been suggested that this may result from individual 
passaging techniques and culturing practices (feeding regimes, passaging frequency, 
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colony dissection) and in the MEFs feeder cells on which they are grown. Thus in 
addition to improving differentiation efficiency, a major goal of this thesis has been 
to establish and characterise a differentiation protocol that minimizes these obvious 
sources of variability, with a view to improving reproducibility. 
 
Clinical trials utilizing HESC-RPE commenced last year, and more centres are 
scheduled to begin their own trials in 2013. Currently the process for generating RPE 
by spontaneous differentiation is robust within certain cell lines but also highly 
inefficient.  HESC are amongst the most complex biological entities to be proposed 
as a source of a therapeutic. The wide spread clinical application of HESC derived 
therapies will depend not only of efficacy of the eventual therapy but also on the 
economic feasibility of said product and the efficiency of the manufacturing process 
is likely to be a major cost determinant. 
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1.7 Project Aims 
 
Chapter 2: Methods for assessing pigmented cell yield 
 
A variety of methods have been used to assess RPE cell yield (see table 1.1). The 
pigmented nature of differentiated RPE makes for a useful marker that can be 
assessed visually. Commonly used parameters such as ‘% pigmented aggregates’ 
however are relatively subjective, do not account for the size of pigmented areas, and 
are laborious to determine, requiring cells to be kept out of the incubator for long 
periods of time. Thus our initial goal is to develop a rapid, non-destructive, 
standardized method for reliably assessing pigmented RPE cell yield over time. This 
method should be such that it can be widely applied to assess the efficiency of 
differentiation methods in an unbiased, automated fashion. 
 
Chapter 3: MEFs co-culture and feeder-free differentiation: Bioprocess 
characterisation  
 
In this chapter we aim to establish the differentiation characteristics of two HESC 
lines Shef3 and 6; to establish whether they are able to differentiate into pigmented 
RPE expressing the characteristic range of markers using the traditional MEFs co-
culture method described by Vugler et al., 2008. We aim to use gene/protein 
expression assays in relation to morphological observations to characterise the 
various stages of differentiation from the loss of pluripotency up to the emergence of 
pigmented cells. Using the methods we develop in chapter 2 we hope to characterise 
the rate of pigmented cell accumulation in the two cell lines, quantify the typical 
differentiated cell yields and assess how these characteristics vary over time in 
culture.   The use of MEFs is undesirable for clinical manufacturing of cell therapies, 
so in the last part of this chapter we will test the ability of Shef3 and Shef6 cells to be 
differentiated into RPE in feeder-free conditions. 
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Chapter 4: Differentiation efficiency: the impact of seeding density and single cell 
dissociation  
 
Starter cell seeding density is one of the ‘traditional’ bioprocess engineering 
parameters that have been central to biopharmaceutical process optimization 
(Kirouac et al., 2008) but it is rarely controlled for in HESC differentiation 
experiments. In the processing of HESC for cell therapies, in addition to the usual 
impact on viability and raw material usage, there is evidence suggesting that seeding 
density may govern early cell fate decisions during differentiation (Bauwens et al., 
2008, Chambers et al., 2009). In this chapter we aim to investigate how HESC 
seeding density affects RPE differentiation yields and its subsequent impact on the 
overall process efficiency. HESC colonies are usually passaged as clumps of 
undefined size, a practise that is labour intensive, introduces significant variability 
and is not amenable to scaled up cell processing.  As an alternative, we aim to 
address whether single cell dissociation, a practise which is suitable for scaled-up 
culture and automation, can produce acceptable RPE yields. Following this we aim 
to establish an optimal seeding density following single cell dissociation, in terms of 
HESC-RPE differentiation efficiency, in feeder-free conditions. 
 
Chapter 5:  Enhancing differentiation efficiency using small molecules 
 
Having established robust feeder-free methods for HESC-RPE cell derivation, the 
aim of this last chapter will be to investigate ways to further enhance yields by 
directing early cell fate decisions using small molecules. Our literature review 
indicates that manipulating early differentiation will likely be the most potent 
strategy in terms of directing differentiation. In order to further understand the 
mechanisms of HESC-RPE differentiation we will look at the how manipulating the 
key pluripotency/differentiation signalling pathways impacts on early neuroectoderm 
conversion, and how this affects long term RPE differentiation.  
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Chapter 2: Materials and Methods 
 
 
 
 
 
2.1 HESC maintenance 
 
2.1.1 MEFs isolation, maintenance and preparation of feeders 
 
MEFs were isolated from CF1 mouse embryos at day 13 post coitum. Using sterile 
tweezers and scissors the heads and internal organs of the embryos were removed 
before immersing in PBS then 0.05% Trypsin/EDTA (Gibco-Invitrogen, Paisley, 
UK) and finely mincing the tissue.  Additional Trypsin/EDTA was added the 
material was placed in the 37°C incubator for 5-10 minutes after which MEFs 
medium was added to quench the reaction, MEFs medium consisted of D-MEM, 
foetal bovine serum (FBS) (10%v/v), NEAA (1% v/v) (all Gibco-Invitrogen). The 
partially digested tissue was transferred to centrifuged tubes and large pieces of 
tissue were allowed to settle the bottom of the tubes. The supernatant was removed 
and re-suspended in fresh MEFs media, then centrifuged at 1000rpm for 3-5 minutes, 
the supernatant was then discarded and the pellet re-suspended in MEFs medium 
before transferring to T75 flasks (NUNC, EasYFlasks, Thermo-Fischer scientific). 
MEFs were allowed to grow for two population doublings and then viably frozen in 
cryopreservation media (40% MEFs media, 50% FBS, 10% DMSO (Sigma-Aldrich)) 
in liquid nitrogen and designated passage zero (P0).     
 
P0 vials were removed from the liquid nitrogen and thawed in the water bath before 
centrifuging (12,000 rpm, 3 mins) and re-suspending in MEFs medium. MEFs were 
grown in NUNC T75 EasYFlasks and passaged every 3 days (at 70-80% confluence) 
with 0.25% Trypsin/EDTA at a split ratio of 1:5-1:2 up to passage 6.   
 
The day before HESC passaging, confluent flasks of MEFs were mitotically 
inactivated by treatment with mitomycin-C (0.01mg/ml, Sigma-Aldrich). MEFs 
media was replaced with 7mls of mitomycin C medium (0.01mg/ml of filtered 
mitomycin C in MEFs media) and incubated for 2 hours. Inactivated MEFs were 
washed 3x in PBS and dissociated by 3 minutes treatment with 0.05% trypsin/EDTA 
at 37°C. Cells were counted using a haemocytometer and seeded onto 0.1% porcine 
Gelatin (Sigma-Aldrich) coated flasks or wells at a density of 9,200/cm2.  
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2.1.2 Shef6 and Shef3 maintenance 
 
Undifferentiated Shef3 and Shef6 HESC were obtained from the UK Stem Cell Bank. 
Cells were maintained in 0.1% Porcine Gelatine (Sigma-Aldrich) coated T25 NUNC 
EasYFlasks (Thermo-Fischer scientific) on  mitomycin-C inactivated mouse embryo 
fibroblasts (MEFs) in Knockout DMEM supplemented with 20% (v/v) Knockout 
serum replacement, 2mM Glutamax 1%(v/v) non-essential amino acids, 4ng/mL 
basic FGF (FGF2) (all Invitrogen) and 0.1mM β-mercaptoethanol (Sigma-Aldrich), 
filtered through a 0.22µm sterile filter. Cells were cultured in a Sanyo IncuSafe 
incubator (Sanyo, MCO-18AIC, Leicestershire, UK) at 37℃ and 5%(v/v) CO2.   
HESC media (5-6mls/ T25) was exchanged every 24 hours after the first day post 
passaging.  Every 3-4 days HESC colonies were passaged. When the majority of 
colonies were large enough to fill a 10x objective, cells were treated with 
0.125mg/ml collagenase IV (Invitrogen) for four minutes at 37°C. Colonies with 
undifferentiated HESC morphology were then dissected into smaller clumps under 
the dissecting microscope using a fine tip Pasteur pipette (Appleton woods, 
Birmingham, UK).  Detached clumps containing around 1000 cells/clump were 
seeded onto fresh MEFs feeders in HESC media at a split ratio of 1:2. 
 
2.1.3 HESC vitrification and thawing 
 
Shef6 and Shef3 obtained from the stem cell bank were banked in liquid nitrogen at 
around passage 30. Vitrification straws (MTG, Bruckberg, Germany) containing 6-8 
colony pieces were thawed and expanded to produce working banks that were again 
banked at around passage 35. HESC freezing was achieved by a process of 
vitrification. HESC colonies were treated with collagenase IV, as above, and cut into 
small pieces as if for passaging. Using a 20µL Gilson pipette colony pieces were 
transferred into droplets of ‘ES-HEPES’ solution (20%v/v FBS, 80% DMEM + 
25mM HEPES (Sigma-Aldrich)). After 1 minute, the pieces were transferred to ‘10% 
freezing solution’ (80% v/v ES-HEPES media, 10% v/v DMSO (Sigma-Aldrich), 
10% Ethylene Glycol (Sigma-Aldrich)) and after 40 seconds again transferred this 
time to ‘20% freezing solution’ (30% v/v ES-HEPES, 30% 1M Sucrose (Sigma-
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Aldrich) in PBS, 20% DMSO, 20% Ethylene Glycol (Sigma-Aldrich) for 10 seconds. 
Following this clumps were sucked up into vitrification straws by capillary action 
and immersed in liquid nitrogen.  
 
In order to thaw cells, vitrifcation straws were thawed directly onto gelatine and 
inactivated MEFs coated IVF dishes (Nunc, Thermo Scientific) in HESC media. 
Cells were left to attach in the incubator with occasional media changes for up to 1 
week, at which point sufficient attachment and colony growth had occurred for 
passaging. Cells were cultured in IVF dishes until 7 IVF dishes were filled with 
colonies at which point the content of all 7 dishes were transferred into 1 x T25 flask. 
  
2.1.4 Karyoptying and Mycoplasma testing 
 
Every thawed batch of Shef6 and Shef3 were subjected to karyotypic analysis after 
prolonged passaging (2-3 months) and use. Karyotyping was carried out by TDL 
genetics (60 Whitfield Street, London) using G banding with up to 20 cells counted 
per sample.  Mycoplasma testing was carried out regularly by Surrey Diagnostics 
(Cranleigh, UK). 
 
2.2 HESC-RPE differentiation 
 
2.2.1 MEFs co-culture differentiation 
 
Shef6 and Shef3 were mechanically passaged following 4 minutes of collagenase IV 
treatment at 37 °C (Invitrogen). Unless other wise stated flasks were split at a ratio of 
1:2. Where experiments tested more than 2 conditions, cells were split pooled and 
split at a 1 in 2 ratio.  The cells were seeded onto mitomycin inactivated MEFs (1 
day post plating) at a density of 9200 MEFs per cm2. The same batch of MEFs was 
used for differentiation experiments throughout the whole project. The day of 
seeding was designated day 0, cells were fed with 6mls of HESC media +bFGF for 
the first 10 days excluding day 1, on which cells were left in the incubator to settle. 
On the 10th day the media was changed to HESC media – bFGF (‘differentiation 
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media’).   Thereafter –bFGF differentiation media exchanged every day (4-5mls) 
until day 50-80. In order to manage multiple asynchronous differentiation 
experiments, an excel spreadsheet and calendar of time lines and was generated for 
all experiments. 
 
 
2.2.2 Feeder free differentiation on Matrigel in Mefs conditioned 
media/mTeSR1 
 
For feeder free differentiation T25 flasks or 6 well plates were coated growth factor 
reduced Matrigel (BD Bioscience, San Diego, CA). Matrigel was thawed at 4°C on 
ice before diluting 1:30 in KO-DMEM. Matrigel coated plates were left wrapped in 
cling film in the hood for 1 hour before removing the excess and seeding cells onto 
them.   For differentiation experiments Shef6 and Shef3 colonies with 
undifferentiated morphology were dissected into clumps in standard +bFGF HESC 
media and transferred to 15ml centrifuge tubes. The colonies were left to settle to the 
bottom of the tube and the supernatant was aspirated. The colonies were then re-
suspended in MEFs conditioned medium (see below) or mTeSR1 medium 
(StemCellTechnologies, Vancouver, BC). Media was exchanged daily until the 10th 
day at which time the media was changed to standard HESC media –bFGF 
(differentiation media) for the remaining 40 days. 
 
2.2.3 MEFs conditioned media 
 
To generate MEFs conditioned media 750,000 mitomycin C treated MEFs were 
seeded onto gelatinised T75 flasks in standard MEFs media. After 24 hours MEFs 
media was replaced with 12 mls/T75 of standard hESC media containing 4ng/ml 
bFGF. After a further 24 hours the MEFs conditioned media was harvested and spun 
down (12,000rpm, 3 minutes) to remove any detached feeder cells.  Batches of MEFs 
media were frozen at -20°C and stored. At the time of use, conditioned media was 
thawed overnight in the fridge an additional 4ng/ml of bFGF was added on the day of 
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use. T75 MEFs feeder flasks were used for 2-3 days maximum (i.e. 2 -3 ‘harvests’), 
and only passage 2-4 MEFs were used.  
 
2.2.4 Feeder free differentiation – Embryoid bodies 
 
To generate embryoid bodies, Shef6 and Shef3 cells at day 4 post passage were 
treated for 4 minutes with type IV collagenase at 37°C then scraped off the surface 
using a plastic, fine tip Pasteur pipette. Colonies were transferred to 30mm non-
adherent bacterial grade culture dishes (Sterilin, Caerphilly, UK) where they formed 
compacted EBs in 2-3 days. Media was exchanged by allowing EBs to settle in a 
centrifuge tube and aspirating the supernatant. Media was exchanged every day and 
switched to –bFGF differentiation media at day 10.  
 
2.2.5 Single cell dissociation differentiation 
 
For single-cell differentiation, flasks of Shef6 and Shef3 ready for passaging (day 3-
4) were examined under the microscope and differentiating colonies were 
mechanically removed using a fine tipped Pasteur pipette (Appleton woods). Cells 
were then washed with PBS and 2mls of TrypLE select enzyme (Invitrogen) was 
added per flask, before incubating at 37°C for 10 minutes. After this time flask were 
tapped vigorously to detach cells. Standard HESC media was added and cells were 
spun down for 3 minutes at 12,000rpm. Cells were then re-suspended in MEFs 
conditioned media or mTeSR1 and counted on a haemocytometer before seeding at 
the specified density onto Matrigel coated plates. MTeSR1 or conditioned media was 
exchanged daily from the 2nd to the 5th day after which media was switched to –
bFGF differentiation media. 
 
2.2.6 Preparation of Growth factor/small molecule differentiation 
media 
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Powdered dorsomorphin (Tocris Biosciences, Bristol, UK) was diluted in DMSO to 
create a 1mM solution which was stored in aliquots at -20°C. Aliquots were added to 
standard HESC media –bFGF 1µL/ml to achieve a final concentration of 1µM. 
Similar procedures were carried out with SB431542 (Tocris Biosciences) to achieve 
a 10µM concentration and PD0325901 (Tocris Biosciences) to achieve a 10µM 
solution. In all small molecule experiments an equal volume of DMSO was added to 
control wells from the same batch of cells. Activin A (R&D systems) was added at 
100ng/ml to standard HESC media –bFGF. Fresh, small molecule/growth factor 
containing media was prepared every 3-4 days.  
 
2.2.7 Cell counts 
 
Viable cell counts were performed in triplicate using the Trypan blue exclusion 
method (Strober et al., 2001).  Shef6 and Shef3 cells were seeded onto matrigel in 
mTeSR1 or MEFs conditioned media at a density of 5000 cells per cm2. Cells were 
harvested every 2-3 days using TrypLE select (Invitrogen); adherent cells were 
washed twice in PBS before treating with 1ml/well of TrypLE for 10 minutes at 
37°C. Cells were diluted in media to achieve a concentration ranging from 250,000 
cells/ml – 2,500,000 cells/ml the optimal range indicated by the haemocytometer 
manufacturer (LW scientific, Lawrenceville, GA). 0.1mls of 0.4% Trypan Blue stock 
solution (Invitorgen) was added per 1ml of cells and solutions were sampled three 
times and counted on eight squares of a haemocytometer.  
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2.3   RPE Expansion 
 
2.3.1 RPE Isolation 
 
Pigmented foci were mechanically isolated from non-pigmented tissue using at day 
50-60.  Cells were treated with 1mg/ml collagenase IV (Invitrogen) for 8-10 hours at 
37°C. Two autoclaved microsurgical microcresent blades were used to cut non-
pigmented tissue away from pigmented foci under the dissection microscope.  The 
foci were then washed in fresh differentiation medium 
 
2.3.2 RPE maintenance 
 
Following isolation, 2-3 pigmented foci were seeded per well onto matrigel coated 
24 well plates in a-MEM RPE medium’ (a-MEM, 1x N1 supplement, 1X NEAA, 
250mg/ml taurine, 13ng/ml Tiiodothyronin, 20ng/ml Hydrocortisone, , 1:100 
Penicllin-streptomycin (all Sigma Aldrich), 2mM L-glutamine  & 15% FBS (Gibco-
Invitrogen). After 3-4 days the serum content was reduced to 5%. After allowing foci 
to adhere for two days, media was exchanged every 2-3 days. 
 
2.4 Microscopy and Immunocytochemistry 
 
Cells were fixed with  4%(w/v) paraformaldehyde (PFA) (Sigma-Aldrich) at room 
temperature for 20 minutes.  PFA was removed and cells were washed with 0.1M 
Dulbecco’s modified phosphate-buffered saline (DPBS). Cells were then 
simultaneously permeabilized and blocked in 0.3% v/v Triton-X100, 5% v/v Goat 
serum in DPBS (all Sigma-Aldrich) for 1 hour at room temperature.  For surface 
markers the Triton X100 was omitted. Primary antibodies were diluted to the 
specified concentrations in 1% Goat Serum, 0.3% Triton-X100, DPBS solution. 
500µL of diluted primary antibody solution was used per well of a six well plate. 
Primary antibodies, their suppliers and the concentrations used are listed in table 2.2 
at the end of this chapter. 
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 Primary antibodies were incubated at room temperature over night. The following 
day cells were washed 3x in 15 minutes in 500µL per well of DPBS on a shaker. The 
appropriate secondary antibodies were diluted in 2% goat serum in DPBS and 500µL 
of diluted secondary solution was used per well.  Secondary antibodies are listed in 
table 2.3, all were supplied by Invitrogen. For each experiment isotype control wells 
were assigned to which were added species matched isotype control antibodies at the 
same concentration as the most concentrated primary antibody in each experiment.  
 
Cells were incubated with the appropriate secondary antibody to match the host 
species and isotype of each primary antibody for 2 hours, covered in foil on a shaker 
at room temperature. Following this wells were washed 3x in 15 minutes in DPBS. 
Diamidino-2-phenylindole (DAPI, Invitrogen, 1:1000) in DPBS was then added for 5 
minutes before washing the cells 3x again prior to storage at -4°C. Fluorescence and 
bright field images were acquired using a Nikon, Eclipse TE2000-U microscope and 
analyzed with NIS-element software (Nikon UK LTD, Surrey, UK). 
 
2.5 Gene expression analysis 
 
 
2.5.1 RNA isolation and storage  
 
RNA extraction was carried out using Qiagen RNeasy kit (Qiagen, Crawley, UK) 
according to manufacturer’s instructions. Cells were harvested by 10 minutes 
incubation with TrypLE select. Detached cells were pelleted, washed in PBS and 
stored at -80°C.  Thawed pellets were disrupted with 500µL ‘RLT’ buffer (Qiagen) 
before homogenizing by passing 8 times through a 19 guage syringe. Following this, 
samples were processed according to manufacturer’s instructions. Contaminating 
genomic DNA was digested using RNAse free DNAse (Qiagen). RNA was eluted 
from the spin columns with 40µL of RNAse free water and the concentration/purity 
was determined by measuring the 260/280nm absorbance ratio on a 
spectrophotometer (NanoDrop ND-1000, Thermo Scientific, Epson, UK).  
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2.5.2 CDNA synthesis  
 
Control and test samples for direct comparison were always subjected to RNA 
extraction and cDNA synthesis on the same day. CDNA was made using Ambion 
RETROscript kit 1st strand synthesis kit (Ambion, Warrington, UK) from 1µg of 
RNA according to manufacturer’s instructions with a total reaction volume of 20µL. 
Random decamers were added to the RNA + RNAse free water and the mixture was 
incubated at 65°C for 5 minutes before cooling to 4°C.   The first strand synthesis 
reaction was run for 60 minutes at 42°C followed by 92°C for 10 minutes, and 
cooling to 4°C. CDNA products were stored at -20°C.  No reverse transcriptase 
(NRT) controls were simultaneously generated, containing RNA and all the 
RetroScript components with the exception of the reverse transcriptase enzyme, the 
volume of which was replaced with RNAse free water.  
 
 
2.5.3 Reverse transcription PCR (RT-PCR) 
 
Primer pairs were a kind gift from Dr. Amanda Carr, and are listed in table 2.4 and 
are designed across exons. CDNA was amplified using Go Taq Polymerase kit 
(Promega, Southhampton, UK) following manufacturer’s instructions. The PCR 
cycle consisted of a denaturing step at 95 °C for 2 min followed by 37 cycles of 
denaturation at 95 °C for 30s, annealing at 52°C (or 3 degrees cooler than the melting 
temperature) for 30s and extension at 72 °C for 30s, an extension step at 72 °C for 2 
minutes and final cooling step at 4°C. PCR products were resolved on a 2% 
agarose/ethidium bromide gel.  The identity of single bands was confirmed by 
comparison to a l Kbp ladder (Promega). NRT controls were included for all samples 
as well as no template controls (NTC) containing all components except primers. The 
house keeping gene for TATA binding protein (TBP) was used as an internal control. 
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2.5.4 Quantitative (real time) PCR (QPCR) 
 
Quantitative real-time PCR was carried out on an Applied Biosystems 7900HT Fast 
Real-Time PCR system using the SYBR Green method. Master mixes were made 
containing Power SYBR (Applied Biosystems), Primers and DNAse/RNAse free 
water. Mini-master mixes (84µL) containing 1µL of cDNA were then made for each 
sample.  25µL triplicate reactions were carried out in a 96 well plate for each sample.  
Test and control conditions were always carried out on the same plate such that the 
plotted relative values reflect changes in gene expression between samples rather 
than others sources of variation in the assay.  
 
Data from the Q-PCR was normalized to the geometric mean of the expression of 
three internal control genes in each sample. These genes (POL, MAN, GNB – see 
table 2.5) were chosen due to their stability across the sample groups, which was 
determined using the GeNorm algorithm (Vandesompele et al., 2002). Forward and 
reverse primers were designed across exons and kindly lent by Dr Mayaan Semo or 
purchased from Qiagen’s quantitect range (Qiagen, Crawley, UK) see table 2.5. 
QPCR data was initially analysed using the SDS 1.7 software (Applied Biosystems). 
Raw fluorescence values were then imported into the ‘DATA Analysis for Real Time 
PCR’ (DART PCR) excel workbook (Pierson, 2003). The DART workbook tests 
amplification efficiencies using the slope of the amplification plot and uses this, in 
combination with the threshold cycle to calculate the theoretical starting fluorescence, 
Ro. Based on the formula Ro = Rct- (1-E)-ct .  Where Rct = the fluorescence at the 
threhold cycle, E= efficiency and Ct is the threshold cycle. The normalised Ro is 
then calculated by dividing the target gene Ro by the average house keeping gene Ro 
(Pfaffl et al., 2001). The DART work book identifies any outliers in terms of relative 
expression values or amplification efficiency within triplicates by one way ANOVA 
which, if detected, were excluded from analysis. Normalised Ro values are then 
expressed relative to the normalised Ro of control samples and the data is plotted as 
normalised relative fold changes. 
 
Relative fold change = Efficiency corrected, normalised expression (test condition)       
Efficiency corrected, normalised expression (control condition). 
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2.6 Statistical Analysis 
 
2.6.1 One and two-way ANOVA 
 
One and two way ANOVA were carried out in the excel workbook ‘RANOVA’  
 
2.6.2 Paired and Unpaired student’s t test 
 
Following one or two way ANOVA, post hoc student’s t-tests were performed in 
excel to test significance within the groups.  In QPCR experiments, where control 
and test conditions were carried out on the same plate, but different biological 
replicates carried out on different plates, 2- tailed, paired t-tests were used to 
compare normalized fluorescence values. Unpaired t-tests were used when the 
subjects between the groups had no specific relation to each other e.g. when 
comparing gene expression data between two cell lines. 
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2.7   Measuring Pigmentation and Confluence 
 
Pigmented HESC-RPE cells are clearly visible with the naked eye against a 
background of non-pigmented cells. This provides an opportunity for rapid on-line, 
non destructive monitoring of the differentiation progress by image analysis. We 
sought to develop an assay to rapidly and reproducibly monitor the changing 
quantities of pigmented cells during hESC-RPE differentiation.  By measuring the 
numbers of individual pigmented foci at specified time points in the differentiation, 
we were able to quantify the relative conversion efficiency in various differentiation 
conditions (see results chapters 3-5). 
 
2.7.1 Scanning Flasks and Wells and Importing to Image J 
 
The first challenge was to find a system for reproducibly capturing images of the 
flasks.  Background lighting in the lab changed considerably over the course of the 
day therefore it was necessary to create a closed system to ensure consistent 
background illumination.  Further criteria are outlined in the table 1. 
 
Requirement Reasoning 
Controlled and reproducible illumination 
of dishes or flasks 
Images captured at different times can be 
compared with confidence 
Fixed distance from lens to flask surface Consistent scaling  
Rapid capturing of images Cells are not removed from incubator for 
prolonged periods of time 
Can tolerate harsh cleaning with Virkon 
and Ethanol 
Must be suitable for use in clean lab  
 
Table 2.1 Image acquisition constraints 
 
With these constraints in mind we designed a system that combined an Epson V750 
flat bed scanner (Epson UK Ltd., Hertfordshire, UK) with a custom made flask 
mounting block and lid designed and constructed in the UCL biochemical 
engineering workshop (Fig. 2.1A).   The mounting block was finished with matt 
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black walls and the lid was matt white to ensure a light background with which the 
pigmented foci would contrast (Fig. 2.1B). The block was designed to contain a T25 
flask shaped hole so that a flask could be clicked into the same place relative to the 
captured area every time, facilitating rapid processing of flask images.  
 
Images were acquired using the supplier software ‘Silverfast Epson version 6.5 
(LaserSoft Imaging, AG, Germany).  The settings for image acquisition were as 
follows: 
 
General Sm: Normal file 
Orig:Transparent 
Positive/Negative: Positive 
Frame:  Q factor: 2.5, 192, 3.57 MByte, 480 DPI  48-24 bit colour 
 
Having tested several variations on the above settings, we found this to produce the 
best contrast between pigmented and background cells, it also acquired images at a 
suitable resolution (as specified by DPI –dots per inch setting- 480) and size 
(3.57MB). Scanned images were then opened in Image J (http://imagej.nih.gov/ij/) 
for further processing.  
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2.7.2 Auto-counting to determine number of Foci 
 
Pigmented foci are visible to the naked eye and currently the best practice is to count 
the number of individual foci manually. This is both time consuming and subjective 
with the size and intensity of pigment undefined. We sought to develop a method for 
automatically counting the number of foci in a flask that could be applied throughout 
the project to accurately compare yields between cell lines and differentiation 
conditions. 
 
Find Edges: The mounting block and lid removes background lighting so that the 
flask is always illuminated to the same extent. Figure 2.2 shows a typical flask of 
differentiating shef6 at day 50. When the imported images were converted from 
colour to grey scale and a threshold is applied, the top and side areas of the flask are 
obscured due to shadows caused by the narrowing flask neck.  This led to non-
pigmented areas being darker than the threshold (red areas) so that only the central 
portion of the flask could be assayed for pigmentation (Fig 2.2A). 
 
We used image J’s ‘find edges’ function to circumvent this problem. This function 
uses a ‘sobel edge detector’ to detect sharp changes in intensity in the imported 
image; applying the ‘find edges’ function highlighted all pigmented foci irrespective 
of their position in the flask (Fig 2.2B). 
 
Noise Removal: Flasks and dishes were wiped with a lint free tissue prior to scanning. 
Despite this, occasionally white flecks appeared on the captured image. These would 
be detected by the find edges function as an area of sharp change in intensity and 
thus need to be removed prior to analysing the image. 
 
Image J has a ‘noise removal’ function (Process> Noise> Remove outliers) which 
replaces a pixel by the median of the pixels within a specified radius if it deviates by 
more that a specified value. The radius, which is used for calculating the median, and 
the threshold, which determines by how much a pixel must deviate from the median 
were defined in order to remove all white flecks.  ‘Which outliers’ was set to ‘bright’ 
so that only pixels brighter than this threshold were corrected.  Fig. 2.3 illustrates 
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how removal of white flecks was achieved when we set the radius to 30 and the 
threshold set to 15. The white flecks visible in the top panel (red circles) have been 
removed by application of the ‘remove outliers’ function and as a result only the 
black, pigmented areas were detected by the find edges function.   
 
Intensity  and Size Threshold: In order to make an accurate estimation of the number 
of pigmented foci, the size and threshold intensity was defined. Images were 
converted from colour into an 8 bit grey scale image, which assigns every pixel a 
value from 1-255 with 255 being the darkest black and 1 being white. By choosing 
the threshold intensity we assigned the pixels which will be defined as pigmented 
cells and incorporate into the RPE foci count.  Currently the best practice is to 
manually count the number of foci so the threshold settings chosen were those that 
most accurately matched those that were counted by eye.  We found that setting the 
threshold to 45/255 selected the pigmented foci (highlighted by the find edges 
function) and excluded background giving the expected result as determined by 
manual counting. Fig. 2.4 illustrates a whole flask to which the above processing has 
been applied. Painstaking manual counting detected 118 individual foci. 
Thresholding the ‘find edges/remove outliers’ processed image at 45/255 detected 
the same number of foci.  Close inspection of the highlighted areas revealed accurate 
highlighting of pigmented areas and exclusion of background (Fig. 2.4 E, F).  
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2.7.3 Validation with manual counts 
 
In order to validate the auto-counts, the numbers of foci were first counted manually 
using the Plugins>analyze>cell counter function which allows the user to mark 
counted areas (Fig. 2.4 B,E). A total of 8 flasks with varying degrees of pigmentation 
were counted three times on three separate occasions. The same images were 
subsequently imported into image J and the ‘remove outliers’, ‘convert to 8 bit grey 
scale’, ‘find edges’ functions were applied as described above. A range of threshold 
and size cut offs were tested until a combination which matched the manual counts 
was determined. The threshold was set at 45 so that all pixels lighter than 45 
(highlighted by find edges function) were included. The size cut off was set at 18 
pixels. The size was an important feature as smaller sizes included areas that were 
not identified by eye and larger areas missed smaller foci.  Figure 2.4 demonstrates 
how performing these functions and then auto-counting particles greater than 18 
pixels in size accurately selected the foci that were also identified by manual counts. 
This was also accurate over the scale of the whole flask (Fig. 2.4 B,C).    
 
The above functions were then combined into an ImageJ Macro (Fig. 2.4 G). The 
macro was tested in 8 flasks of Shef6 with varying levels of pigmentation. The 
numbers of foci in each of the 8 flasks were counted manually on 3 separate 
occasions. And the macro was used to determine foci numbers on three separate 
occasions. The results in Fig 2.4 H show how utilising the macro reduces variability 
in the counted numbers and is accurate over a range of pigmentation levels.  
 
This ‘auto-count’ marco was applied to images of flasks and wells captured on the 
scanner throughout all the experiments described in the project. 
2.7.4 Determining % pigmented Area 
 
In rare instances where very high RPE yields were generated at day 50, it was not 
possible to distinguish individual pigmented foci. In order to compare relative RPE 
yields in these instances, Image J was used to quantify the total pigmented area 
above a specified threshold.  Images were converted to greyscale 8-BIT (black and 
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white) images using the IMAGE: TYPE submenu.  The THRESHOLD function 
(IMAGE: ADJUST submenu) was then used to select only the pigmented areas.  
These experiments were carried out in wells in which shadowing due to the shape of 
the vessel did not exclude large areas, as was the case in T25 flasks (Fig. 2.5A). Thus 
the find edges function was not required. Close analysis of individual pigmented 
particles was used to determine the most suitable threshold value (Fig 2.5B).  We 
noticed that media volume and changes in colour due to pH affected the contrast in 
the wells, something that had not been a problem when the find edges function was 
applied. Thus a careful routine of exchanging the media and filling to a precise 
volume of 2mls per well before scanning was obeyed. Following the use of the 
THRESHOLD function the total % area was determined using the ANALYZE: 
ANALYZE PARTICLES submenu with the following settings: SIZE: 15–INFINITY, 
CIRCULARITY: 0–1, SUMMARIZE: On, EXCLUDE ON EDGES: OFF. 
CIRCULARITY is set to include all shapes, and EDGE EXCLUSION was set to 
include particles at the perimeter of the selected area. The total well area was 
selected for analysis, excluding the very edge of the well.  
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2.7.5  Estimation of cell seeding density following mechanical 
passaging 
 
In order to visualise undifferentiated HESC colonies, flasks were scanned on an 
Epson V750 flat bed scanner as before but in with the lid on the mounting device 
removed. Against the dark background HESC colonies were visible (Fig 2.6A). 
Acquired images were imported into ImageJ and individual colonies were counted 
using the Plugins>analyze>cell counter function.  In addition the % confluence was 
determined at day 6 in x flasks before dissociating cells (TrypLE enzyme, 10 mins, 
37°C) and counting on a haemocytometer. These measurements were used to 
generate a calibration curve relating % confluence to actual cell numbers (Fig 2.6B). 
The scans were carried out at day 6 post seeding.  The cell numbers plotted ranges 
from  1,200,000/25 = 48,000/cm2 to 7,207,000/25 = 288,280/cm2.   Assuming a 
continuous growth rate during the six days, a doubling time of 40 hours after a latent 
period of 1 day (Park et al., 2010), the cells are likely to undergo approximately (5 x 
24)/40 =3 population doublings.  
 
If No = Initial seeding density, Nt= Population at day 6 and  n= the number of 
population doublings in 6 days.  
 
Then  No = Nt / 2n  
 
The various split ratios tested in chapter 4 were scanned at day 6 and generated a 
range of confluence measurements with a minimum of 10.5 % and a maximum of 
41.0% confluent. Using the calibration curves the maximum and minimum seeding 
density tested was determined as follows: 
 
From the equation of the straight line calibration curve (Fig 2.7B):   
 
Total Cell number at day 6 = 128218 (% confluence) + 451296 
 
Therefore for 10.5% and 41.0 % confluence the total cell numbers are 1.8 million 
and 
99 
5.8 million respectively (72,000 - 228,000/cm2). 
 
 Applying the formula  No = Nt / 2n  where n= 3.   The approximate range of seeding 
densities tested were between 9, 000/cm2  and 29,000/cm2. 
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 Primary Antibody Host/Isotype Concentration Supplier 
Oct4 Mouse IgG 1:300 Santa Cruz 
*Tra160 Mouse IgM 1:300 Millipore 
*Tra181 Mouse IgM 1:300 Millipore 
*SSEA1 Mouse IgM 1:300 Sheffield* 
*SSEA3 Mouse IgG 1:300 Sheffield* 
Nestin Mouse IgG 1:500 Millipore 
Pax6 Mouse IgG 1:300 Millipore 
Otx2 Rabbit Poly 1:1000 Millipore 
MitF Mouse IgG 1:50 Santa Cruz 
Chx10 Rabbit IgG 1:300 Sigma-Aldrich 
CRALBP Mouse IgG 1:300 Thermo Scientific 
Bestrophin Mouse IgG 1:300 Millipore 
Pmel17 Mouse IgG 1:300 Abcam 
Zo1 Mouse IgG1 1:200 Invitrogen 
Isotype Control Mouse IgM 1:200 Sigma-Aldrich 
Isotype Control Mouse IgG 1:200 Abcam 
Isotype Control Rabbit  IgG 1:200 Abcam 
 
Table 2.2. Primary antibody sources and working dilutions. (*antibodies gifts from Peter Andrews’s 
lab at Sheffield university). ** = antibodies raised against cell surface antigen for which the 
permeabilization step was omitted. 
 
Secondary Antibody, Host/Isotype Supplier Concentration 
Alexa Flour 488 Goat Anti-mouse IgG Invitrogen 1:200 
Alexa Flour 488 Goat Anti-rabbit IgG Invitrogen 1:200 
Alexa Flour 555 Goat Anti-mouse IgG Invitrogen 1:200 
Alexa Flour 555 Goat Anti-rabbit IgG Invitrogen 1:200 
Alexa Flour 488 Goat Anti-mouse IgM Invitrogen 1:200 
Alexa Flour 555 Goat Anti-mouse IgM Invitrogen 1:200 
 
Table 2.3. Secondary antibody sources and working dilutions. 
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Gene GenBank 
Accession 
Sequence 
Otx2 NM_172337 FOR TAAACCAGCCCCTCTGTTTG 
REV TCTCGCATGAAGATGTCTGG 
Pax6 NM_000280 
 
FOR TCAGCTCGGTGGTGTCTTTG 
REV GTCTCGGATTTCCCAAGCAA 
MitF  NM_198177 FOR AGTTGCTGGCGTAGCAAGAT 
REV ATGGAGGCGCTTAGAGTTCA 
Tyrosinase NM_000372 FOR TGCCAACGATCCTATCTTCC 
REV GACACAGCAAGCTCACAAGC 
PMEL17 NM_006928 FOR GTGGTCAGCACCCAGCTTAT 
REV GAGGAGGGGGCTATTCTCAC 
TBP  NM_003194 FOR GAACCACGGCACTGATTTTC 
REV CCCCACCATATTCTGAATCT 
 
Table 2.4.  RT-PCR primers. Shortened gene name, GenBank accession number of amplified product, 
forward and reverse sequences. Annealing temperature was set at 52°C. 
 
Gene GenBank 
Accession 
Sequence 
POL 
 
NM_000937  FOR GCGGGGTGAAGTGATGAAC 
REV ATCATCGGGATGGGTGCTGT 
MAN NM_016219 FORACCGTGGAGAGCCTGTTCTA 
REV GTTTGGGTCATCGGAGAAGA 
GNB 
 
NM_006098 FOR GAGTGTGGCCTTCTCCTCTG 
REV GCTTGCAGTTAGCCAGGTTC 
OCT4 
(POUF51) 
NM_002701 FOR GACAACAATGAAAATCTTCAGGA 
REV TTCTGGCGCCGGTTACAGAACCA 
Nanog NM_024865 FOR TCCCTCCTCCATGGATCTCGC 
REV CTGAGGCCTTCTGCGTCACA 
TDGF NM_001174136 FOR TCCTTCTACGGACGGAACTG 
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REV AGAAATGCCTGAGGAAAGCA 
Otx2 NM_021728 FOR GCGCAGCTAGATGTGCTGGA 
REV CACTGCTGCTGGCAATGGTC 
Pax6 NM_000280 FOR CCATCAGACCCAGGGCAATC 
REV GGTCTGCCCGTTCAACATCC 
Six3 NM_005413 FOR CCCAGCAAGAAACGCGAACT 
REV CATTCCGAGTCGCTGGAGGT 
Lhx2 NM_004789 FOR AGAGCACCTGGACCGTGACC 
REV ACTTGTCCACGCCCGTGTTT 
MitF  NM_198177 FOR TTGTATCTCAGTTCCGCCGAGC 
REV TGCTTTACCTGCTGCCGTTG 
Chx10 NM_182894 FOR AAGAAGCGGCGACACAGGACAATG  
REV TTGGCTGACTTGAGGATGGACTCG 
Tyrosinase NM_000372 FOR AGAACCTGATGGAGAAGGAATGCTG 
REV GGTCCCCAAAAGCCAAACTTGC 
PMEL17 NM_006928 FOR GATGGGCAGGTTATCTGGGTCAAC 
REV GCTGGAATGAGCAAGAGGCACATAG 
Bestrophin NM_004183 QT00023282 
CRALBP NM_000326 QT00001239 
Nestin NM_006617 QT01015301 
Brachyury 
(T) 
NM_003181 QT00062314 
AFP NM_00134 QT00085183 
Gata6 NM_005257 QT00233331 
Sox17 NM_022454 QT00204099 
CDX2 NM_001265 QT00027807 
 
Table 2.5. QPCR primers.  Shortened gene name, Genbank accession numbers and forward and 
reverse primer sequences. Some primers were sourced from Qiagen’s pre-validated ‘Quantitect’ range 
for which the catalogue numbers  starting QT are quoted.  
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Chapter 3: MEFs co-culture and feeder-free 
differentiation:  Bioprocess characterisation 
3.1 Introduction 
 
The first and most commonly used method for deriving pure populations of RPE 
from pluripotent HESC involves ‘continuous adherent’ culture on mitotically 
inactivated MEFs, followed by manual isolation of pigmented foci, re-plating and 
expansion on a substrate such as Matrigel. This method has been used  in a  number 
of HESC lines, producing well characterised RPE cells which have been transplanted 
into animal models of ocular diseases (Klimanskaya et al., 2004, Lund et al., 2006, 
Vugler et al., 2008, Buchholz et al., 2009, Carr et al., 2009b, Liao et al., 2010). The 
number of independent studies reporting successful derivation of HESC-RPE using 
this continuous adherent co-culture method demonstrates that the method is robust. It 
is not, however, well defined. There remains considerable variation in reported RPE 
yields (see table 1.1), a number of cell lines which fail to generate RPE and 
significant differences in the reported time scales required to generate RPE (Rowland 
et al., 2011, Vaajasaari et al., 2011).  
 
The factors which drive spontaneous formation of HESC-RPE in these culture 
conditions are not fully understood although the so called ‘default model’ of neural 
differentiation in embryonic stem cells (Munoz-Sanjuan et al., 2002) has been 
implicated (Vugler et al.,. 2002). HESC derived neuroectodermal cells have been 
shown to adopt anterior neuroepithelial characteristics in the absence of exogenous 
signalling (Pankratz et al., 2007, Elkabetz et al., 2008). Thus without adding any 
growth factors or small molecules to direct cell fate, a large proportion of HESC will 
theoretically differentiate into cells similar to the anterior neural plate from which all 
retinal cell types are derived during eye development in vivo  (Zaghloul et al., 2005).  
The mitotically inactivated MEFs used in HESC-RPE differentiation do, however, 
secrete a variety of growth factors including members of the TGFβ superfamily and 
proteins involved in IGF, BMP and Wnt signalling (Gerber et al., 2007, Prowse et al., 
2007, Bendall et al., 2009, Hongisto et al., 2012).  A number of these factors are 
critical to HESC maintenance but may also act to direct efficient RPE differentiation. 
For example, activin A is actively secreted by MEF feeder cells (Hongisto et al., 
2012), in vivo activin A mimics the action of the extraocular mesenchyme and 
induces RPE differentiation (Fuhrmann et al., 2000) and in HESC culture, exogenous 
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activin A significantly enhances RPE yields when added to differentiating HESC 
(Idelson et al., 2009, Meyer et al., 2009, Hongisto et al., 2013).   
 
In a cell culture environment, factors other than the presence of molecules directing 
cell fate decisions are likely to be equally influential in determining the HESC-RPE 
differentiation efficiency; such as undifferentiated and differentiated cell survival and 
proliferation rates. In the following sections, the bioprocess of RPE differentiation 
using the ‘continuous adherent’ method in MEFs co-culture is described in two new 
cell lines (Shef6 and Shef3). The method is also applied to a novel feeder-free 
continuous adherent differentiation system that facilitates high yielding and animal 
cell free differentiations. At the time of carrying out these experiments, feeder-free 
adherent HESC-RPE differentiation had yet to be demonstrated although it has now 
been shown by others (Zahabi et al., 2011, Rowland et al., 2012, Sridhar et al., 2013). 
   
The initial aims of this study were to determine whether Shef6 and Shef3 were able 
to generate RPE in MEFs co-culture and in feeder-free conditions, to define the 
relative quantity of RPE foci generated in defined conditions, to establish time lines 
and to characterise any significant differences in the process of RPE emergence 
between the two cell lines. The step wise differentiation process consists of HESC 
expansion and early differentiation, acquisition of forebrain and eye field 
characteristics, emergence of pigmented foci, foci isolation/enrichment and RPE 
expansion. At each stage, gene expression, immunocytochemical and image analysis 
assays are carried out in order to characterise the phenotypes of the emerging cells 
(Fig. 3.1). 
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3.1 Characterisation of HESC lines Shef6 and Shef3 
 
Due to the propensity of HESC to undergo spontaneous differentiation and acquire 
karyotypic abnormalities in culture (Brimble et al., 2004,  Draper et al., 2004), our 
cell lines, Shef3 and Shef6, were characterised regularly using morphological 
examination, immunocytochemistry and karyotypic analysis.  By comparing the 
morphologies of colonies to pluripotency marker expression, it was possible to 
identify and select pluripotent colonies for continued passaging. 
 
 
3.1.1 Morphology and HESC marker expression 
 
Shef6 and Shef3 were maintained on mitotically inactivated mouse embryonic 
fibroblasts (MEFs) at a density of 9200 cells/cm2. Undifferentiated cells in both 
HESC lines had a similar appearance. The cells were small, round and grew in 
tightly compacted colonies, with a characteristic high nucleus to cytoplasm ratio 
(Thompson et al., 1998) (Fig. 3.2 A, D). At the colony edges, cells were slightly 
larger and more elongated. Colonies were usually passaged onto fresh MEFs feeders 
when they were large enough to fill a 10x objective (approximately 15,000 cells 
(Loring et al., 2007)). When colonies were allowed to grow much larger than this or 
left on old MEFs for prolonged periods, distinctive changes in cell morphology 
became increasingly common. Cells in the centre of colonies would gradually 
become larger and less compacted forming a hole like structure surrounded by 
compacted cells (Fig. 3.2 B, E).  After 15 days of continuous culture, the majority of 
colonies had lost their HESC like morphology and some had formed thick, multi-
layered clumps of differentiating cells (Fig. 3.2 C,F). 
 
Immunocytochemistry was carried out on cultures of Shef6 and Shef3, 5 days post 
passaging. HESC markers including transcription factor Oct4, keratin sulphate-
associated antigens Tra160 & Tra181 and the glycosphingolipid antigen, SSEA3, 
were used to assess undifferentiated phenotype. The majority of colonies observed in 
Shef6 and Shef3 were immunopositive for all of these HESC markers (Fig. 3.3); 
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however, a small number of differentiating colonies were also present. These 
colonies contained cells with reduced expression of HESC markers (Oct4, Tra160, 
Tra181, SSEA3) and were commonly found at the centres of large colonies (Fig. 3.4 
A).  Areas where HESC marker expression was absent were immunopositive for 
SSEA1 (Fig. 3.4 C), a marker of early differentiation in HESC (Draper et al., 2002). 
 
These results illustrate the heterogeneity typical in HESC MEFs co-culture. In an 
effort to minimise differentiation and improve reproducibility, we selectively 
passaged only colonies with undifferentiated morphology. 
 
 
3.1.2  Karyotypic stability 
 
Shef6 and Shef3 cell lines were karyotyped regularly. Karyology was carried out at 
TDL genetics (60 Whitfield Street, London) using G banding with up to 20 cells 
counted per sample. In the majority of cases Shef3 had a normal male 46 XY 
karyotype (Example Fig 3.5 A.) and Shef6 had a normal female 46 XX karyotype 
(Fig 3.4 B). On one occasion a sub-population of abnormal cells with 47 
chromosomes including an extra copy of chromosome 5 (TRISOMY 5) was detected 
in passage 81 Shef3 (Fig 3.5 C). This same abnormality (TRISOMY 5) was also 
detected on one occasion in a subpopulation of Shef6 passage 72 cells in addition to 
a sub-population with an extra copy of chromosome 17 and a translocation between 
the short arm of one X chromosome and the long arm of one chromosome 18 at 
breakpoint q11.2.   On these occasions no notable differences in cellular morphology, 
HESC marker expression or RPE differentiation capacity was observed. Within this 
limited sample size we observed no direct correlation between passage number and 
the incidence of karyotypic abnormalities; cells as late passage as 103 were found to 
have a normal karyotype (Fig 3.5 A).  
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3.2 Shef3 and Shef6 undergo spontaneous differentiation on MEFs 
forming pigmented foci with varying efficiencies 
 
The Shef6 and Shef3 HESC lines were derived by Harry Moore’s group in Sheffield 
using a microdrop culture system. The same group had previously derived the Shef1 
cell line which will be used to derive HESC for clinical trials (Carr et al., 2013) using 
similar methods (Draper et al., 2004, Aflatoonian et al., 2010). HESC-RPE 
differentiation in these two cell lines has yet to be reported in a published study. In 
this section we show, for the first time, that both cell lines are able to produce 
pigmented RPE. The changes in gene and protein expression during the process of 
continuous adherent differentiation in MEFs co-culture (Vugler et al., 2008) are 
described and the differentiation rate and efficiency in the two cell lines is assessed 
and compared. 
 
3.2.1 Spontaneous differentiation yields a subset of cells with 
anterior neuroepithelial characteristics  
  
Mechanically passaged clumps (approximately 1000 cells per clump) of Shef6 and 
Shef3 were seeded onto MEFs where they established typical round and compacted 
colonies of Oct4 immunopositive cells (Fig. 3.6 B, F). Cells were fed daily with 
+bFGF HESC expansion media and allowed to proliferate. By day 10, colony 
borders began to merge and Oct4 expression was lost in the centres of colonies (Fig. 
3.6 C, G.). Imaging of whole flasks revealed how individual colonies become 
increasingly large and opaque with time in culture (Fig. 3.6 A). At day 15, 
morphological examination revealed an increasing abundance of ‘holes’ in the centre 
of colonies containing less compacted Oct4 negative cells (Fig. 3.6 D, H). By day 20, 
Oct4 expression was almost undetectable by immunocytochemistry; cells had formed 
multilayered ridges and adopted a variety of distinct morphologies (Fig 3.6 E, I). 
Imaging of the whole flask at day 20 revealed a thick, opaque layer of cells covering 
the entire flask surface (Fig 3.6 A). 
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RNA was extracted from differentiating flasks over the first 15 days of early 
differentiation and QPCR was used to compare the relative changes in pluripotency 
gene expression. From days 3-6 there was a relative increase in expression of all 
HESC markers (Fig. 3.6 J). Relative expression of all HESC markers then decreased 
from day 6 onwards demonstrating a down regulation in the pluripotency circuitry 
with time. 
 
At day 20, immunocytochemistry was used to detect the presence of markers of 
neuroectoderm differentiation, Pax6 (Zhang et al., 2010), and anterior forebrain 
specification, Otx2 (Boncinelli et al., 1995). These transcription factors are critical to 
the step wise induction process that will eventually lead to a retinal phenotype 
(Zaghloul et al., 2005. Meyer et al., 2009).  Pax6 and Otx2 proteins were detected in 
clustered, neural-rosette structures found on multilayered and compacted ridges of 
cells (Fig. 3.7 A-F). These clusters were abundant in flasks at day 20 (Fig 3.7 G, H).  
QPCR was carried out on RNA extracted from whole flasks of Shef6 at time points 
leading up to day 25 (5 flasks all derived from the same starter culture). Pax6 
expression increased steadily from day 10 onwards, culminating in a 50 fold increase 
in relative Pax6 expression by day 25 (Fig. 3.7 I).  Otx2 expression did not undergo 
any large fold changes in gene expression over time (Fig. 3.7 J); this is likely due to 
the role played by this transcription factor during multiple stages of development 
including maintenance of the epiblast, forebrain specification and later RPE 
differentiation (Simeone et al., 1998, Bovolenta et al., 1997). This pattern of Otx2 
and Pax6 expression was also found in differentiating cultures of Shef3 by RT PCR 
up to day 50 (5 flasks derived from same starter culture). The Pax6 RT-PCR primers 
amplified both the Pax6+5a and Pax6-5a isoforms. Both have distinct DNA binding 
domains and the larger (Pax6+5a) is thought to be particularly critical to retinal 
development (Azuma et al., 2005). RT-PCR revealed that the expression of Pax6 
increased steadily over time in culture, with the larger fragment (arrow) becoming 
increasingly strongly expressed over time (Fig 3.7 K). 
118 
119 
120 
3.2.2 Pigmented foci first appear around day 30 following an 
upregulation in eye field and RPE gene expression 
 
Between days 10 and 20 of differentiation a lot of cell death was observed in 
differentiating cultures and the media would turn an intense yellow colour between 
daily media changes indicating significant lowering of pH over 24 hours. By day 25 
the intense colour changes had subsided and a thick contiguous sheet of cells was 
seen. Fluid filled bubbles were also frequently observed indicating a fluid pumping 
action and water-tight connectivity across the cell sheet.   In both cell lines, small 
pigmented foci were first easily detectable by eye between 25 and 32 days post 
seeding (15-22 days post bFGF withdrawal) (Fig. 3.8 A,B, arrows).  
 
Immunocytochemistry or FACs analysis was challenging at this stage as cells were 
very difficult to dissociate and a large amount of debris from the extra cellular matrix 
and dead cells interfered with the fluorescence signal. Extraction of RNA from lysed 
cells for QPCR was carried out to assess changes in gene expression over this time. 
The emergence of pigmented cells in Shef3 and Shef6 was accompanied by an 
increase in expression of Tyrosinase, Pmel17 and MitF from days 20-50 as detected 
by QPCR time course analysis (Fig 3.8 C-E) and RT PCR (Fig 8F);  these genes are 
critical for the synthesis of pigment in RPE (Bharti et al., 2006). There was a basal 
level of Pmel17 expression detected in HESC (Fig 3.8 F) but this was upregulated as 
pigment accumulated. In shef3, the RT-PCR time course suggested an earlier 
upregulation in MitF expression (day 10) than that detected by QPCR in Shef6 (days 
20 onwards). Temporal Tyrosinase expression faithfully followed the visible 
emergence of pigmented cells in both cell lines. 
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3.2.3 The kinetics of RPE accumulation in Shef6 and Shef3 
 
In designing a manufacturing process for a biological product an important 
consideration is the optimal time for harvesting the product. Measuring the 
emergence of pigmented foci over time allows us to carry out ‘on-line’ monitoring of 
HESC-RPE differentiation. The emergence of pigmented foci in Shef6 and Shef3 
was measured over up to 84 days of differentiation. Flasks of Shef6 (N=3) from 
passages 42-48 and Shef3 (N=3) from passages 45-47 were fed daily with 
differentiation media. Each flask was scanned every 3-5 days from day 25 onwards 
and images imported into Image J (see chapter 2 methods). Using the foci counting 
macro developed in Image J the kinetics of RPE accumulation in the two cell lines 
were established (Fig. 3.9).   
 
Pigmented foci were first detected earlier in Shef3 at Day 25, in Shef6 foci were first 
detected at day 32 in 3 out of 4 flasks. The rate of foci accumulation per cm2 from 
days 30-50 was significantly greater in Shef6 (0.5 foci/cm2/day, N=4), than Shef3 
(0.3 foci/cm2/day (N=3), (student’s unpaired t-test p<0.05). In Shef3 the rate of foci 
accumulation began to decrease from around day 50 onwards at which point each 
flask contained on average 157 ± 16 foci; in contrast, in Shef6, pigmented foci 
numbers continued to accumulate rapidly past day 50 (271 ± 13 per flask) up to the 
last measured time point day 58, (369 ± 38 per flask).  Comparing time points at 
which all flasks were measured, (days 25, 32, 42, 50 and 58), two way ANOVA 
revealed a significant effect of time (F(4,20) = 47.5, p<0.001), cell line (F(1,20) = 
18.4, p<0.001) and a significant interaction (F(4,20) = 14.31 p<0.001), indicating 
that the cell line effect increased with time in culture. Post-hoc unpaired student’s t-
test revealed significantly greater numbers of pigmented foci in Shef6 at days 50 and 
58 (p<0.01). 
 
These data show that the optimal time for harvesting RPE foci differs between the 
two cell lines; an earlier time point (~ day 50) is optimal in Shef3, whereas a longer 
time in culture would increase process efficiency in Shef6. 
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3.2.4 RPE yields are compromised at high HESC passages 
 
Human embryonic stem cells are heralded for their ability to expand indefinitely in 
culture; in spite of this, several studies have reported changes in cell behaviour over 
time in culture (Enver et al., 2005, Baker et al., 2007). In order to determine how 
time in culture might affect the ability of Shef6 and Shef3 to generate RPE, cells 
from both lines were differentiated using the above protocol over a broad range of 
passage numbers.  In each case, the number of pigmented foci per T25 flask was 
measured at day 50 using the auto-counting macro in Image J (see methods). All 
other variables were kept constant (MEFs batch, MEFs seeding density, media 
volume, media composition, time in culture, flask split ratio at passaging).  
 
 Cells were banked in small quantities at passage 30 therefore the earliest passage 
numbers at which cells were in sufficient quantities to carry out differentiation were 
between 40 and 45, the oldest passage numbers tested were between 80 and 90 (Fig. 
3.10 A,B). Combining the data from both cell lines and grouping the data into 
passage numbers (p) 40-50, 50-60 and 70-90, a decrease in foci yield was observed 
with increasing passage number (Fig. 3.10A). Two way ANOVA revealed a 
significant effect of passage number on foci numbers per cm2 (F(2,10)= 70.9, 
p<0.01) and a significant effect of cell line (F(1,10) = 5.8, p<0.05), but no significant 
interaction (F(2,10)=2.02, p=0.23). Both cell lines produced the highest RPE yields 
in the p40-50 group (Mean (Shef6 p 40-50) = 10.7 ± 0.9 SEM foci per cm2, Mean 
(Shef3 p 40-50) = 6.3 ± 0.7 foci per cm2).  Thereafter a drop off in foci yield was 
observed, with the combined yields of both cell lines at p50-60, significantly lower 
than in the p40-50 group (Student’s unpaired t-test p<0.01) and the combined yields 
in the 70-90 group significantly lower than the p40-50 group (p<0.01) (Mean (p40-
50 Shef6+Shef3)= 9.3±1.0 foci/cm2, (p50-60 Shef6+Shef3)= 3.0±1.0 foci/ cm2, (p70-
90 Shef6+Shef3) =0.2±0.1 foci/cm2). 
 
These data demonstrate a significant decline in RPE differentiation efficiency with 
increasing passage number.  To our knowledge, this is the first report demonstrating 
that the length of time for which the HESC have been in culture is a critical factor 
influencing the expected RPE yield.  
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3.3 RPE enrichment and Expansion 
 
After 50 days of differentiation we consistently observed large numbers of individual 
pigmented foci in low passage Shef6 and Shef3.  Pigmented cells occupy only ~0.1-
2% of the total surface area with foci nestled within a large amount of extracellular 
matrix and non-pigmented cellular material.  The next stage in the bioprocess 
requires the separation of pigmented foci from surrounding, non-pigmented material. 
 
3.3.1 Pigmented foci are manually isolated and re-plated to form 
‘cobblestone’ pigmented epithelial sheets that are positive for 
RPE markers. 
 
At day 60 the morphologies of several emerging foci were examined. We found there 
to be considerable variation in the size and shape of pigmented foci (Fig 3.11). In 
some cases a monolayer of pigmented cells could be observed fanning out from a 3 
dimensional heavily pigmented centre (fig 3.11 A, D); in other cases heavily 
pigmented, multilayered foci remained in small discrete areas (Fig 3.11 C). These 
differences are likely related to local spatial constraints and the asynchronous 
emergence of pigmented foci. 
 
At this time point the contiguous cell sheet was resistant to enzymatic dissociation. 
Trypsin had very little impact regardless of the concentration or treatment time. 
Collagenase at a high concentration (1mg/ml) was more effective at breaking apart 
the cell sheet.  Overnight collagenase treatment (1mg/ml, 8-10 hours) facilitated 
manual dissection of the individual foci with microsurgical blades. Although time 
consuming, this manual dissection method yielded foci that successfully adhered to 
Matrigel coated plates and expanded to form largely homogenous, pigmented 
epithelial sheets. 
 
The adherence and growth of cells from four typical foci was imaged over 35 days.   
Two days after the initial dissection most of the foci had successfully adhered to the 
Matrigel coated plates and proliferating cells were visible around the edges (Fig. 3.12 
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B). By day 7 pigmented cells with epithelial morphology were visible in all wells 
(Fig. 3.12 C). At day 18 the monolayers had expanded further (Fig. 3.12 D). In one 
well a contaminating cell type was visible at day 18 (arrow) which appeared to be 
restricting pigmented RPE proliferation; closer analysis revealed a non pigmented 
structure from which neuronal projections were emanating (Fig. 3.13 A,B). By day 
35 this structure appeared to have receded and pigmented epithelial cells occupied 
the whole area surround the foci (Fig. 3.13 C,D).  The rate at which pigmented cells 
accumulated in the wells appeared to vary considerably.  At day 35 pigmented, 
epithelial cells occupied the entire field of view in 2 out of the 4 wells (column 1, 4), 
and less than half of the same area in the remaining two (column 2,3). This did not 
appear to correlate with the size or rate of attachment of the original foci. 
 
In order to confirm the identity of the pigmented epithelial cells, expanding foci from 
both Shef6 and Shef3 were immuno-stained with RPE markers. Pigmented, 
polygonal cells from both cell lines stained positively for mature RPE cell markers 
CRALBP, Bestrophin, Otx2 and ZO1 (Fig. 3.14 A,B).   
 
Examples of multiple foci expanding in 24 well plates are shown in Fig. 3.15 A, B; 
the most heavily pigmented areas are visible closest to the original point of foci 
adherence (marked by arrows).  Bestrophin expression was restricted to these heavily 
pigmented cells found close to the adherent foci (Fig 3.15 D) demonstrating the 
specificity of the antibody to pigmented, non-proliferating RPE. Stitching multiple 
10 x microscope images together further demonstrated the change in pigmentation 
(high to low) and morphology (polygonal to elongated) with increasing distance from 
the adherent foci (Fig 3.15 C) as did immuno-staining for tight junction protein ZO1 
(Fig. 3.15 E). These characteristics of expanding RPE are consistent with 
observations in HESC derived from other cell lines (Vugler et al., 2008 (Shef1, 
Shef7), Liao et al., 2010 (H1, H9)). 
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3.4 Feeder-free differentiation in Shef6 and Shef3 
 
 
Mitotically inactivated MEF ‘feeders’ have been used in derivation and culture of 
human embryonic stem cells since the discovery of HESC (Thomson et al., 1998) 
and are an integral part of a number of published HESC-RPE differentiation 
protocols (Rowland et al., 2011). The use of MEFs may prove problematic in the 
manufacture of cells for cell therapy by risking the introduction of animal derived 
pathogens, and impeding the standardization of differentiation protocols (Chin et al., 
2007, Akopian et al., 2010). It is, therefore, desirable to generate HESC-RPE in 
feeder cell free culture environment. In these experiments we test RPE differentiation 
in the commonly used feeder-free systems employing Matrigel and MEFs 
conditioned media (CM) (Xu et al., 2001) and the commercially developed defined 
mTeSR1 media (Ludwig et al., 2006).  
 
At the time of these experiments, feeder cell free HESC-RPE differentiation using 
the continuous adherent method was yet to be demonstrated. In this section we aimed 
to answer the following questions:   
 
1. Can feeder-free HESC culture generate RPE in Shef6 and Shef3 using the 
continuous adherent method without the addition of growth factors or small 
molecules? 
2. What effect does the replacement of MEFs with feeder-free matrices and media 
have on RPE yields? 
 
 
3.4.1 Neuroectoderm conversion efficiency at day 15 in feeder cell 
free conditions 
 
Pax6 is a neuroectoderm fate determinant homeobox gene that is critical to the 
formation of both neuroectoderm and eye field (Zhang et al., 2010). It has previously 
been observed that Pax6 expression increases steadily over time during RPE 
differentiation in MEFs co-culture in both Shef6 and Shef3 (Fig. 3.7 I, K).  In order 
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to assess the neuroectoderm conversion efficiency in feeder-free cultures, Pax6 
upregulation in Shef6 and Shef3 was evaluated after 15 days of culture in feeder-free 
conditions. Shef6 and Shef3 cells were seeded onto MEFs or Matrigel and expanded 
for 10 days in HESC media or MteSR1 respectively, before switching to –bFGF 
differentiation media for the remaining 5 days. For comparison, cells from the same 
starter cultures were also differentiated as floating embryoid bodies, i.e. in the 
absence of external stimuli from MEFs, mTeSR1 or Matrigel.  Experiments in Shef6 
and Shef3 were carried out concurrently and over a range of passages in an attempt 
to decipher the inherent differentiation capacity of the cell lines (Fig. 3.16).   
 
Pax6 expression increased from days 5-15 indicating a degree of neuroectodermal 
conversion in all conditions. One way ANOVA was used to assess the significance 
of differences in Pax6 expression following the 3 differentiation methods. In Shef6, 
there was an overall statistically significant difference between all three methods 
(F(2,6)=37.6, p<0.01), with the embryoid body method producing the greatest 
upregulation (average fold increase 76.9 ± 7.3), followed by feeder-free 
differentiation on Matrigel with mTeSR1 (average fold increase = 46.1 ± 12.4) and 
with MEFs co-culture giving the lowest relative upregulation (average fold increase 
= 4.0 ± 2.2). In Shef3, the embryoid body method also gave the greatest fold increase 
(Average= 44.5 ± 5.4), though this was significantly lower than the upregulation seen 
in Shef6 embryoid body differentiation (p<0.05, student’s unpaired t-test).  In Shef3, 
MEFs co-culture produced a relatively large fold increase in Pax6 expression 
(Average = 32.5 ± 1.3); this was significantly higher than that seen in Shef6 in 
similar conditions (p<0.01, unpaired t-test) and was higher than (though not 
significantly different to) the fold increases in Matrigel + mTteSR1 (Average = 13.6 
± 9.9, p=0.3, paired t-test) suggesting that Shef3 is more prone to spontaneous rapid 
neuroectoderm differentiation in MEFs co-culture conditions. 
 
Shef6 and Shef3 cell growth rates were measured in the feeder cell free Matrigel 
+mTeSR1 condition (Fig 3.16 B). Both Shef6 and Shef3 proliferated successfully in 
Matrigel + mTeSR1 with viable cell numbers increasing over time. Shef6 however 
had a significantly higher growth rate than Shef3. Two way ANOVA revealed a 
significant  effect of time (F(2,18) = 227.5, p<0.001) and the cell line (F(1,18) = 
914.3, p<0.001) on total cell numbers and a significant interaction (F(2,18)=108.1,  
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p<0.001) with total viable cell numbers significantly higher at all time points in 
Shef6 (p<0.05, N=4, Student’s unpaired t-test).  
 
These results show that optimal conditions for neuroectodermal conversion differ 
between cell lines. Feeder-free differentiation on Matrigel significantly enhances 
Pax6 upregulation in Shef6 relative to MEFs co-culture but reduces it in Shef3 within 
the same time frame. In the absence of external stimuli (embryoid body 
differentiation), Pax6 is upregulated in Shef6 to a significantly greater degree than in 
Shef3 suggesting an enhanced innate propensity for neuroectodermal differentiation 
in Shef6. 
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3.4.2 Shef3 rapidly differentiate in absence of MEFs or MEFs-
conditioned media 
 
In order to further study the impact of feeder-free differentiation, Shef3 colonies 
were observed during the first ten days of differentiation in MEFs co-culture and 
feeder cell free conditions on Matrigel.  
 
Cell morphology is very difficult to observe in floating EBs so cells were instead 
plated onto Matrigel where they adhered and were fed with standard HESC media 
+bFGF. As before, Shef3 cells were also plated onto Matrigel and fed with MEFs 
conditioned media (CM) and on MEFs fed with standard HESC media for 
comparison. Colonies were observed in all conditions at day 3 and day 10 (Fig 3.17 
A.). In the Matrigel +HESC media condition, cells with differentiated morphology 
were abundant at the edges of colonies at day 3; cells grown on Matrigel in the 
presence of CM, however, formed colonies with typical HESC morphology. 
Colonies appeared to be larger in the Matrigel + CM condition compared to typical 
MEFs co-culture; this may be due to the lack of spatial constraints imposed by MEFs 
or due to enhanced HESC growth rates in Matrigel + CM.   At day 10, multilayered 
cell sheets with a variety of non HESC-like morphologies were visible in the 
Matrigel only condition in the presence of conditioned media; however, monolayers 
of compacted HESC-like cells were observed across the flasks. In MEFs, co-culture 
colonies had grown considerably in size and were beginning to merge but had not yet 
become completely confluent. 
 
QPCR was carried out on samples of Shef3 differentiating in the three conditions at 
day 10.  As before, Pax6 expression was significantly different in all conditions (one 
way ANOVA F(2,6)=150.0, p<0.05). Pax6 expression was higher in the adherent, 
Matrigel only condition than the other conditions (p<0.01, paired student’s t-test), 
demonstrating that rapid differentiation and upregulation of Pax6 occurs in the 
absence of MEFs or CM whether cells were differentiated in floating embryoid 
bodies or adhered to Matrigel (Fig 3.17 B). 
 
138 
3.4.3 Temporal gene expression changes during differentiation in 
feeder cell free conditions 
 
After 10 days expansion in the three conditions, the media was switched to 
differentiation media (HESC media –bFGF) for the remaining forty days of 
differentiation.   Cells from each condition were harvested at days 5, 10, 20, 30 and 
50 of differentiation for RT-PCR analysis (Fig 3.18.).   
 
In MEFS co-culture, Pax6 RNA was detectable at day 10 and continued to increase 
in abundance up to day 50. In Matrigel+CM a similar pattern was seen although the 
transcript appeared less abundant at days 10 and 50.  In the Matrigel only condition, 
however, expression was detected at day 10 only to be down regulated thereafter.    
A similar pattern was seen in Otx2 and Pmel17 expression with expression 
maintained, increasing over 50 days in the MEFs co-culture and Matrigel+CM 
condition, but down regulated from day 20 in the Matrigel only condition. MitF 
expression was also down regulated at day 50 in this condition. Temporal expression 
of Tyrosinase followed the appearance of pigment first detectable at days 20-30 and 
increasing in abundance over time in MEFs co-culture and MEFs-CM but virtually 
absent at days 30 and 50 in the Matrigel only condition. 
 
These results demonstrate that although differentiation in the absence of MEFs or 
MEFs-CM leads to rapid differentiation (as evidenced by early Pax6 expression), this 
method fails to sustain the gene expression necessary for long term RPE 
differentiation.   
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3.4.4 The effect of feeder-free differentiation on Shef3 RPE yields 
 
RPE foci numbers were counted using the auto-count macro in Image J (see 
methods) from scans of flasks taken at day 50 following differentiation in the three 
conditions in three separate experimental runs. It was observed that Shef3 produced 
significantly greater RPE yields when differentiated in MEFs co-culture relative to 
the other conditions (One way ANOVA, F(2,6) = 76.8, p< 0.05, student’s unpaired t-
test, p<0.001) (Fig 3.19 A).  At day 50, Shef3 in the Matrigel only conditioned had 
produced very few foci (Average =0.11± 0.05foci/cm2). Poor cell coverage across 
the flask was observed with only isolated colonies surviving.  Cells in the Matrigel + 
CM condition had a slightly improved yield (Average= 0.35± 0.27 foci/cm2) but not 
significantly so (p=0.43), despite a thick layer of cells covering the whole flask. 
QPCR analysis was carried out at day 50 in the three conditions. There was a 
significant difference in Tyrosinase and Pmel17 expression at day 50 between 
differentiation conditions (One way ANOVA, F(2,6)= 26.5, p<0.01, F(2,6)= 33.7, 
p<0.01 respectively) with the co-culture method resulting in significantly greater 
expression than in Matrigel only (p<0.01, student’s paired t-test) and Matrigel + CM 
(p<0.01). There were no significant differences in gene expression between Matrigel 
only and Matrigel + CM in either Tyrosinase or Pmel17 expression. 
 
Pigmented foci emerging in Matrigel + CM had a similar appearance to those seen in 
MEFs co-culture at day 50 (fig 3.19 C). The foci were manually extracted and 
expanded on Matrigel where they formed monolayers of pigmented cells with typical 
RPE morphology.  The pigmented cells were immunopositive for RPE markers 
Bestrophin and CRALBP (Fig 3.19 D). 
 
These results back up the findings in early differentiation and time course 
experiments. Although differentiation in the absence of MEFs or CM leads to rapid 
neuroectodermal conversion, it is not conducive to the production of high RPE yields. 
Very few RPE foci were generated in the Matrigel + CM condition relative to MEFs 
co-culture suggesting that additional growth factors or small molecules will be 
required to induce high yielding RPE differentiation in feeder-free shef3 culture.  
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3.4.5 The effect of feeder-free differentiation on Shef6 RPE yields 
 
In contrast to Shef3, differentiation in feeder-free conditions appeared to improve 
neuroectodermal conversion rates in Shef6, as evidenced by the significantly larger 
upregulation in Pax6 expression at day 15 in feeder-free conditions (Fig 3.16).   
 
The same conditions tested in Shef3 were tested in long term HESC-RPE Shef6 
differentiation experiments; cells were seeded into standard MEFs co-culture or onto 
Matrigel in HESC media or CM. In addition, the commercially available defined 
media, mTeSR1, was tested in combination with Matrigel. Colonies were observed at 
day 2 and day 8.  At day 2, HESC-like colonies were present in all conditions (Fig 
3.20 A) although the colonies were larger and more compacted in the MEFs co-
culture and Matrigel +mTeSR1 conditions. Similar to the observations in Shef3, 
Shef6 colonies grew into undifferentiated monolayers with compacted, HESC-like 
morphology by day 8 in all conditions, with the exception of the Matrigel only 
condition in which differentiating colonies were abundant.  Cell proliferation rates 
were measured in the mTeSR1 vs. CM condition over 8 days in culture (Fig. 3.20 B).  
Two way ANOVA revealed statistically significant differences in cell numbers over 
time between cells grown in mTeSR1 and CM; there was a significant effect of the 
media on cell numbers (F(1,18) = 17.1, p<0.01), and time (F(2,18) = 203.5, p<0.01) 
and a significant interaction (F(2,18) =  47.7, p<0.01) indicating an increasing effect 
of the media on cell numbers over time. After the first 3 days, cell numbers were 
significantly higher in wells fed with MEFs-CM (student’s paired t-test N=4 p<0.01) 
perhaps reflecting the greater similarity between MEFs co-culture and MEFs-CM 
and a required period of adaption of cells to the new mTeSR1 media. By day 8, 
however, cell numbers in mTESR1 fed cells were significantly higher (p<0.01, 
paired student’s t-test) which could be a result of the very high bFGF concentration 
in mTeSR1 (100ng/ml) (Ludwig et al., 2006). 
 
The impact of feeder-free differentiation on Shef6 RPE yields was determined by 
measuring the number of pigmented foci following 50 days of differentiation in the 
four conditions (Fig. 3.21).  Feeder-free differentiation on Matrigel substantially 
enhanced RPE yields in Shef6 (N=2 passage numbers 42, 54).   The greatest RPE 
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yield was observed when cells were expanded in mTeSR1 media (N=2, Average 
Foci/cm2= 15.9 ± 1.1) followed by CM (Average 13.0 ± 6.1 Foci/cm2), then MEFs 
co-culture (Average =7.6 ± 2.9 Foci/cm2). In line with this finding, the normalised, 
relative expression of RPE genes Pmel17 and Tyrosinase was greatest in the Matrigel 
+ mTeSR1 condition followed by Matrigel + CM, MEFs co-culture and the lowest 
relative expression  in the Matrigel + HESC media condition.   
 
In addition to the differences in RPE foci abundance, we observed differences in the 
thickness of the cell sheet at day 50 when cells were expanded in the different 
conditions.  Shef6 that were expanded in CM formed a patchy cell sheet at day 50 
(Fig 3.22 A) and large areas with sparse cell coverage were visible (Fig 3.22 B,C). 
Most of the thickened areas, however, contained an abundance of pigmented RPE 
cells, including large epithelial monolayers in addition to the usual discrete foci (Fig 
3.22 D,E). In contrast, cells that were expanded in mTeSR1 had formed thick, 
opaque sheets at day 50 which were dotted with small but abundant RPE foci (Fig. 
3.22 F-H). 
 
Whilst mTESR1 media facilitates rapid growth and undifferentiated maintenance of 
HESC, it does not contain an identical growth factor compliment to MEFs or CM. 
MTeSR1 derived pigmented foci were isolated and expanded in RPE medium. The 
expanding foci displayed typical RPE morphology and were immunopositive for 
RPE markers CRALBP, Bestrophin and MitF (Fig 3.23) thus confirming the RPE 
identity of these mTeSR1 derived pigmented cells. 
 
These results back up the findings in early differentiation experiments; Shef6 cells 
also require an expansion step in CM or mTESR1 and will not generate RPE foci on 
Matrigel alone.  In contrast to Shef3, Shef6 undergo enhanced neuroectodermal 
conversion in feeder-free conditions relative to MEFs co-culture leading to high RPE 
foci yields. Both Shef6 and Shef3 have reduced cell sheet thickness and coverage in 
Matrigel+CM relative to MEFs co-culture, but an expansion step in defined mTeSR1 
media increases cell sheet coverage as well as RPE Foci yields. 
146 
147 
148 
149 
 150 
3.5 Discussion 
 
 
Continuous adherent differentiation of HESC in MEFs co-culture is one of the most 
commonly used methods for deriving HESC-RPE; this method continues to produce 
high pigmented cell yields from a wide range of cell lines (Klimanskaya et al., 2004, 
Vugler et al., 2008, Buchholz et al., 2009, Carr et al., 2009b, Laio et al., 2010, Clarke 
et al., 2012). It has been repeatedly shown that pigmented cells derived using this 
method are akin to native RPE  with appropriate morphological characteristics, 
protein and RNA expression profiles and functional properties (Klimanskaya et al., 
2004, Vugler et al., 2008, Buchholz et al., 2009, Carr et al., 2009b, Laio et al., 2010, 
Clarke et al., 2012). In this chapter we have demonstrated for the first time the 
derivation of pigmented RPE cells from two new cell lines, Shef6 and Shef3, which 
expand to form pigmented, ‘cobblestone’ monolayers of cells expressing a range of 
typical RPE markers. 
 
Early spontaneous differentiation followed a similar course in the two cells lines; 
differentiating colonies were found in increasing abundance as the cultures grew 
over-confluent with differentiating cells first detectable in the centres of large 
colonies. By day 20 the edges of colonies had formed multi-layered ridges in which 
Pax6/Otx2 positive neural rosettes formed. The spontaneous emergence of 
Pax6/Otx2 positive neural rosettes has been described in other cell lines (Pankratz et 
al., 2007, Chambers et al., 2009, Hu et al., 2010a) and is consistent with the default 
neural model of human embryonic stem cell differentiation, wherein HESC derived 
neuroectodermal cells adopt anterior neuroepithelial characteristics in the absence of 
exogenous signalling (Pankratz et al., 2007, Elkabetz et al., 2008).  The RPE is the 
first differentiated cell type to emerge during development of the human eye and 
pigmentation is first detected between post ovulatory weeks 5-6 (O’Rahilly, R., 
1975). HESC lines are derived from blastocysts at day 5-7; the emergence of 
pigmented cells in our cultures between days 25 and 32 post seeding, therefore, is a 
little faster than the timing of RPE emergence in vivo (Meyer et al., 2009) given the 
10 day expansion step prior to bFGF withdrawal. It is difficult to assign a specific 
start point to the differentiation in this protocol, however; the loss of Oct4 expression 
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was seen during the 10 day expansion step but was asynchronous amongst colonies 
(Fig 3.6). Our observations are at the shorter end of the range of times described by 
others using similar protocols; for example, the emergence of pigmented foci has 
been observed at 17-30 days post seeding (Vugler et al., 2008, Carr et al,. 2009b), 
and at 35-60 days (Klimanskaya et al., 2004, Lund et al., 2006). Consistency is 
evidently a problem when generating HESC-RPE by this method.  Very careful 
maintenance of the HESC starter culture and selectively passaging only equally sized 
colonies with undifferentiated morphology greatly improved reproducibility in our 
experiments and allowed us to gather meaningful data on the effects of external 
factors on differentiation yields. Where possible, we tried to keep passage number 
ranges small within each experiment. Nevertheless, 50 days is a long time in cell 
culture and we found contamination of the cultures to be a continual problem.  GMP 
accredited clean room facilities and the automation of cell feeding procedures would 
greatly reduce these risks. 
 
In designing a manufacturing process for a biological product an important 
consideration is the optimal time for harvesting the product; harvesting the product 
too early can mean significant losses in potential yield, harvesting too late wastes 
time and resources as well as incurring unnecessary risks of contamination or other 
sources of damage to the product (Placzek et al., 2009). In the case of RPE 
differentiation, the pigmented phenotype lends itself to non-destructive ‘on-line’ 
monitoring of emerging RPE by image analysis enabling determination of 
differentiation rates and thus the optimal time to harvest the RPE product.  
Determination of the differentiation rates of other morphologically distinct cell types, 
such as neurons, have been attempted using complex image recognition software and 
time lapse microscopy systems set up inside incubators (Lappalainen et al., 2010); or, 
in the case of cardiomyocyte differentiation, by manual counting of visibly 
contracting areas (Passier et al., 2005).  In our case, regular imaging of whole flasks 
using the scanning device described in chapter 2, followed by automated image 
processing was a robust, inexpensive and time efficient way to establish HESC-RPE 
differentiation rates. 
 
We found that the two cell lines used have significantly different RPE differentiation 
rates. In Shef3, RPE Foci numbers did not increase significantly past day 50. 
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Continuing to culture Shef3 beyond this time would use up resources without 
increasing the RPE yield. Shef6 cultures commenced rapid differentiation up to 10 
days later, however, and the rate of RPE accumulation was still high up to day 58. 
Harvesting pigmented foci at the same time in both cell lines would clearly be 
inappropriate. Our results demonstrate the value of determining differentiation rates 
for each cell line and incorporating this into the design of manufacturing processes 
for any HESC derived cell therapy product.  Although early clinical studies using 
HESC derived RPE make use of only one cell line (Schwartz et al., 2012), the advent 
of IPSC technology and the prospect of generating HLA matched cell therapies is 
predicted to demand the use of multiple cell lines (Carpenter et al., 2009).  
 
Differentiation-rate analysis in more HESC lines will be required to establish 
whether the disparity between Shef6 and Shef3 RPE accumulation rates are typical 
among cell lines or whether one is more typical than the other. We were able find 
evidence of only one other analysis of RPE differentiation rates in the literature, 
carried out in the H9 cell line (Rowland et al. 2010).  In this study, a steady increase 
in foci numbers was observed from day 28, reaching up to 4 foci per cm2 at day 51. 
The average rate of accumulation was 0.15 foci/cm2/day (days 30-50 post seeding). 
In our system Shef6 had an RPE accumulation rate of 0.53 ± 0.03 foci/cm2/day and 
Shef3 0.27 ± 0.02 foci/cm2/day (days 30-50 post seeding). Unfortunately, this study 
did not record the differentiation rate past day 50 so it is unclear if this rate was 
maintained up to day 60 (as in Shef6), or declined (as observed in Shef3).  We were 
able to monitor differentiation up to day 84 in Shef3; in Shef6 flasks, however, the 
cell sheet tended to become increasingly fragile over time and frequently began to 
peel off the culture plastic surface such that measurements could only be taken up to 
day 58. Cell sheet peeling is a drawback of the continuous adherent method for RPE 
differentiation; GMP compliant measures to tackle this problem (e.g. tethering the 
cell sheet) have yet to be described and would be a helpful development in RPE 
manufacturing methods. 
 
The observation that pigmented cells appeared earlier in Shef3 may reflect a more 
rapid departure from pluripotency in Shef3. Throughout continuous culture we noted 
that spontaneous differentiation during routine maintenance was more common in 
Shef3. It was also observed that the HESC growth rates were significantly lower in 
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Shef3 (Fig 3.16 B). The higher RPE foci yields that were consistently observed in 
Shef6, as well as the higher Pax6 expression following EB differentiation, indicate a 
greater innate preference for neuroectoderm differentiation, as has been described in 
other cell lines (Osafune et al., 2008). However, the contribution of cell growth rates 
and spontaneous differentiation rates may be of equal importance in determining 
differentiated cell yields (Tavakoli et al., 2009). 
 
One of the important advantages of using HESC as a starting material for cell 
therapies is that the cells can undergo considerable expansion in culture without 
compromising their pluripotency (Thomson et al., 1998, Reubinoff et al., 2000). In 
spite of this a number of groups have reported changes in cell behaviour over time in 
culture (Draper et al., 2004, Enver et al., 2005, Baker et al., 2007).  We sought to 
determine the effect of prolonged culture on HESC-RPE differentiation yields. We 
observed a significant reduction in RPE yield with increasing passage number. 
Previously reported differences between high and low passage cells include 
enhanced growth rates, improved single cell cloning efficiency and a reduction in 
apoptosis, changes which are attributed to the selective pressures imposed by serial 
passaging (Enver et al., 2005, Herszfeld et al., 2006). It has also been suggested that 
culture adapted cells will become increasingly differentiation resistant (Baker et al., 
2007) though this has not previously been systematically investigated. Our 
observation of the gradual decline in RPE yield over time in cultures is, therefore, a 
novel and important insight into the behaviour of differentiating HESC. A significant 
reduction in process efficiency with time will be an important consideration in the 
design of a HESC-RPE manufacturing process.  These data indicate that, ideally, 
only cells from the low passage numbers should be used in HESC-RPE manufacture 
using the spontaneous differentiation method.  
 
The image analysis methods applied here allows us to determine relative HESC-RPE 
conversion rates; the absolute number of RPE cells yielded however, will depend 
entirely on the ability of the operator to mechanically isolate individual foci and the 
proliferative capacity of individual foci.  The mechanical isolation step is critical as 
non-RPE contaminating cell types could compromise both the safety and efficacy of 
a cell therapy for AMD. We detected up to 300 individual pigmented foci emerging 
from a typical low passage Shef6 flask; manual isolation of this many foci is clearly 
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impractical. This part of the process could also benefit from automation. One 
promising technology for this purpose is laser-assisted micro dissection and pressure 
catapulting (LMPC) (Terstegge et al., 2009); this method uses a laser to cut tiny 
areas of adherent cells and pressure to propel the cut out areas into solution. Another 
solution may come from a carefully optimised enzymatic dissociation step as has 
been developed for the isolation of neural rosettes from differentiating HESC 
cultures (StemDiffTM Neural Rosette Selection (STEMCELL technologies)). 
 
We observed that the rate at which the RPE monolayer expanded from individual 
foci was highly variable; after a month in culture, pigmented cells filled the whole 4x 
field of view around some foci, and only half the area in other cases. It would be 
interesting to determine if the proliferative capacity of individual foci is related to 
their size or the time at which they first emerge in culture. Since the pigmented foci 
appear at different time points over a time span of one to two weeks, it is reasonable 
to assume that the isolated foci have a range of developmental maturity which has 
been shown to be a function of time in culture and expansion status (Zhu et al., 2013). 
It has been widely noted that HESC derived RPE have limited proliferative capacity, 
necessitating their repeated derivation from undifferentiated cells; loss of RPE 
phenotype has been reported to occur after 3-5 passages with cells losing 
pigmentation and acquiring a fibroblastic character (Vugler et al.. 2008, Buchholz et 
al., 2009, Kokkinaki et al., 2011).  
 
 Despite variation in proliferation from the adherent foci, pigmented cells derived 
from our cultures consistently displayed typical RPE morphology and were positive 
for RPE markers including MitF, CRALBP, Bestrophin, ZO1, Otx2 and Pax6.  Pax6 
expression in the RPE diminishes over time in vivo (Martinez-Morales et al., 2004) 
and thus Pax6 expression in our cultures indicates a relatively immature phenotype. 
This is consistent with observations by others that HESC-RPE has an expression 
profile similar to foetal RPE (Lu et al., 2009, Liao et al., 2010).  The expansion 
capacity of HESC-RPE will be an important parameter in the design of a 
manufacturing process and more research is required in this area.  
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Feeder-free Differentiation: 
 
MEFs ‘feeders’ are utilised in a clinically approved protocol for the manufacture of 
HESC-RPE for the treatment of macular degeneration (Schwartz et al., 2012).  The 
use of MEFs entails a number of processing challenges and regulatory complications 
however including batch to batch variability and xenogeneic contamination.  We 
sought to derive RPE from Shef6 and Shef3 in feeder-free continuous adherent 
conditions and to asses the impact on relative RPE yields. 
 
It has been proposed that the specific growth factors secreted by MEFs are 
particularly conducive to RPE differentiation (Vugler et al., 2008). MEFS secrete 
TGFβ superfamily members including activin A (Hongisto et al, 2012), which 
enhances MitF expression and pigmentation in vivo (Fuhrmann et al., 2000). They 
also secrete proteins involved in  IGF, BMP and Wnt signalling (Gerber et al., 2007, 
Bendall et al., 2009) pathways that are involved in the embryonic development and 
maintenance of RPE (Martinez-Morales et al., 2004).  Since the work presented here 
was carried out, three other groups have reported successful feeder-free HESC-RPE 
derivation using the continuous adherent method (Zahabi et al. 2012, Rowland et al. 
2012, Sridhar et al., 2013) and several have derived HESC-RPE via an EB based 
protocols that do not require feeder cells (Nistor et al., 2010, Vaajassari et al., 2011, 
Meyer et al., 2011,  Kokkinaki et al., 2011, Nakano et al., 2012, Mellough et al. 2012, 
Hongisto et al., 2012). In these studies, the feeder-free derived isolated RPE product 
has proven indistinguishable from those derived in MEFs co-cultures. In this study, 
we demonstrate that feeder-free differentiation has a significant impact on RPE yield. 
We found that Shef3 differentiation benefited significantly from the use of MEFs, 
whereas Shef6 cells were able to produce high RPE yields on Matrigel following 
expansion in CM or mTeSR1.  It remains unclear whether these differences in the 
responses of the two cell lines are due to the effect of MEFs on growth/survival or 
specific mechanisms to do with eye field specification. Apart from this study, there 
has been only one recently published account directly comparing pluripotent stem 
cells-RPE differentiation efficiency in MEFs co-culture to feeder-free culture 
(Rowlands et al. 2012). In this study it was found that H9 cells generated ~50% 
fewer pigmented foci/cm2 on Matrigel relative to hs27 human feeders.  Interestingly 
in the IPSC line iPS (IMR90)-3, the Pigmented cell yield at was significantly higher 
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in feeder-free conditions (Matrigel) than in MEFs, similar to our findings in Shef3 
and Shef6 respectively.  
 
In spite of the apparently favourable RPE-inducing properties of MEFs, their use in 
the manufacture of a cell therapy has some obvious disadvantages. Only early 
passage MEFS seem to be conducive to HESC maintenance, necessitating the 
repeated extraction and establishment of new MEF cell cultures and introducing 
significant batch to batch variability (Chin et al., 2007. Akopian et al., 2010). 
Variability between feeder batches has been shown to cause significant differences in 
their ability to support HESC growth and in the extent and range of HESC 
differentiation in the culture dish (Chin et al., 2007), thereby impeding the 
standardization of stem cell cultures. Undefined components such as MEFs and 
serum also interfere with studies on the effects of exogenous agents of stem cell 
differentiation (Vallier et al., 2009).   The use of MEFS also carries an associated 
risk of animal-related pathogenic contaminations which complicates the regulatory 
landscape in cell therapies destined for human use (Rao et al., 2008). Alternative 
animal-free strategies for HESC maintenance include the use of human derived 
foreskin fibroblasts and so called ‘autogenic’ feeders derived from HESC lines 
themselves (Richards et al., 2002, Chen et al., 2009) but these carry many of the 
same problems as MEFs in terms of standardization and reproducibility of stem cell 
cultures. 
 
A number of feeder-free media formulations for HESC maintenance have been 
developed but with limited success.  MEFs conditioned media (CM) in combination 
with Matrigel has proven to be a robust method for feeder cell free HESC 
maintenance (Xu et al., 2001).  CM can be manufactured in large quantities, batch 
tested and stored, but it is only a partial solution to the problems described above. A 
number of defined feeder-free media formulations have also been developed in 
recent years. The most prominent of these were comprehensively tested by 4 
laboratories in over 10 cell lines as part of the international stem cell initiative 
(Akopian et al.. 2010).  The conclusion of this extensive study was that only two, 
commercially developed medias, mTeSR1 and STEMPRO are up to the task of 
robust HESC maintenance comparable to MEFs-CM or MEFs co-culture.   At the 
time of conducting these experiments mTeSR1 in combination with growth factor 
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reduced Matrigel was the most widely published feeder-free method.   MTeSR1 
contains high concentrations of the growth factors FGF and TGFβ which stimulate 
major anti-differentiation signalling pathways. In addition, it contains lithium 
chloride, a GABA agonist/non specific WNT antagonist (Ludwig et al., 2006). 
Matrigel is a basement membrane preparation derived from the Englebreth-Holm-
Swarm sarcoma, the major components are Laminin, collagen IV, entactin and 
heparin sulfate proteoglycan (Product specification sheet, BD biosciences). The 
Matrigel matrix has proven to be particularly good for pluripotent HESC 
maintenance as well as RPE differentiation and maintenance (Rowland et al., 2012, 
Nakano et al., 2012, Zhu et al., 2013). 
 
In this study, we used Pax6 upregulation as a method for determining neuroectoderm 
conversion rates in Shef6 and Shef3 during early differentiation in feeder-free 
conditions. Our finding that the most rapid neuroectodermal conversion was 
achieved in the absence of MEFs or MTeSR1/CM was not surprising, given that 
MEFs and MteSR1 stimulate key pluripotency signalling networks such as FGF and 
activin/nodal/TGFβ (Beattie et al., 2005, Vallier et al., 2005, Greber et al. 2007, Xu 
et al., 2008). It was interesting to note that Shef6 EBs had a significantly greater 
Pax6 upregulation than Shef3 over a range of passages. This suggests that Shef6 has 
a higher innate propensity for neuroectoderm conversion, which may go some way to 
explain the larger RPE yields we consistently observed in Shef6.  Differences in the 
propensities of HESC lines to undergo differentiation into particular lineages have 
been widely noted (Allegrucci et al., 2007, Osafune et al., 2008, Kim et al., 2010, 
Lappalainen et al., 2010). 
 
Despite the efficient short-term neuroectoderm conversion, we found that Shef6 and 
Shef3 cells that were plated directly onto Matrigel in the absence of MEFs, CM or 
mTeSR1 failed to produce RPE foci within 50 days. Temporal gene expression 
analysis demonstrated a significant down regulation in critical RPE genes from days 
20-30 in these cultures.  These results suggest that an ‘expansion step’ at the start of 
the process in the presence of a suitable expansion media  (Mefs, CM or mTeSR1) is 
critical to effective RPE differentiation, in both cell lines. 
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There are several possible explanations for this. The ratio of RPE foci generated per 
undifferentiated cell seeded is small, especially in Shef3.  In the absence of an 
expansion medium, there is only a short period of proliferation before cells begin to 
differentiate, and the colonies do not reach confluence. Several days expansion in a 
medium such as mTeSR1 or CM prior to growth factor withdrawal may be required 
to increase the statistical likelihood of consistently generating RPE. A second 
possibility it that high cell density is a requirement for effective RPE differentiation; 
others have noted a reduction in neuroectoderm conversion efficiency at low cell 
density (Chambers et al., 2009). A third possibility is that factors secreted my MEFs 
and found in mTESR1 specifically prime HESC for RPE differentiation and in their 
absence the majority of cells differentiate into non-pigmented cell types that do not 
express Otx2,  Mitf, Tyrosinase, or Pax6 past day 30.  The finding by others that 
pigmented RPE form in floating Embryoid bodies in the absence of MEFs, CM or 
mTeSR1 (Idelson et al., 2009, Meyer et al., 2011) suggests that these media are not 
intrinsically critical. Nevertheless, the majority of these EB based protocols add 
supplements and growth factors to stimulate neural/retinal differentiation which is 
suggestive of poor yields in their absence (Osakada et al., 2009, Nistor et al., 2010, 
Nakano et al., 2012, Zhu et al., 2013- see table 1.1). 
 
In this study we demonstrate the derivation of HESC-RPE from Shef3 and Shef6 in 
feeder cell free conditions. Perhaps surprisingly, we observed different responses in 
the two cell lines to feeder-free differentiation.  Shef6 responded to feeder-free 
conditions by significantly increasing relative Pax6 upregulation and producing 
enhanced RPE foci yields relative to MEFs co-culture, whereas Shef3 had 
significantly reduced Pax6 expression and RPE foci yields in the same conditions. 
Evidently MEF feeders supply Shef3 with growth factors that encourage 
neuroectodermal and RPE differentiation but are absent in CM/mTeSR1, 
alternatively a component of Matrigel inhibits RPE differentiation in Shef3.  Shef3 
had a significantly slower growth rate in Matrigel+mTeSR1 than Shef6, perhaps the 
Shef3 cultures did not reach sufficiently high densities by the time differentiation 
was initiated.  It has been well documented that significant differences in growth 
rates exist between HESC lines (Cowan et al., 2004, Tavakoli et al., 2009), in 
addition genotypic and epigenetic differences between cell lines affect their 
endogenous expression of FGFs, Nodal, BMPs as well as expression of FGF/ TGFβ 
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receptors and cell attachment proteins (Akopian et al., 2010). These differences 
affect the relative ability of different cell lines to proliferate and remain 
undifferentiated. Our results suggest that the differing growth factor requirements of 
the two cell lines not only determine their ability to grow and differentiate but also 
critically impact their capacity to produce RPE in feeder-free conditions. 
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2.6 Conclusion 
 
 
Here we describe in detail the generation of HESC-RPE in continuous adherent 
MEFs co-culture in two new cell lines Shef6 and Shef3.  In both cell lines, RPE foci 
appeared spontaneously around day 25-32 consistent with the appearance of 
pigmented cells during embryonic development (O’Rahilly 1975).  Although both 
cell lines underwent a similar sequential expression of markers appropriate to the 
various developmental stages, the rate at which RPE foci began to accumulate in 
culture differed significantly.  The process of spontaneous differentiation in MEFs 
co-culture is highly variable due to a number of undefined and uncharacterised 
components in the differentiation set up. The genetically and epigenetically distinct 
cell lines contribute further to the unpredictability of RPE cell yields.  We describe 
the use of a simple, efficient, semi-automated method for reproducibly measuring 
differentiation efficiency. This method enabled us to compare RPE yields confidently 
over time and revealed a distinctive reduction in differentiated cell yields with 
increasing passage number in both cell lines: a property of HESC in culture that has 
been implied but never shown (Barker et al., 2007).  In addition, we use this method 
in combination with gene expression analysis to characterise the responses of the two 
cell lines to feeder-free culture. We found that commonly used feeder-free methods 
employing Matrigel +conditioned media/mTeSR1 produced significantly higher RPE 
yields in Shef6 but were insufficient for differentiation in Shef3.  We hypothesise 
that this result is due to inherent differences in autogenous signalling controlling 
growth factor responses and growth rates and between the two cell lines.  HESC 
expanded on MEFs are already being used in a clinical study aimed at treating 
macular degeneration (Schwartz et al., 2012).  As the field expands and, as predicted, 
multiple cell lines are used to create patient specific RPE cell therapies, 
comprehensive characterisation of parameters such as differentiation rates and 
analysis of the optimal differentiation methods for each cell line will be essential for 
cost effective manufacturing. 
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Chapter 4: Differentiation efficiency: the impact of 
seeding density and single cell dissociation 
 
 
 
4.1. Introduction 
 
From a manufacturing perspective, the ideal RPE differentiation process will 
generate the largest quantity of RPE with the minimal usage of raw materials, 
physical lab space, labour and time. The critical raw materials in this process include 
undifferentiated HESC, expansion and differentiation media, tissue culture plastic 
and mouse/human feeders or Matrigel. 
 
The HESC seeding density is fundamental in determining raw material usage. Higher 
density seeding will require an input of more undifferentiated HESC per culture unit 
(T25 flask) but, assuming HESC-RPE differentiation efficiency remains constant, 
higher density seeding will require less physical lab space, labour and media per RPE 
foci generated. Therefore an assessment of the relative costs of generating 
undifferentiated HESC versus the cost of materials used per flask will be required to 
determine the most financially efficient conditions. In addition it will be necessary to 
determine what impact, if any, HESC seeding density has on the HESC-RPE 
conversion rate (differentiation efficiency). Seeding density is a difficult variable to 
control using standard HESC culturing procedures where HESC colonies are 
manually cut into clumps of undefined size before seeding. Perhaps as a consequence 
there have been few studies correlating HESC seeding density with target cell yield 
or examining the impact of changes in seeding density on differentiation efficiency. 
There are currently no published studies addressing this issue in HESC-RPE 
differentiation. 
 
In addition to the impact on raw material usage, there is evidence suggesting that 
seeding density may govern early cell fate decisions during differentiation protocols; 
this could be critical to the final RPE product purity. The maintenance of 
pluripotency in HESC relies on autocrine and paracrine signalling from neighbouring 
undifferentiated cells (Peerani et al., 2007). The size of cell colonies, their proximity 
to each other and the overall cell density influences the balance between pluripotency 
and differentiation as well as cell fate decisions (Chin et al., 2007, Bauwens et al., 
2008, Peerani et al., 2007).  Bauwens et al. have previously used micro-patterning to 
establish HESC colonies of defined size and found that larger colonies have higher 
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Oct4 and Pax6 expression, indicating better conditions for maintenance and an 
enhanced propensity for neuroectoderm differentiation in larger colonies. Peerani et 
al. found that higher local cell density had a positive correlation with the expression 
of pluripotency marker Oct4, and Chin et al. have shown that serial passaging at low 
cell density increases spontaneous differentiation. This is in part attributed to the 
active secretion of FGFs, activin A and Noggin by pluripotent HESC. As discussed 
in chapter 3, these factors play key roles in the maintenance of the pluripotency 
network and inhibition of differentiation-inducing signals such as BMP.  In a study 
aiming to generate dopaminergic neurons from HESC, it was observed that varying 
the initial seeding density had a direct impact on the relative proportions of 
differentiated cells yielded; high plating densities were found to enhance the 
proportion of cells adopting an anterior neuroepithelial phenotype whereas plating at 
low density lead to more cells with a neural crest identity when subjected to a 
multistage directed differentiation (Chambers et al., 2009).  
 
In the HESC-RPE differentiation protocol described by Vugler et al., 2008 
(described in chapter 3), differentiation is initiated in part by allowing the cells to 
become over confluent. Variations in seeding density will also influence the time 
taken for the monolayer of cells to reach confluence and could thereby affect the rate 
of differentiation. 
 
 Despite the many RPE differentiation protocols devised and published in recent 
years (Table 1.1), there has been no account of the influence of seeding density on 
the RPE differentiation process or description of optimum seeding densities for 
efficient RPE production. Given the importance of this variable in defining raw 
material usage (and therefore processing costs), as well as its likely impact on 
lineage decisions, this is an important gap in our understanding of optimum 
differentiation conditions. 
 
This chapter describes an investigation into the influence of HESC seeding density 
on RPE differentiation yield in co-culture with MEFs feeders after mechanical 
passaging and in feeder-free conditions, using single cell dissociation. Experiments 
are described to test the hypothesis that seeding density has a significant impact on 
RPE differentiation yield and efficiency. The effects of cell density on pluripotency, 
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early lineage decisions and eventual RPE yield are examined. A single cell seeding 
protocol is described which is more amenable to scale up than traditional passaging 
methods and allows for the establishment of an optimal range of seeding densities 
that generate the maximal yield per cell seeded and per cm2.  
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4.2 Mechanical passaging  
 
4.2.1 Mechanical passaging can lead to uneven colony 
distribution and variable differentiation rates 
 
Mechanical dissection of HESC colonies with a pipette is the most common method 
used to passage HESC in order to maintain pluripotency and cell viability (Loring et 
al., 2007, Watanabe et al., 2007). Dissected HESC colonies (~1000 cells per clump) 
were transferred to a fresh flask of inactivated MEFs and the flasks were shaken 2-3 
times to encourage even distribution of the clumps.  
 
Scanning T25 flasks at day 6 against a dark background enabled visualisation of 
HESC colonies. It was observed that dissociated clumps would often aggregate, 
leading to an uneven distribution across the flask surface (fig 4.1 A). This could be 
partially avoided by seeding at lower density. Immunostaining with Oct4 at day 
seven showed that HESC in the aggregated clusters appeared to have down-regulated 
Oct4 relative to those colonies with more space in which to expand; cells in 
aggregated clusters had also undergone morphological changes (fig 4.1 B). After 50 
days of differentiation, pigmented foci were visible. The foci were unevenly 
distributed in a pattern which mimicked the uneven HESC colony distribution at day 
10 (fig 4.2 A). Areas with high HESC colony density produced many RPE foci at 
day 50 (white circles), whereas areas with low colony density at day 2 had produced 
no pigmented foci by day 50 (red circles). In these low density areas there was poor 
cell coverage at day 50 despite visible HESC colonies at day 15 (arrow). This 
suggests poor cell survival following long-term differentiation in low density areas. 
Taken together, this demonstrates the necessity for controlled seeding density and 
even cell distribution in order to synchronise differentiating populations and generate 
RPE at a consistent and reproducible rate. 
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4.2.2 HESC colony density and RPE yield 
 
In order to keep a constant seeding density during HESC maintenance the ‘split ratio’ 
is often maintained (e.g. one flask is split into two or three at each passage).  To 
determine the impact of different split ratios on RPE yield, undifferentiated Shef6 
HESC were mechanically passaged and seeded at three different split ratios: 1 into 4 
(low density), 1 into 2 (medium density) and 2 into 1 (high density). The actual 
number of colonies seeded for each run were counted at day 7 (table 4.1) and the 
continuous adherent RPE differentiation protocol was carried out for a total of 50 
days. The number of pigmented foci in each flask was measured from days 40-50 
using the scanning device and auto-count analysis in Image J (see chapter 2, 
materials and methods). One high density flask was discounted from the analysis due 
to uneven distribution of HESC colonies following seeding. In all cases the numbers 
of pigmented foci increased from days 40-50, but there were differences between 
those seeded at high and low density (Fig. 4.3 B-E). 
 
Two way ANOVA revealed a significant effect of seeding density on pigmented foci 
number (Fig. 4.3 B).  There was a significant effect of time on foci number (F(3,28) 
= 49.1,  P<0.001) a significant effect of density on foci number (F(2,28) = 19.4, 
p<0.001) and a significant interaction (F(6,28) = 14.1, p<0.001) suggesting that the 
density effect increased with time in culture. At day 50 the average RPE foci yields 
were greater in the high seeding density group (mean = 611 ± 106 SEM foci per 
flask) than in the medium (mean = 234 ± 35) or low density groups (mean = 99 ± 18). 
 
RNA was extracted from the day 50 cultures and QPCR was carried out to determine 
expression of Tyrosinase and Pmel17, two genes critical to the process of melanin 
synthesis and RPE differentiation. The expression of Pmel17 and Tyrosinase is 
shown relative to expression in the low density condition for each of the runs (Fig. 
4.4). Expression of both genes correlated with the quantity of visible RPE foci at day 
50, with the higher density conditions having the greatest fold increase in Pmel17 
and Tyrosinase gene expression. 
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4.2.3   Differentiation Efficiency per HESC Colony 
 
Having established a relationship between HESC seeding density and RPE yield over 
time it was next sought to determine which seeding density gave the most efficient 
differentiation per HESC colony. Split ratio is an arbitrary measurement being 
entirely dependent on how confluent the starting culture was before splitting – 
something that may vary over time in culture and between different labs.  A more 
relevant measurement is the number of colonies seeded. To determine this, flasks 
were scanned against a dark background at day 6 and the number of individual 
colonies counted using ImageJ software. The variability in number of colonies 
seeded was particularly large at higher seeding densities (table 4.1). 
 
 
  Number Of Colonies Seeded 
Flask Split Ratio 1 in 4 1 in 2 2 in 1 
Run1 (p44) 302 405 812 
Run2 (p45) 322 486   
Run3 (p47) 288 456 701 
              
Table 4.1 Number of colonies at different split ratios over three passages 
 
For each flask, the number of RPE foci per HESC colony seeded was plotted against 
the number of HESC colonies seeded per T25 flask.  Figure 4.5 shows how the 
efficiency of the differentiation correlated positively with seeding density (R2 = 
0.916).  The highest efficiency obtained was 0.88 RPE foci per HESC colony, which 
was achieved when >800 HESC colonies were seeded per T25 (the highest density 
tested). The lowest efficiency was 0.24 RPE foci per HESC colony, when 288 
colonies were seeded (the lowest seeding density tested) per T25 (Fig. 4.5).   In these 
experiments the same number of MEF feeders/cm2 were used at all seeding densities 
and the same volume of culture medium (5ml) was used for daily media changes. 
Within this range therefore it can be concluded that the higher the seeding density, 
the more efficient the differentiation, in terms of all raw material usage. 
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Given the above trend, higher seeding densities (4 in 1) were tested. However, 
peeling off of the cell sheet prior to the beginning of pigmentation was repeatedly 
observed at these higher densities (N=3). Variations in the culture system used were 
therefore examined. A feeder-free differentiation system using a coating of Matrigel, 
as a substrate instead of MEFs feeders and gelatine was evaluated for its ability to 
support greater HESC adherence at higher seeding densities. 
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4.3 Single cell dissociation and feeder-free differentiation 
 
In terms of reproducibility, enzymatic dissociation of colonies into single cells before 
seeding may afford several advantages. Firstly, single cell dissociation and cell 
counting allows for tight control of seeding density and improved reproducibility 
between experiments. Secondly, single cells are less prone to aggregation, and 
thirdly, each cell is exposed to a more homogeneous environment, as there are no 
longer distinct populations of cells in the centre, as opposed to at the edges, of 
colonies (Ellerstrom et al., 2007). With this in mind, HESC-RPE differentiation 
following single cell dissociation was attempted. 
 Colonies with obvious differentiation were removed under the dissecting 
microscope prior to treating whole flasks with TrypLE select enzyme (Invitrogen). 
Cells in suspension were counted before seeding at defined concentrations onto 
Matrigel (BD Biosciences). Cells were then expanded for 5 days in MEF-conditioned 
medium (CM) or mTeSR1 defined medium before undergoing 45 days of 
differentiation in –bFGF differentiation media. 
In order to operate at a similar range of densities to the previous, mechanical 
passaging experiments, a calibration curve was created to assess the approximate cell 
numbers in flasks containing HESC clumps of undefined size. This curve relates the 
number of cells to measurements of % confluence at day 6 (see Chapter 2, Materials 
and Methods section 2.6.5).  From this graph we extrapolated the seeding densities at 
day 0 and determined that the range was between 9,000 and 29,000 HESC/cm2 (See 
materials and methods section 2.6.5). The results from section 4.2 showed the 
efficiency of the differentiation improving with increasing cell density, but cell sheet 
peeling interfered with experiments at higher densities. Thus the next sets of 
experiments were carried out to test a range incorporating higher seeding densities - 
from 8,500 cells/cm2 (8.5K) up to 100,000 cells/cm2 (100K).    
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4.3.1 Early differentiation following single cell seeding over a 
range of densities 
 
Single cell seeding allows accurate repetition of the same density between 
experiments at different passage numbers. Cells were seeded at densities up to 
100K/cm2 and down to 8.5K/cm2.  In the 8.5K/cm2 condition, cells often did not 
survive following single cell dissociation; at all other densities cells survived the 
dissociation process and proliferated in the absence of ROCK inhibitor up to day 
15(Fig. 4.6A). At day 15, differences in the architecture of the differentiating cells 
were visible; thick and compact multilayered ridges forming around ‘holes’ of less 
compact cells were visible in the 50-100K conditions. These thick ridges did not 
form to the same extent in 17-25k plating density conditions (Fig 4.6 A, lower panel).  
Immunocytochemistry revealed that these thickened ridges contained Pax6 positive 
cells (Fig. 4.6 B).   
 
QPCR was carried at day 15 on cells seeded over this range of densities (Fig. 4.6 C). 
Within each set, there was a slight increase in the relative expression of Pax6 at high 
density peaking at a 2.3 fold increase at 100,000/cm2. One way ANOVA revealed 
significant differences in Pax6 expression with density (F(3,8)=4.5, p<0.05).  
Specifically Pax6 expression was significantly higher is the 100K/cm2 than the 
25K/cm2 condition (paired student’s t-test, p<0.05). 
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4.3.2 Time course of gene expression reveals the impact of 
seeding density on the timing of early differentiation. 
 
Following mechanical passaging, it was observed that seeding density affected the 
rate of RPE differentiation and that the highest seeding density condition 
differentiated the most rapidly, producing the greatest RPE yield.  It was also noticed 
that areas of the flask with high colony density showed a down-regulation of Oct4 
protein relative to low density areas (Fig 4.1B).  In order to measure the progress of 
early differentiation in feeder-free differentiation QPCR was carried out at five time 
points following seeding at three different densities 50,000/cm2, 25,000/cm2 and 
17,000/cm2 (50K, 25K and 17K). The rate of departure from pluripotency was 
determined by measuring Oct4 mRNA, and the rate of early eye field formation was 
determined by measuring Rx mRNA. 
 
Cells were expanded for five days in conditioned medium (CM) before switching to 
–bFGF differentiation medium to initiate differentiation. By day ten (5 days 
differentiation), Oct4 expression was down regulated relative to the expression at day 
0. The extent of this down-regulation was similar in the 50k (0.14 fold) and 25K 
(0.10 fold) condition but was less pronounced in the low density condition (0.55 
fold). From days 15-25, Oct4 expression remained higher in the low density 
condition, suggesting that high seeding density is required for effective Oct4 down-
regulation during differentiation (Fig. 4.7 A). 
 
Rx expression had distinctive peak in both the 25K and 50K condition. In the 25K 
condition, expression peaked at day 10 (26 fold increase); interestingly in the 50K 
condition this peak occurred later, at day 15 (26 fold increase), and appeared to be 
increasing again at day 35 (16 fold). This suggests that cells are entering the eye field 
stage of differentiation earlier in the 25K condition than in the 50K condition (Fig. 
4.7 B).  
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4.3.3 Seeding density determines pigmentation rate in feeder-free 
differentiation following single cell dissociation. 
 
Shef6 cells from a range of passages were seeded onto Matrigel-coated plates at a 
range of seeding densities from 17,000/cm2 and 100,000/cm2. Media was changed 
daily for 5 days using either conditioned medium (CM) (Fig. 4.9 A,B) or mTeSR1 
(Fig 4.10 A,B,C,D) and then for the remaining 45 days in standard –bFGF 
differentiation medium. 
 
 
4.3.3.1 Conditioned Media (CM)Expansion  
 
Two long-term differentiation experiments were carried out using cells expanded in 
CM as this media gave the highest yield in previous experiments in Shef6 (chapter 3). 
In the first run (passage number 60 Fig. 4.9 A), such a large proportion of the surface 
area became pigmented by day 50 that it was not possible to measure the number of 
individual foci. At the 17k density pigment appeared in discrete foci, but at higher 
density large non-discrete areas of pigmenting cells emerged that increased in 
intensity over time (Fig 4.8). In order to compare RPE yield across the different 
conditions, therefore, the % pigmented areas, as opposed to the number of foci, were 
measured. Both the large non-discrete pigmented areas and the small discrete foci 
stained positively for Otx2 (Fig. 4.8).  In this first run, pigmented foci were clearly 
visible by days 33-35 in the 17-35K conditions (fig 4.9 A), but absent in 50,70 and 
100K wells.   
 
Similarly in the second run (passage number 68), pigmentation had begun in 
17,25,35 and 50K but was not visible in the 70 and 100k wells from days 33-35 (fig 
4.9 B). By days 40-50, the 70K and 100k wells had also begun to pigment but had 
not reached the same yield in terms of % surface area as the 25 and 35K wells. 
Peeling and lifting off of the cell sheet had occurred by day 40 in one of the heavily 
pigmented 25K wells (arrow); this may have affected the measurement in run 1, as 
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contraction of the cell sheet could increase the pigment intensity in portion that is 
still attached. Over the range of seeding densities tested 25-35K appeared to be the 
optimum in both runs following expansion in CM, peaking at 51-62% pigmentation 
in the first run (passage 60, Fig 4.9 A) and peaking at 4-6% in the second run 
(passage 68,  Fig. 4.9 B). 
 
Cells were harvested at day 50 for QPCR analysis of gene expression. The 
expression of RPE genes Bestrophin, CRALBP, MitF and PMel17 varied with 
seeding density in a pattern that mirrored the % pigmentation data (Fig. 4.9A). The 
expression of these genes peaked at day 25-35K/cm2 before levelling off at 50-
70K/cm2 and decreasing from 70-100K/cm2. Expression of the pigment synthesis 
gene tyrosinase decreased slightly with increasing seeding density. Expression of 
transcription factor Otx2 likewise decreased slightly down to 0.2 fold at 100K/cm2 
(fig 4.9C). 
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4.3.3.2 MTeSR1 Expansion  
 
Expansion in conditioned media on Matrigel appeared to be conducive to good RPE 
yields in shef6 (as described in chapter 3). However there was high variability 
between the two runs, peaking at 62% in the first run, and only 6% in the second run. 
This may be partly attributed to the variability in MEF feeders. In an effort to combat 
this variability the same experiment was carried out using mTeSR1 defined media 
(Stem Cell Technologies, Vancouver, Canada) for the five day expansion step. 
 
Four further long-term differentiation experiments were carried out using cells 
expanded in mTeSR1. Peeling of the cell sheet was more common in this system 
This may be due to the extra stress incurred by changing to/from mTeSR1 medium 
or the higher growth rates seen in mTeSR1 leading to unsustainable cell densities.. 
This lead to the loss of several wells over the 50 days time period.  In the first run 
(passage 50, Fig. 4.10 A), cells in the 25-35K wells (the optimum density in the 
previous CM experiments) did not survive the 50 days differentiation period but cells 
in the 17, 50, 70 and 100K/cm2 wells survived and the  peak pigmentation (9%) was 
seen in the 50K/cm2 condition. Similar to the results in the previous CM experiments, 
pigmentation was notably reduced in the high density (70-100K/cm2) wells. In the 
second run (passage 51, Fig. 4.10 B) wells at 17,25,35 and 50K/cm2 survived the 50 
days. In contrast to the conditioned medium experiments, the peak pigmentation was 
seen not at 25-35K/cm2 but at 50K/cm2 where it reached 2.9%. In the third run 
(passage 52, Fig. 4.10 C), the pattern at day 35 was similar, with pigmented foci 
visible in the 17 and 50K/cm2 cultures and none yet detectable in the 70-100K/cm2 
cultures. Unfortunately contamination prevented measurement at day 50 in the 70-
100K/cm2.  In the fourth run (passage 68, Fig 4.10 D) all wells survived but severe 
peeling prohibited accurate measurement at day 50. However at day 35, peak 
pigmentation levels were seen between 35 and 50K/cm2 consistent with the previous 
runs. 
  
Cells from the first run following mTeSR1 expansion (passage 50, Fig 4.10 A) were 
harvested at day 50 for QPCR analysis of gene expression.  The expression of RPE 
genes Bestrophin, CRALBP, MitF and Pmel17 also mirrored the % pigmentation 
pattern seen in Fig 4.10 A with relative expression peaking at 50K before decreasing 
187 
from 70–100K. Otx2 expression peaked at a higher density of 70K and, as before, 
there were little density related changes in Tyrosinase expression. 
 
The results of the above six feeder-free single cell dissociation experiments are 
summarised in Figure 4.11.  The fold changes in pigmentation relative to the lowest 
density condition (17K/cm2) were calculated for each of the 6 experimental runs.  
For runs where peeling or contamination prevented measurement at day 50, day 35 
measurements were used to calculate fold changes. One way ANOVA revealed that 
pigmentation levels varied significantly with seeding density (F (4,17) = 3.0, p<0.05). 
The overall average peak fold increase was observed at 35K/cm2, where % 
pigmentation was on average 5.6 x higher than at 17K, and on average 6.4 x higher 
than at 100K/cm2.   Post Hoc analysis revealed a statistically significant difference 
between the 35 and 100K/cm2 conditions (p<0.05 student’s, unpaired t-test).   
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4.3.4 Differentiation efficiency per HESC. 
 
As in section 2.1.3, the data were normalised to the number of cells seeded in order 
to determine the differentiation efficiency at each seeding density. The % 
pigmentation data were converted to mm2 and divided by the number of HESC 
seeded.  Despite the significant variation in yields between runs, within each run the 
maximum efficiencies were achieved at seeding densities between 17 and 35,000 
cells per cm2 (Fig. 4.12) after which the overall efficiency declined in all runs .   The 
maximum efficiency was observed in the first conditioned media expansion run 
(passage 68, Fig, 4.9 A) at a seeding density of 25K/cm2 and was 2.0 mm2  
pigmented RPE per 1000 HESC seeded. 
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4.4 Discussion 
 
 
The data presented in this chapter show unequivocally that seeding density has a 
significant impact on the rate of RPE differentiation as determined by gene 
expression and pigmentation data recorded over a ten to fifteen day period in both 
MEFs feeder, mechanically passaged systems and feeder-cell free enzymatically 
passaged systems. By comparing the RPE yields at various densities we were able to 
determine HESC-RPE conversion efficiencies, a previously unreported parameter 
that is fundamental to bioprocess engineering. In addition we found there to be an 
optimal range of HESC seeding densities out with which RPE yield is notably 
compromised. 
 
In the cells passaged by mechanical dissection, within the range tested, higher plating 
density led to improved differentiation efficiency per HESC colony. This may be due 
to seeding density governing the rate at which cells reach confluence, exit 
pluripotency and begin differentiation (i.e. timing), or to do with impact of seeding 
density on lineage decisions during early differentiation, or both.  
 
During early differentiation, seeding density is likely to have a strong affect on 
pluripotency, and potentially in priming the cells for a particular differentiation 
trajectory. Previous studies in HESC have found that higher densities favour 
differentiation towards neuroectoderm and anterior neuroepithelial fate (Bauwens et 
al., 2008, Chambers et al., 2009) and are therefore likely to be favourable for RPE 
differentiation.  Another potentially important factor is the effect of seeding density 
of nutrient depletion. As the cells become more confluent, the availability of 
nutrients and oxygen may become limiting to cell growth. Where differentiations are 
carried out in wells or flasks of a defined size and media exchange is carried out 
every 24 hours, the recommended maximum volume of culture medium per culture 
vessel puts an upper limit on the availability of nutrients during this period, which 
will be more or less severe dependent on cell density (King et al., 2007). Nutrient 
and depravation could drive cells to exit pluripotency and begin differentiating. 
HESC colonies seeded at higher density may also receive a lower dose per colony of 
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anti-differentiation molecules emanating from the MEF feeders (Heng et al., 2004) 
since the same number of MEFs were seeded per flask regardless of colony numbers. 
 
In our system, where there is little extraneous chemical stimulation to initiate 
differentiation (except for the removal of supplementary FGF from the medium), 
seeding density will also determine the dosage of anti-differentiation signalling 
emanating from surrounding undifferentiated HESC, with cells in a higher density 
environment receiving a higher dose (Peerani et al., 2007).  Nutrient depletion may 
also limit the proliferation of the desired progenitor cells and cause considerable loss 
of viability (King et al., 2007). Thus there is a case for seeding at both high and low 
density in terms of inducing rapid, and efficient HESC-RPE differentiation. 
 
In our system, it would appear that nutrient depletion, in addition to spatial 
restrictions that occur as the cells become confluent, are important driving forces 
causing cells to exit from pluripotency.  This, together with the undefined 
neuroectoderm-favouring properties of high plating densities, could explain the 
increased rate at which pigmented foci begin appearing in our system and the 
enhanced overall RPE yield. 
 
From a manufacturing perspective, a high density seeding strategy is advantageous 
as the same number of RPE foci can be derived using less medium, less space and 
less labour. In addition our results in section 4.3 show that the ‘efficiency’ of the 
differentiation (per HESC colony) improves with increased cell plating density, with 
the highest efficiency (0.88 foci/HESC colony) seen at the highest density tested. 
Thus in addition to the savings in space and raw materials, this strategy reduces the 
number of HESC required to generate a given amount of RPE.  An upper limit to this 
trend was not reached in these first experiments; however an increased incidence of 
peeling of the cell sheet was noted at very high density (4 into 1 split ratio).  As 
discussed in Chapter 3, cell sheet peeling can be deleterious to differentiation yields; 
when cells lift off the surface as one contiguous sheet a tight ball of aggregated cells 
can form, the interior of which is likely exposed to an environment of sub-optimal 
oxygen and nutrient transfer. Disturbing the cell sheet with the pipette tip, excessive 
movement of the flask, time out of the incubator and prolonged culturing appear to 
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increase the incidence of cell peeling.  Preliminary results also suggest that very high 
seeding density increases the incidence of cell sheet peeling in this system. 
 
 
Mechanical passaging of HESC is a useful method for weeding out cells with 
differentiated morphology and maintaining undifferentiated cell stocks (Loring et al., 
2007). This method incurs a lot of operator variability however, with the size of 
resulting colonies dependent on individual passaging technique and the 
determination as to what constitutes ‘differentiated morphology’ is open to 
individual interpretation. It is also challenging to count cell numbers and control the 
seeding density- factors which we have shown to be critical to the yield. Whilst 
mouse embryonic stem cells can be trypsinised and form colonies at clonal density, 
human embryonic stem cells are vulnerable to dissociation induced apoptosis 
(Ohgushi et al., 2010, Watanabe et al., 2007 ). This has been an obstacle in the 
development of technologies to manipulate and control HESC behaviour (Hernandez 
et al., 2011).  The propensity for HESC to undergo apoptosis upon dissociation can 
be partially overcome by the addition of a Rho-associated kinase (ROCK) inhibitor 
(Watanabe et al., 2007).   
 
 
We found that the addition of ROCK inhibitor was not necessary when cells were 
plated at a density of 17,000/cm2 or above, although cell death was observed at lower 
densities. It has been suggested that routine passaging by single cell dissociation puts 
an extra selective pressure on HESC that can lead to a higher rate of acquisition of 
karyoptypic abnormalities (Brimble et al., 2004, Draper et al., 2004). In these 
experiments, Shef6 stocks were maintained by mechanical passaging and 
enzymatically dissociated with TrypLE express (Invitrogen) before the initiation of 
differentiation only. Shef6 has been proven to remain karyotypically stable in similar 
conditions for up to 8 passages (Hernandez et al., 2011) thus we deemed it unlikely 
that they would accumulate significant karyotypic changes during the 2-3 population 
doublings that occur during the expansion stage.  Transferring cells to a feeder-free 
defined medium (mTeSR1) system appeared to put an additional strain on cells that 
may have contributed to the high incidence of cell sheet peeling.  In MEFs 
conditioned media however the cell sheet remained largely intact at all the densities 
197 
tested. In future experiments, a gradual adaptation from MEFs feeder - feeder-free 
differentiation systems may be beneficial.  
 
Seeding HESC as single cells allowed us accurately repeat a large range of plating 
densities, despite this, there was notable variability in RPE differentiation yield 
between runs even when using defined media.  Fold changes within each run 
however remained consistent and statistically significant; indicating that the optimum 
density remained despite differences in the yields between batches of HESC. The 
optimal yield was achieved when cells were seeded at 35K/cm2 in which wells 
yielded on average 5.6 times more pigmentation than in the 17K/cm2 condition and 
6.4 times more than in the 100K/cm2 condition. 
 
As discussed earlier, high seeding density can have both positive and negative 
influences on HESC-RPE differentiation. As seen in the mechanical passaging 
experiments, nutrient depletion and accelerated confluence appeared to increase the 
rate of differentiation with increasing HESC density from 17K up to 35-50K/cm2.  
Increasing plating densities above this point however decreased the rate or HESC-
RPE differentiation. This led to a reduced yield at day 50, and reduced differentiation 
efficiency per 1000 cells seeded as well as reduced expression of RPE markers, in 
spite of the reported increase in neuroectodermal/anterior neuroepithelium 
conversion rates at high density (Bauwens et al., 2007, Chambers et al., 2009).  
Notably, previous studies in HESC have not tested such high densities (e.g. 
Chambers et al., 2009, maximum density 25K/cm2). 
 
It is interesting to observe the peak in RPE productivity and it’s subsequent decline 
at very high density; as mentioned earlier putting more cells into each culture vessel 
reduces the space and raw material requirements but only if the same RPE output can 
be derived per cm2 .  At these very high seeding densities, a high dose of paracrine 
anti-differentiation signalling emanating from surrounding undifferentiated HESC 
may delay the onset of differentiation (Peerani et al., 2007).  Although the time 
course of gene expression revealed that Oct4 was down-regulated more rapidly at 
higher density, the peak in Rx, a gene essential for demarcation of the eye field and 
optic cup was delayed at high density (50K/cm2). Another indication that the onset 
of differentiation is delayed at high density comes from looking at the morphology of 
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cells at day 50.  Although dark pigment above the detectable threshold was more 
abundant in discrete foci at 17-35K/cm2 densities, inspection of the very high density 
wells (70-100K/cm2) revealed large contiguous areas of very lightly pigmented cells 
that were Otx2 positive and reminiscent of immature RPE. This suggests that given 
more time or chemical stimulation to differentiate that the 70-100K condition would 
produce high yields of pigmented cells.  In primary RPE cultures (Koh et al., 2000) 
and more recently differentiating HESC (Buchholz et al., 2013), vasoactive intestinal 
peptide (VIP) has been shown to speed up RPE maturation in culture; and could be 
used  to enhance the yields in these high density cultures. 
 
Despite the numerous recent studies on HESC-RPE differentiation, HESC to RPE 
conversion efficiencies are rarely reported.  Following single cell dissociation we 
have shown that greatest amount of RPE produced per 1000 HESC cells occurred 
when cells are seeded at densities between 17 and 35,000 cells /cm2. Seeding cells at 
higher density may reduce raw material usage per mm2 of RPE generated but, as is 
clear from these results, will reduce differentiation efficiency per HESC cell and 
increase the time taken to generate RPE product. Thus the design of an RPE 
manufacturing process should consider the relative costs of the numbers of HESC, 
space and raw materials required per RPE foci generated and yet not fail to account 
for the changes in HESC-RPE conversion efficiency that will occur as these 
parameters are adjusted.  
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4.5 Conclusion 
 
Seeding density is rarely controlled for in HESC differentiation experiments, 
probably due in part to the perceived incapacity of the cells to undergo single cell 
dissociation and clonal propagation (Watanabe et al., 2007).  Here we have devised a 
method to determine the approximate seeding density in traditional clump passaged 
HESC and shown how the colony seeding density has a significant impact on the 
HESC-RPE conversion rate.  In addition we have demonstrated that single cell 
dissociation of our cell line, Shef6, does not lead to widespread cell death provided 
the density is sufficiently high. Enzymatic single cell passaging is much more 
amenable to automated and scaled up cell manufacturing processes and facilitates the 
even seeding of cells at reproducible densities.  Here we have shown that single cell 
seeding can be used to generate high RPE yields, a finding that has been 
subsequently confirmed by others (Maruotti et al., 2013).  Following single cell 
dissociation we have carried out experiments that show there to be an optimal 
seeding density above and below which RPE yield and overall HESC-RPE 
differentiation efficiency is significantly reduced. Differentiation efficiency and 
HESC seeding density will have significant cost implications in any HESC-RPE 
manufacturing process and are important targets for research and optimisation; these 
results show how the HESC-RPE conversion efficiency is highly dependent on the 
HESC seeding density. 
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Chapter 5: Enhancing differentiation efficiency using 
small molecules 
 
 
 
 
 
 
 
 
 
  
 
.   
 
 
 
 
 
 
 
 
 
 
5.1 Introduction 
 
In the previous chapters we have characterised the process of spontaneous HESC-
RPE differentiation in Shef6 and Shef3.  We have demonstrated how cell line, time 
in culture, passaging methods, MEFs vs. feeder-free culture and HESC seeding 
density have a significant impact on the timing of pigmentation and eventual RPE 
yield during spontaneous differentiation, underlining the sensitivity of RPE 
differentiation to changes in processing parameters.  We found that the Shef3 cell 
line was less able to generate high RPE yields in a variety of conditions, possibly due 
to a reduced innate preference for neuroectoderm conversion. In transferring the 
differentiation system to feeder-free conditions we showed that Shef3 produced 
particularly poor RPE yields.  In this final chapter we sought to enhance RPE 
differentiation in these low yielding conditions using small molecules known to 
induce neuroectoderm conversion in HESC.  
 
In addition to the many descriptions of spontaneous HESC-RPE differentiation 
(Kawasaki et al., 2002, Klimanskaya et al., 2004, Lund et al., 2006, Vugler et al., 
2008, Buchholz et al., 2009, Carr et al., 2009, Liao et al., 2010, Rowland et al., 2012) 
many published protocols employ growth factors and/or small molecules with the 
aim of directing differentiation towards the desired retinal lineage. Of these, only a 
few have gone so far as to characterise the capacity of these growth factors/small 
molecules to improve the efficiency of RPE generation relative to spontaneous 
differentiation (see chapter 1, table 1.1). For example, Zahabi et al., report the 
generation of 40% RPE65+ve cells from H6 HESC line following treatment with 
noggin, bFGF, Retinoic acid and Shh, but do not report the yield in the absence of 
these factors. A number of studies have anecdotally reported improvements in MitF 
positive-cell or pigmented RPE cell yields following treatment with a range of 
growth factors and/or small molecules, but have not quantified them. At the time of 
carrying out this work only one study had fully characterised and quantified the 
‘induced’ RPE yields relative to spontaneous differentiation in floating cell 
aggregates (Idelson et al., 2009) –see chapter 1, table 1.1 for a history of HESC-RPE 
differentiation methods. Since then others have quantified improvements or 
otherwise in pigmented cell yields following treatment with factors such as activin A, 
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(Hongisto et al., 2012, Rowland et al., 2012, Mellough et al., 2013, Buchholz et al., 
2013, Zhu et al., 2013) 
 
 The rational for HESC-retinal cell differentiation protocols generally comes from 
our knowledge of vertebrate eye development, with most protocols targeting 
neuroectodermal differentiation and formation of the anterior forebrain. Protocols for 
retinal cell derivation commonly use pro-neural factors at the beginning of the 
differentiation, such as: Noggin (BMP inhibitor), DKK1 (Wnt inhibitor) and LeftyA 
(Activin/nodal inhibitor); small molecule equivalents such as SB431542, CKI-7 and 
less targeted neuralizing supplements such as B27, N2 and Nicotinamide (NIC) 
which are known to enhance neural cell survival during differentiation (Lamba et al., 
2006, Osakada et al., 2008, Osakada et al., 2009, Idelson et al., 2009, Nistor et al., 
2010,  Meyer et al., 2009, Zahabi et al., 2012, Mellough et al., 2012, Buchholz et al., 
2013).  In addition, some protocols include factors at a later stage that are known to 
induce early optic vesicle development e.g. IGF, Shh (Lamba et al., 2006, Zahabi et 
al., 2012, Mellough et al., 2013, Zhu et al., 2013) and pattern the developing retina 
e.g. Activin A, Wnt antagonist CHRIR90021 (Idelson et al. 2009, Meyer et al., 2011, 
Nakano et al., 2012, Zhu et al., 2013) or induce maturation of RPE e.g. Vasoactive 
intestinal peptide (VIP), (Buchholz et al., 2013). 
   
 
The efficacy of some of these protocols has proven difficult to replicate; a problem 
that is likely due in part to the innate differences in stem cell lines, as we have 
discussed in previous chapters. Embryonic stem cells will generally adopt anterior 
neuroepithelial characteristics in the absence of exogenous signalling (Muñoz-
Sanjuán et al., 2002, Pankratz et al., 2007, Chambers et al., 2009). It has been well 
documented that the rate and efficiency with which different HESC lines undergo 
spontaneous neuroectodermal differentiation is highly variable (Osafune et al., 2008, 
Kim et al., 2010, Boulting et al., 2011).  We have observed this in our cell lines, with 
Shef3 appearing to undergo significantly less efficient neuroectodermal 
differentiation than Shef6 (chapter 3). These variations may be because some cell 
lines are more resistant to differentiation than others, or because some lines 
preferentially differentiate into other germ layers.  
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 Inhibition of BMP and activin/Nodal signalling pathways, using growth factors or 
small molecules, has proven highly effective at inducing efficient neuroectoderm 
differentiation in a large number of HESC lines regardless of their innate 
differentiation propensity (Chambers et al. 2009, Patani et al., 2009, Zhou et al., 
2010, Kim et al., 2010, Morizane et al., 2011). The use of small molecules, as 
opposed to recombinant growth factors, to direct differentiation is highly favourable 
for commercial manufacturing processes; not only are the small molecules 
significantly less expensive, but they also offer less batch-to-batch variability and 
avoid the cost and complexity of introducing another xenogeneic component to the 
manufacturing process (Allsopp et al., 2010). Dorsomorphin is a small molecule 
protein kinase inhibitor that was discovered during a screen in zebrafish (Yu et al., 
2007), it can be used to induce highly efficient neuroectodermal conversion in HESC, 
either on its own (Zhou et al., 2010), or in combination with other small molecules 
(Kim et al., 2010, Meyer et al., 2011, Morizane et al., 2011). In addition to blocking 
BMP type I receptors, (thereby inhibiting SMAD 1/4/8 phosphorylation), 
dorsomorphin interferes with several TGFβ superfamily type receptors and has been 
shown to dampen activin/nodal signalling in a BMP independent manner, similar to a 
low dose of SB431542 (thereby reducing activin-induced phosphorylation of SMAD 
2/3) (Zhou et al., 2010).  The ability of dorsomorphin to induce ‘dual SMAD’ 
inhibition makes it a useful tool for enhancing neuroectodermal differentiation in 
HESC in a simple, cost-effective, one-step method.  
 
In this study, the efficacy of dual SMAD inhibition was tested in our cell lines. Shef6 
and Shef3 were found previously to have significantly different innate propensities 
for RPE differentiation.  The mechanisms that cause Shef6 to respond well to feeder-
free differentiation and to consistently produce an enhanced RPE yield relative to 
Shef3 (chapter 3) are unknown, although higher Pax6 expression during the earliest 
stages of differentiation suggests the early process of neuroectodermal conversion 
may be critical.  The experiments described in this chapter sought to determine 
whether small molecules could be used to enhance early neuroectodermal conversion 
in our cell lines and to investigate whether this intervention could improve RPE 
differentiation yields. It was of particular interest to determine whether yields could 
be improved in Shef3, a cell line which we had found previously to be particularly 
inefficient at generating RPE in feeder-free conditions. 
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5.2 Dorsomorphin enhances neuroectoderm conversion 
shef6 and shef3 
 
5.2.1 Small molecule inhibitors effect cell morphology, Pax6 and 
Oct4 expression 
 
Given the numerous and often conflicting reports on the efficacy of various small 
molecule combinations in different cell lines, experiments were undertaken to 
determine a suitable regime for use in Shef6 and Shef3. Three small molecules 
known to interact with major signalling pathways involved in HESC differentiation 
and germ layer specification (table 5.1) were tested. 
 
Molecule Target Pathway References 
dorsmorphin (DM) BMP / Smad 1/5/8 
(+Activin/Smad 2/3) 
Kim et al., 2010 
Zhou et al., 2010 
SB431542 (SB) Activin/Smad 2/3 Chambers et al., 2009 
PD0325901 (PD) FGF/ERK Greber et al., 2011 
 
Table 5.1 Small molecules that interact with major HESC signalling pathways 
 
Shef6 and Shef3 were seeded as single cells onto Matrigel-coated 6-well plates at the 
previously determined optimal density of 35,000/cm2 (chapter 4). The cells were 
expanded for five days in defined mTeSR1 medium. This was followed by ten days 
of differentiation in –bFGF differentiation media supplemented with one of three 
small molecule combinations or DMSO only as a control. At the end of this period 
cells were analysed by immunostaining for markers of pluripotency (Oct4) and 
neuroectoderm differentiation (Pax6), (Zhang et al., 2010).  
 
In Shef3 control samples at day fifteen, patches of compacted cells containing what 
appeared to be neural-rosette like structures were visible (Fig. 5.1 A, arrow), though 
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they were not at this stage Pax6-positive (Fig. 5.1 B). Wells also contained areas of 
less compacted cells (Fig 5.1 C). There were no Oct4-positive cells detected at this 
time, suggesting that cells are either differentiating into other germ layers or that they 
are in an intermediate Oct4-negative and Pax6-negative state.  In contrast, wells that 
had been treated with dorsomorphin contained no rosette-like structures but large 
contiguous areas of compacted, Pax6 positive cells (Fig 5.1 E,F) interspersed with a 
few ‘holes’ of un-compacted, Pax6-negative cells. In the DM+SB condition (Fig. 5.1 
I, J)  a similar picture of Pax6-positive islands around Pax6-negative holes emerged, 
with the ‘holes’ appearing larger than in the DM only condition (Fig. 5.1 I). Finally 
in the DM+SB+PD condition, Pax6-positive cells appeared in similar sized 
compacted islands with defined, highly compacted borders (Fig. 5.1 N).  In all 
conditions Oct4-positive cells were not detected at day fifteen.  
 
In Shef6 control samples, thick, dense ridges of cells had formed around ‘holes’ by 
day fifteen of differentiation (Fig. 5.2 A-C). Pax6-positive neuroepithelial rosettes 
were abundant on these dense ridges (Fig. 5.2 B, arrows). Oct4-positive cells were 
not detectable at this time point (Fig. 5.2 D) indicating that neuroectodermal 
differentiation was advanced in Shef6 by day fifteen. Similar to what was observed 
in Shef3, dorsomorphin treated cells had formed contiguous sheets of Pax6-positive 
cells (Fig 5.2 F). Unlike Shef3 there were no large holes containing Pax6-negative 
cells. A similar phenomenon was observed in the DM+SB condition, with even more 
compacted Pax6-positive cell sheets forming (Fig 5.2 I, J). In the DM+SB+PD Pax6-
positive cells were sparser, appearing only on thickened islands surrounded by Pax6-
negative cells. In all conditions Oct4 immunoreactivity was negligible, with the 
exception of the dorsomorphin only condition where a faint signal was detected in 
some areas (Fig. 5.2 H).   
 
These results demonstrate that dorsomorphin treatment alone is sufficiently potent to 
generate high Pax6 cell yields in both of our cell lines as has been described by 
others (Zhou et al., 2010). Given a recent report that SB431542 reduces RPE cell 
yields (Zahabi et al., 2011) and the apparent reduction in Pax6-positive cell numbers 
upon the addition of FGF/ERK inhibitor PD0325901, it was decided to carry out 
long-term differentiation experiments using dorsomorphin alone. 
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5.2.2 Dorsomorphin suppresses the down regulation of 
pluripotency gene expression in differentiating Shef6 but not 
Shef3. 
 
One report has described how inhibition of BMP signalling by dorsomorphin can 
partially suppress differentiation and maintain pluripotent patterns of gene expression 
at the early stages of HESC differentiation (Morizane et al., 2011).  Oct4 protein was 
largely undetectable in our cell lines following ten days of differentiation with or 
without dorsomorphin treatment (Fig. 1-2). Nevertheless, QPCR was carried out to 
determine if pluripotency genes were still being expressed at day 15. Initially the 
expression at day 15 was assayed relative to expression in hESC at day 0.  
Expression of pluripotency genes decreased by 40-90 fold in the control wells, but 
only 5-11 fold in the dorsomorphin treated wells (Fig. 5.3 A). 
 
In order to confirm this effect, pluripotency gene expression at day fifteen was 
measured in Shef6 (N=3) and Shef3 (N=3) in dorsomorphin and untreated control 
wells. In Shef3, transcript levels were low at day fifteen and there were no significant 
differences in expression between dorsomorphin treated and untreated controls for 
any of the genes tested (Fig. 5.3 B). In Shef6 however, there was an increase in mean 
Nanog and TDGF expression in dorsomorphin treated wells relative to control wells 
(Fig. 5.3 B) but little change in Oct4 expression. There was a significant difference in 
the relative expression of pluripotency genes Nanog and TDGF in response to 
dorsomorphin treatment between Shef6 and Shef3 (student’s unpaired t-test, p<0.05, 
N=3). 
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5.2.3 Dorsomorphin selectively up regulates neuroectoderm gene 
expression and down regulates mesoderm, endoderm and 
trophectoderm gene expression in Shef3 and Shef6.  
 
QPCR was used to monitor the expression of other markers of neuroectoderm 
differentiation in dorsomorphin treated and control samples. Six3 and Lhx2 are 
involved in demarcation of the eye field (Zuber et al., 2003) but are also critical 
earlier in neuroectoderm and forebrain specification (Zhang et al., 2010). Pax6 is a 
neuroectoderm fate determinant and Nestin is involved in early neuralization. All 
neuroectoderm markers were robustly upregulated relative to control wells in the 
presence of dorsomorphin, in both Shef3 and Shef6 (Fig. 5.4).  
 
BMP signalling in HESC can induce mesoderm and trophectoderm differentiation 
(Xu et al., 2002, Zhang et al., 2008) and Activin/Nodal/TGFβ signalling has been 
shown to induce endoderm differentiation (D’Amour et al., 2005). The addition of 
1µM dorsomorphin to culture media has been shown to interrupt both BMP and 
Activin signalling. Markers of mesoderm (Brachyury, AFP), endoderm (Gata6, 
Sox17) and trophectoderm (CDX2) differentiation were all robustly down-regulated 
in the presence of dorsomorphin relative to control in both cell lines (Fig. 5.4).  
 
One way analysis of variance demonstrated a highly significant difference in 
dorsomorphin induced changes in gene expression between groups of markers of the 
various germ layers (neuroectoderm, mesoderm, endoderm and trophectoderm) in 
both Shef6 (F(3,26)=13.3, p<0.001) and Shef3 (F(23,3) = 10.5, p< 0.001).  Post hoc 
analysis (student’s unpaired t-test) revealed that fold increases in neuroectoderm 
gene expression in response to dorsomorphin differed significantly from expression 
of markers of the other germ layers (p<0.001), but that there were no significant 
differences between the dorsomorphin induced effects on mesoderm, endoderm or 
trophectoderm gene expression (p=0.2-0.4). These results suggest that dorsomorphin 
treatment has a specific affect on enhancing neuroectoderm gene expression whilst 
suppressing expression of markers of the other germ layers in both cell lines. 
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Comparing dorsomorphin induced changes in gene expression between the two cell 
lines, we found there to be a greater fold down regulation in mesoderm, endoderm 
and trophectoderm genes in Shef3 (Average fold change = 10.3 fold) than in Shef6 
(Average fold change = 3.4), one way ANOVA F(1,28) = 3.8 p<0.05,  but no 
statistically significant difference in the upregulation in neuroectoderm genes (Shef3 
Average = 4.9 fold increase, Shef6 average = 3.5 fold). 
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 5.2.4 Dorsomorphin enhances neuroectoderm differentiation at a 
range of seeding densities. 
 
Given the critical impact of seeding density on differentiation efficiency, the ability 
of dorsomorphin to induce Pax6 expression was tested over a range of HESC seeding 
densities.  At all densities there was a distinct difference in cell morphology in 
dorsomorphin treated vs. control wells: in control wells circular ‘holes’ of less-
compacted cells surrounded by thick compacted ridges were observed (Fig. 5.5 A, 
marked ‘H’ and ‘R’ respectively), whereas in dorsomorphin treated wells, compacted, 
multilayered sheets covered the whole well regardless of density.  Compacted cells 
found in the dorsomorphin treated cultures and in the ‘ridges’ formed in control wells 
were immunopositive for Nestin whereas non-compacted cells found in the circular 
‘holes’ were not (Fig. 5.5 B).  Pax6 expression at day 15 was measured in 
dorsomorphin treated and control wells over a range of cell seeding densities (Fig. 
5.5 C, D). The relative up-regulation of Pax6 in dorsomorphin treated cultures 
declined slightly with increasing seeding density, but the differences were not 
significant. 
 
On the basis of these results it was concluded that ten days of 1µM dorsomorphin 
treatment is sufficient to enhance neuroectoderm differentiation and suppress 
differentiation into other lineages in both Shef3 and Shef6.   
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 5.2.5 Time course of eye field transcription factor expression 
demonstrates sustained up regulation following DM treatment. 
 
Activin/BMP type signalling has been shown to be critical to RPE differentiation at 
the optic cup stage of eye development in vivo (Fuhrmann et al., 2000) and to 
augment RPE yields in a number of HESC models (Idelson et al., 2009, Meyer et al., 
2011). With this in mind, dorsomorphin was removed from the medium after ten 
days to allow the equivalent necessary developmental stages to proceed 
uninterrupted.  In order to determine whether the increases in neuroectodermal gene 
expression seen at day fifteen were sustained beyond the ten day period of 
dorsomorphin supplementation, QPCR analysis was carried out over a time course of 
35 days. Cells were harvested for QPCR analysis at day 0, 5, 15, 25 and 35 and the 
normalised quantities of mRNA were expressed relative to the quantity in the starting 
HESC cultures cell (day 0).  
 
In Shef3: the expression of Six3, a critical eye field transcription factor, increased 50 
fold from days 5-15 in dorsomorphin treated wells, peaking at day 15 before 
decreasing to 30 fold and remaining at that level until day 35. In the control wells 
Six3 expression increased only 12-15 fold in the same time frame (Fig. 5.6 A).  Lhx2, 
another important eye field transcription factor, expression rose steadily in the 
dorsomorphin treated samples, reaching a peak at day 25 at 170 fold. The control 
Shef3 samples however peaked at a much lower level of around 40 fold, also at day 
25. 
 
In Shef6: Six3 expression followed a similar pattern but was upregulated 480 fold in 
dorsomorphin treated wells between days five and fifteen, before decreasing to 
around 70 fold. In control Shef6 wells Six3 expression increased 70 fold from days 
five to fifteen, a substantially larger increase than in Shef3 control wells (Fig. 5.6 B).  
Similarly Lhx2 expression rose rapidly to 170 fold in the dorsomorphin treated 
sample (similar to the level seen in dorsomorphin treated Shef3), compared to 40 
fold in the control, before under going a slow decline to 140 fold over the following 
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20 days. In the control sample Lhx2 expression peaked at 130 fold at a later time 
point, between days fifteen and thirty five (Fig 5.6 B).   
 
These data demonstrate peaks in eye field transcription factor expression in both cell 
lines, as have been reported by others (Meyer et al., 2009); they also demonstrate a 
much greater upregulation of Six3 mRNA in Shef6 than Shef3. In addition they show 
that ten days of dorsomorphin treatment enhances expression of eye field 
transcription factors and that this leads to a sustained up regulation of these genes 
post dorsomorphin withdrawal in both cell lines. 
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5.3 Shef3 Dorsomorphin treatment and RPE yield  
 
Having determined that early dorsomorphin treatment enhances neuroectoderm 
differentiation and sustains the upregulation of genes required for determination of 
the eye field, we next sought to investigate the effect of on RPE differentiation yields 
from Shef3 in both MEFs co-culture and feeder-free systems.  
 
5.3.1  Pre-treatment with Dorsomorphin during MEFs-co culture 
enhances RPE yield 
 
Shef3 cells at a range of passages were split 1:2 and seeded onto inactivated MEFs 
feeders. After 10 days expansion in standard HESC media +bFGF, 1µm 
dorsomorphin or DMSO (control) was added to the –bFGF differentiation media for 
the following ten days. Cells were then fed daily with standard hESC –bFGF media 
until day 50 of differentiation at which point flasks were scanned and the number of 
foci determined using the auto-counting method as described (Chapter 2, Materials 
and Methods). The yield of pigmented foci was enhanced by pre-treatment with 
dorsomorphin (Fig. 5.7 A, C) and the average fold increase in foci numbers 
dorsomorphin/control was 4.1 ± 0.4 SEM, N=3, the increase was not found to be 
statistically significant however. In control samples the yield of RPE per cm2 
typically varied with passage number, with lower passage number cells producing 
greater yields (Fig 5.7 C), as described in chapter 3. Pigmented foci were extracted 
from dorsomorphin treated flasks and plated onto Matrigel where they expanded and 
exhibited typical RPE morphology (Fig. 5.7B). 
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5.3.2 Dorsomorphin enhances RPE cell yield in high passage 
‘feeder-free’ cultures 
 
The chemical induction step was next tested in the feeder-free system using 
Matrigel-coated six-well plates, mTeSR1 expansion medium and seeding single cells 
at the optimal density of (35,000/cm2). It had previously been observed that Shef3 
cells produce relatively poor RPE yields in feeder-free conditions and at high 
passage numbers (Chapter 3), making this system a good target for a more directed 
differentiation. 
 
After 5 days expansion in mTeSR1, cells were treated with 1µM dorsomorphin (or 
DMSO control) in –bFGF differentiation media for 10 days, before switching to 
standard –bFGF differentiation media for the remaining further 35 days. At day 50, 
the plates were scanned, pigmentation was measured and cells were harvested for 
QPCR or re-plated onto Matrigel for immunocytochemistry. 
 
In line with our observations of Shef3 differentiation at high passage and in feeder-
free conditions in chapter 3, control wells at day 50 contained few pigmented foci; 
mostly appearing at the edges of the wells (Fig. 5.8 A,B), however the average 
number of foci per cm2 was higher following this single cell dissociation protocol 
than via the clump passaging method used in chapter 3 (6.7 ± 3.3 foci/cm2  vs. 0.4 ± 
0.3 foci/cm2 clump passaging, feeder-free conditions).  
 
In the corresponding dorsomorphin treated samples however, pigmentation was 
abundant and distributed across the whole well surface; appearing both in discreet 
foci and in larger contiguous areas (Fig. 5.8 A, B).  The % pigmentation was 
significantly higher in dorsomorphin treated wells (Fig. 5.8 C), (one way ANOVA, 
F(1,10) = 8.0, p<0.01). The average fold increase in % pigmented area 
dorsomorphin/control wells was 5.0 ± 0.7 (SEM, N=6).  The increase in number of 
foci/cm2 was also significant (F (1,10)=9.6, p<0.01). Pigmented foci were manually 
extracted from the dorsomorphin treated wells and expanded on Matrigel. Pigmented 
epithelial sheets exhibiting cobblestone morphology and immunopositive for Otx2, 
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ZO1, CRALBP and MitF were observed (Fig. 5.9 D), thus confirming the HESC-
RPE phenotype of the dorsomorphin derived cells.  
 
QPCR analysis was carried out in order to compare gene expression in dorsomorphin 
treated and control wells at day 50. Consistent with the increased number of 
pigmented foci, there was a significant upregulation in the expression of RPE 
associated markers in dorsomorphin treated wells relative to controls (Pmel17, Otx2 
and Pax6 (N= 4, p<0.05, student’s paired t-test) but not MitF (P=0.09) (Fig. 5.8E).  
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 5.4 Shef6 Dorsomorphin treatment and RPE yield 
 
In Chapter 3 it was shown how Shef6 has a greater capacity for RPE differentiation 
than Shef3 in undirected spontaneous differentiation, in a variety of culture systems 
over a range of passages.  Immunostaining revealed that Shef6 cells had produced 
Pax6 positive neural rosettes more efficiently than Shef3 at day fifteen  in feeder free 
conditions (Fig. 5.1, 5.2). Dorsomorphin treatment was able to induce further 
augmentation of neuroectoderm gene expression in Shef6 (Fig. 5.3) and 
differentiation into a near uniform layer of Pax6-positive cells (Fig. 5.2).  Thus it was 
hypothesised that dorsomorphin treatment may be able to enhance RPE 
differentiation yields in Shef6. In this section, long term differentiation experiments 
were carried out on dorsomorphin-treated Shef6 to assess the impact of this early 
increase in neuroectoderm differentiation on RPE yield. 
 
5.4.1 Dorsomorphin has minimal effects on RPE yield in MEFs co-
culture  
 
As with Shef3, mechanically passaged flasks of Shef6 from a range of passages were 
split one in two and, after ten days expansion in +bFGF HESC medium, treated for 
ten days with either 1µM dorsomorphin or an equal volume of DMSO (control). The 
flasks were scanned at day fifty and the number of pigmented foci counted using the 
auto-counting method described (Chapter 2, Materials and Methods). In three 
separate experiments, a small increase in the number of foci was detected in the 
dorsomorphin treated flasks, with an average fold change of dorsomorphin/control of 
1.3 ± 0.1 SEM (Fig. 5.9 A,C), which was not statistically significant. As in Shef3, 
pigmented foci extracted from dorsomorphin treated flasks displayed typical RPE 
morphology following expansion on Matrigel (Fig. 5.9B). 
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 5.4.2 In feeder-free cultures DM treatment significantly reduces 
pigmentation 
 
Differentiation experiments were next carried out in a defined, feeder-free system. 
Shef6 were dissociated into single cells and seeded at optimum density (35,000 /cm2) 
on Matrigel-coated six-well plates.  As with Shef3, cells were expanded for five days 
in mTeSR1, differentiated for ten days in –bFGF media in the presence of 
dorsomorphin or DMSO, then a further 35 days differentiation in –bFGF 
differentiation media.  
 
As described in previous chapters, Shef6 produced high RPE yields in feeder-free 
culture following single cell dissociation; the control wells contained large numbers 
of discrete, pigmented foci that were distributed evenly across the wells (Fig. 5.10, 
A). The average number of foci in control wells was 48.3 ± 4.6 SEM foci /cm2 (N=6) 
and the mean pigmented area was 4.0 ± 1.3% SEM (Fig. 5.10 A, B left panel). In 
stark contrast, dorsomorphin treated wells had significantly reduced numbers of 
pigmented cells at day fifty (Fig. 5.10 A,B, right panel), in some wells a few foci 
were visible at day fifty (Fig 5.10 A, arrows). The difference in % pigmentation and 
number of foci was statistically significant between dorsomorphin and control wells 
(ANOVA, F(1,10)= 8.2, p<0.01), (Fig. 10C). Examination of control wells under the 
microscope revealed pigmented, cobblestone RPE surrounded by a non-pigmented 
cell type; in the dorsomorphin-treated wells, however, no pigmented foci were 
visible and cells had a non-epithelial, disordered appearance reminiscent of a 
neuronal progenitor cell type (Fig. 5.10 B). In order to check that differentiation was 
not merely delayed by the addition of dorsomorphin, two wells were allowed to 
differentiate for up to sixty days. At this time point there were still no traces of 
pigmented RPE or epithelial morphology (data not shown). 
 
The large decrease in pigmented cell yield was accompanied by a down-regulation in 
RPE genes Pmel17, Otx2, MitF and Tyrosinase (Fig. 5.10D). Interestingly there was 
no decrease in Pax6 expression, a gene that is expressed in both the early RPE and 
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neural retina during formation and patterning of the optic cup (Martinez-Morales et 
al., 2004, Bharti et al., 2012). 
 
One way ANOVA revealed a statistically significant difference in the effect of 
dorsomorphin on RPE gene expression (MitF, Pmel17, Otx2) between Shef3 
(average fold change DM/control =10.3 ± 3.6 SEM), and Shef6 (average = 0.5 ±0.1 
SEM), F (1,19) = 5.5 p<0.01). 
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 5.4.3. Comparison of MitF and Chx10 expression suggests a 
neuroretinal phenotype is emerging in Dorsomorphin treated 
Shef6. 
 
The large up regulation in eye field transcription factors seen in dorsomorphin-
treated Shef6 over the thirty five day gene expression time course (Fig. 5.6 B) 
suggests that the treatment is not inhibiting but augmenting differentiation towards 
early retinal cell types. Both the RPE and neural retina are derived from the optic 
neuroepithelium. During the optic vesicle stage of vertebrate development, bi-potent 
retinal progenitors differentiate into pigmented RPE or neuroretinal progenitors 
depending on their position and exposure to signals emanating from surrounding 
tissues (Fuhrmann et al., 2000), a similar phenomenon has been observed in HESC 
models (Meyer et al., 2009, Nakano et al., 2012). The RPE-neural retina cell fate 
decision is largely governed by differential expression of Chx10 and MitF (Horsford., 
et al. 2005) and the relative proportions of neural retina vs. RPE in HESC have 
proven highly sensitive to exogenous signalling (Meyer et al., 2011, Nakano et al., 
2012). In order to investigate whether dorsomorphin-treated Shef6 were adopting a 
neuroretinal identity at the expense of RPE, the expression of these two transcription 
factors in Shef6 and Shef3 were compared.    
 
Expression of MitF and Chx10 was found to be mutually exclusive in day fifty Shef6 
samples, with MitF localised to pigmented, epithelial RPE and Chx10 localised to an 
adjacent, non pigmented cell type (Fig. 5.11 A).  QPCR was used to measure the 
relative expression of MitF and Chx10 in whole wells of Shef6 and Shef3 at day 50. 
 
In Shef3, Chx10 was only slightly upregulated in dorsomorphin-treated wells (1.4 
fold ± 0.1 SEM, N= 4), whereas in Shef6 there was a larger average upregulation 
(dorsomorphin/Control 5.2 fold ± 1.0 SEM, N=3), and the difference between 
dorsomorphin induced Chx10 augmentation in Shef6 and Shef3 was found to be 
significant (ANOVA, F(1,5) = 15.0, p<0.05).  In contrast, MitF expression was 
upregulated in dorsomorphin treated Shef3 (3.0 fold ± 0.8, N=3) and downregulated 
in dorsomorphin-treated Shef6 relative to control wells (0.7 fold ± 0.13, N=3). Again, 
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the difference between Shef3 and Shef6 was statistically significant (ANOVA, F(1,5) 
= 2.4, p<0.05). To confirm the upregulation of Chx10 at the protein level, Shef6 cells 
were taken from day 50 wells and expanded on Matrigel. The non pigmented cells 
taken from dorsomorphin treated Shef6 were almost uniformly positive for Chx10 
whereas pigmented, cobblestone RPE cells from the corresponding control wells 
were Chx10-negative (Fig. 5.11 D, E).  
 
These results suggest that dorsomorphin treatment is enhancing differentiation 
towards a Chx10-positive, early neuroretinal phenotype in Shef6 and doing so at the 
expense of differentiation towards pigmented RPE. 
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5.4.4 Activin A supplementation does not induce RPE 
differentiation in DM treated cultures 
 
Signalling from adjacent tissues has proven critical to patterning of the retina during 
ocular development (Fuhrmann et al., 2000, Eiraku et al., 2011). Members of the 
TGFβ superfamily of signalling molecules secreted from the adjacent extraocular 
mesenchyme trigger MitF transcription and RPE differentiation, where as FGFs from 
the surface ectoderm upregulate Chx10, initiating neuroretinal differentiation 
(Fuhrmann et al., 2000). Activin A has been shown to mimic the action of signalling 
from the extraocular mesenchyme and enhance RPE differentiation yields in animal 
models as well as differentiating hESC (Fuhrmann et al., 2000, Idelson et al., 2009, 
Meyer et al., 2011).  
 
It was therefore sought to determine whether the addition of activin A to 
dorsomorphin-treated Shef6 could skew the balance in favour of RPE differentiation. 
100ng/ml of activin A was added to dorsomorphin treated Shef6 from days twenty to 
forty, a time window within which the in vitro equivalent of the optic vesicle stage of 
eye development is thought to occur (Meyer et al., 2009, Idelson et al., 2009).  
Whilst untreated controls and activin A supplemented wells became heavily 
pigmented by day 50 (Fig. 5.12 A, B), activin A added to dorsomorphin-treated wells 
contained little to no pigmentation as in the dorsomorphin only wells (Fig. 5.12 C, D).  
In addition, activin A treatment alone (no dorsomorphin pre-treatment) had no 
significant impact on RPE yields (N=3, Fig. 12 E). From these results we can 
conclude that activin A at this concentration, added in this time window, was not 
sufficient to stimulate RPE differentiation.    
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 5.5 Discussion 
 
Our findings from previous chapters have been brought together in the design of a 
density optimised, feeder-free differentiation protocol for generating HESC-RPE.  
We have shown that single cell dissociation and differentiation on Matrigel following 
an expansion step in mTeSR1 reproducibly generates high RPE yields in Shef6. 
Spontaneous differentiation of Shef3, however, generated poor RPE yields in feeder-
free conditions, potentially due to inefficient neuroectoderm conversion in the 
absence of MEFs feeders. In this chapter we sought to induce efficient 
neuroectoderm conversion using dual SMAD inhibition in a simple, one-step method, 
employing small molecules. 
 
The cell lines used in this study (Shef6 and Shef3) have demonstrated highly 
divergent capacities for neuroectodermal differentiation and RPE differentiation, 
with Shef6 consistently yielding more pigmented cells regardless of differentiation 
methods. As discussed in chapter 3, a number of studies have highlighted the 
variable ‘innate’ differentiation capacity of different HESC and IPSC lines (Osafune 
2008 et al., Hu et al., 2010a, Lappalainen et al., 2010, Kim et al., 2011). Variability 
in RPE yields across cell lines has also been noted (Idelson et al., 2009, Vjasaari et 
al., 2011, Zhu et al., 2013). These variations in differentiation behaviour have been 
attributed to endogenous signalling and growth factor responsiveness brought about 
by genetic variation (Boulting et al., 2011, Abeyta et al., 2004), epigenetically 
inherited adaptations to culture and passaging methods (Akopian et al., 2010, Enver 
et al., 2005, Tavakoli et al., 2009) and in the case of IPSCs, an epigenetic ‘memory’ 
of their cell type of origin (Hu et al., 2010b, Buchholz et al., 2009). 
 
 Irrespective of the reasons for it, the significant variability in target cell yields when 
different cell lines are subjected to the same expansion and differentiation protocol is 
highly problematic and hampers the standardization of research in this field. The 
advent of IPSC technology and the prospect of generating HLA matched HESC 
based therapies is predicted to demand the use of multiple cell lines (Carpenter et al., 
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2009) and the varying responses of different cell lines to culture conditions is  likely 
to prove challenging in the design and costing of manufacturing processes.  
 
Some recent studies have proposed the idea of a short induction step to coax resistant 
cell lines towards the desired lineage (Kim et al., 2011, Boulting et al., 2011).  Dual 
inhibition of BMP and activin/nodal signalling pathways (dual SMAD inhibition) is 
an efficient method for inducing neuroectoderm differentiation (Chambers et al. 2009, 
Patani et al., 2009, Zhou et al., 2010, Kim et al., 2010, Morizane et al., 2011). For 
example treatment of differentiating HESC with BMP antagonist noggin (targeting 
SMAD 1/5/8) and the Activin/Nodal inhibiting drug SB431542 (targeting SMAD 
2/3) has been shown to produce a population of over 80-90% Pax6 +ve cells, 
(Chambers et al. 2009, Zhou et al., 2010).  This so called ‘dual SMAD inhibition’ 
method produces neuroepithelial cells that are Otx2 and FoxGB1 positive, 
confirming an anterior neural identity (Chambers et al., 2009).  These studies led us 
to consider ‘dual SMAD inhibition’ to induce efficient neuroectoderm differentiation 
and enhance RPE differentiation in the previously low RPE-yielding Shef3.  
 
Dorsomorphin is a small molecule protein kinase inhibitor that was discovered 
during a screen in zebrafish for small molecules that perturb dorsal-ventral axis 
patterning (Yu et al., 2007). It has been used to induce highly efficient 
neuroectodermal conversion in HESC via dual SMAD inhibition (Zhou et al., 2010, 
Kim et al., 2010, Meyer et al., 2011, Morizane et al., 2011). Zhou et al., found that 
treating HESC with 1µm dorsomorphin for ten days generated 80-90% Pax6 positive 
cells, similar to the potency of noggin and SB431542. Small molecules such as 
dorsomorphin are cheaper, more stable and better able to penetrate large cell masses 
that recombinant growth factor equivalents such as Noggin. Their use is highly 
favourable for commercial manufacturing processes in that they also offer less batch-
to-batch variability and avoid the cost and complexity of introducing another 
xenogeneic component to the manufacturing process (Allsopp et al., 2010).  
 
Others have found the efficacy or dorsomorphin to improve when combined with 
activin/nodal inhibitors SB431542 (SB) (Morizane et al., 2011) or with a 
downstream inhibitor of FGF signalling, PD325901 (PD) (Greber et al., 2011). Thus 
three small molecule antagonists of major signalling pathways were tested for their 
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ability to improve the efficiency of neuroectoderm differentiation and RPE 
differentiation in Shef3, and their responses compared to Shef6.  We observed that 
dorsomorphin on its own was capable of eliciting a large increase in Pax6-positive 
cells in both Shef6 and Shef3. In view of a recent report that SB431542 treatment 
can reduce RPE yields (Zahabi et al., 2011), it was decided to carry out long-term 
differentiation experiments using dorsomorphin only. 
 
Dorsomorphin treatment specifically and significantly enhanced neuroectoderm gene 
expression in both cell lines and at a range of cell seeding densities in both defined 
(mTeSR1) and MEFs-conditioned medium. This was accompanied by a significant 
down regulation in genes involved in the developing mesoderm, endoderm and 
trophectoderm.  This is consistent with the reported requirements for BMP and 
activin/nodal type signalling to induce endoderm/trophectoderm and mesoderm 
differentiation respectively (Vallier et al., 2009, Pera et al., 2004, Xu et al., 2002) 
and dorsomorphin’s ability to block these signals.  
 
Expression of pluripotency genes was appropriately downregulated relative to HESC 
by day 15, although there was a notable difference in the dorsomorphin-induced 
response between the cell lines. Dorsomorphin treatment appeared to reduce the time 
dependent down regulation of some pluripotency genes (Nanog, TDGF) relative to 
controls in Shef6, whereas it had no such affect in Shef3.  The reasons for this 
disparity are unclear. BMP signalling is a major pro-differentiation mechanism 
acting in early HESC, causing differentiation towards trophectoderm and primitive 
endoderm lineages via SMAD 1/5/8 phosphorylation (Xu et al., 2002, Pera et al., 
2004). The action of BMPs are normally countered by BMP antagonists (noggin, 
gremlin) secreted by MEFs feeder cells or MEFs-conditioned medium (Xu et al., 
2005), or by high quantities of FGF and TGFβ such as are present in mTeSR1 
medium (Ludwig et al., 2006).  In the absence of MEFs or mTeSR1, a BMP 
antagonist such as dorsomorphin could reduce the rate of differentiation; why this 
occurs in one cell line and not the other remains unclear.  We have noted previously 
that Shef3 is more prone to spontaneous differentiation than Shef6, which is likely to 
do with differing levels of endogenous signalling in the two cell lines; perhaps Shef6 
has higher autocrine FGF or Activin/Nodal signalling, which is not adequately 
suppressed by this dose of dorsomorphin. This question requires further investigation, 
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ideally by comparing dorsomorphin-induced reduction in SMAD2/3 and 1/5/8 
phosphorylation in the two cell lines.  
 
In spite of the slight pluripotency sustaining activity of dorsomorphin in Shef6, this 
cell line underwent more efficient neuroectodermal conversion.  Time course 
analysis assessing the relative upregulation from the start of differentiation in the 
expression of eye field transcription factors (Six3 and Lhx2) in each cell line 
demonstrated a greater fold increase in Shef6, suggesting that a greater proportion of 
the cells are differentiating towards the early eye field phenotype in Shef6. These 
time course studies also demonstrate that the effect of the treatment lasted beyond the 
ten day period during which dorsomorphin was added to the medium. This is 
consistent with the theory that retinal specification progresses via a series of steps 
that gradually restrict fate potential, starting with the expression of eye field 
transcription factors from a subset of neuraly-induced embryonic cells, the numbers 
of which are increased by dorsomorphin treatment (Zaghoul et al., 2005).  
 
A highly significant increase in the appearance of pigmented RPE in Shef3 in feeder-
free conditions was observed in dorsomorphin treated wells, and an accompanying 
upregulation in RPE gene expression.  In the control conditions few pigmented areas 
were visible; the addition of dorsomorphin, however, prompted a five fold increase 
in the total pigmented area.  Whilst it is difficult to accurately compare protocols, due 
to the different methods used to assess yield, Osakada et al., found that DKK1 and 
LeftyA treatment yielded a similar fold increase in MitF positive monkey ES cells 
(Osakada et al., 2008).   Similarly, Idelson et al. reported variability between HESC 
lines but HES1 showed an increase of 13% - 51% of aggregates containing 
pigmented clusters following the addition of activin A – a 3.8 fold increase (Idelson 
et al., 2009). Other more recent studies also report similar increases (Hongisto et al., 
2012, Buchholz et al., 2013, Mellough et al., 2013 - see table 1.1).  
 
Although the dorsomorphin based induction appeared to increase the RPE foci yield 
in MEFs co-culture also, there was fairly substantial variation in RPE yields. This 
may be due to the large range of passages over which these differentiation 
experiments were carried out – a variable which we have previously noted to have a 
profound affect on differentiation yields (chapter 3). The fold increase in foci 
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numbers was consistent across passages however (fold increase 
dorsomorphin/control = 4.13 ± 0.4 foci/cm2, N=3). 
 
The success of dorsomorphin treatment in the otherwise low yielding, high passage 
Shef3 raises the possibility that small molecule based neural induction could be used 
to substantially increase the useful lifespan of HESC lines (i.e. the number of 
passages over which they are productive), provided karyotypic stability was not 
compromised.  This could lead to significant cost savings. In addition, cell lines that 
generally produce poor RPE yields could be coaxed into productive differentiation. 
This type of strategy may become particularly important with the advent of IPSC 
technology, where the idea of patient-specific cell lines for personalised cell 
therapies is being proposed. In this scenario there would be a need for strategies that 
guarantee good RPE yields in all cell lines, regardless of their innate propensity for 
RPE differentiation in feeder-free, clinically appropriate differentiation conditions. 
Boulting et al. have already shown how a short, dual SMAD inhibition based neural 
induction step prior to an extensive directed differentiation can promote good yields 
of functional motor neurons in otherwise ‘recalcitrant’ IPSC lines (Boulting et al., 
2011). 
 
In chapters 3 and 4 we have demonstrated highly efficient RPE differentiation in 
Shef6 in MEFs co-culture and feeder-free, without the need for chemical induction.  
The differentiation efficiency was severely compromised at high passage numbers 
however (chapter 3, Fig. 3.10). Thus we tested the ability of dorsomorphin treatment 
to improve RPE yields further.   
 
In stark contrast to its beneficial effect in Shef3, Dorsomorphin severely inhibited 
pigmentation in Shef6 and significantly reduced RPE yields in feeder-free conditions. 
dorsomorphin treatment of Shef6 produced a highly enriched, homogeneous 
population of Pax6-positive cells at day 15 but failed to generate pigmented cells 
within the normal time frame or up to 60 days after seeding, despite inducing a 
sustained upregulation of genes critical to eye development.  At day 50, a 
homogeneous sheet of non-pigmented cells were found in the dorsomorphin treated 
wells which were immunopositive for the neuroretinal marker Chx10; this was 
accompanied by a significant increase in Chx10 mRNA and a down regulation in 
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MitF mRNA. These results show that dorsomorphin reproducibly induces 
neuroretinal differentiation at the expense of pigmented RPE in Shef6. This 
surprising result reveals some interesting features of spontaneous HESC-RPE 
differentiation. It has been shown in chick optic explants that RPE will not develop 
normally in the absence of the extraocular mesenchyme, which normally lies 
adjacent to the developing retina (Fuhrmann et al., 2000). Subsequently, a similar 
phenomenon has been described in mouse ESC derived optic cup structures derived 
from mouse ESC aggregates. Eiraku et al. have shown that separating the ‘optic cup’ 
like structure from attached non-retinal cells resulted in a failure to produce RPE, 
causing all cells to express Chx10 and adopt a neuroretinal fate (Eiraku et al., 2011).   
 
Dorsomorphin enhanced neuroectoderm conversion in the Shef3 cell line, but some 
Pax6-negative cells remained at day fifteen (Fig. 5.1), in Shef6, however, 
dorsomorphin generated a relatively homogenous population of Pax6+ve cells (Fig. 
2);  in the absence of MEFs feeders or Pax6-negative, non-neuroectodermal cells 
therefore, differentiation into the  RPE pigmented cell type may not be induced.  
These Pax6 negative, non-neuroectodermal cells may be critical to the normal 
process of RPE differentiation, carrying out a function akin to the BMP/Activin 
producing extraocular mesenchyme in eye development. The exact identity of these 
cells has not been determined in this study, comprehensive characterisation of these 
cells and the nature of the cytokines they secrete could make for fruitful future work. 
 
Similar observations, of a population of Chx10 positive neuroretinal progenitors in 
place of RPE has recently been reported in EB based systems (Meyer et al., 2011, 
Nakano et al., 2012). Nakano et al. found that Wnt/Shh induced EBs contained 
Chx10 positive and MitF negative emerging neuroepithelium. They showed that 
augmentation of Wnt signalling was required to turn otherwise neuroretina-primed 
cells into pigmenting RPE.  In our system a large increase in expression of the eye 
field transcription factor Six3 was seen in Shef6 (500 fold at day fifteen compared to 
50 fold in Shef3). Six3 has been shown to mediate suppression of Wnt signalling in 
the anterior neural plate in a process that enhances neuroretinal specification (Liu et 
al. 2010). Six3 mediated Wnt inhibition may be an important mechanism 
contributing to the suppression of RPE and augmentation of the neuroretinal 
phenotype in dorsomorphin treated Shef6. 
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 Interestingly, in the experiments described here, dorsomorphin treatment proved 
more effective in Shef6 in the MEF co-culture system.  Whilst it did not cause a 
substantial increase in RPE yield, there was a slight increase in yield (average 
1.3±0.1 foci/cm2), and the treatment did not halt pigmentation altogether as seen in 
the feeder-free cultures.  Hongisto et al., have recently demonstrated that a low level 
of activin A is secreted by MEF feeder cells and that this enhances RPE 
differentiation in co-culture systems.  The same process may be occurring in Shef6 
MEFs co-culture, promoting RPE differentiation in an otherwise neural retina 
favouring environment. As discussed in previous chapters, feeder cells are 
undesirable for robust, scaled up HESC-RPE manufacture; however, these results 
suggest that in the absence of feeders there may be a limit to the purity of RPE cells 
that can be generated from HESC differentiation.   
 
A potential solution to this problem may be to simulate the action of extraocular 
mesenchyme by the addition of recombinant growth factors or small molecules that 
mimic its action; the appropriate timing and concentrations of the relevant factors 
will need to be determined.  Various reports have demonstrated that it is possible to 
coax RPE differentiation from isolated or pure retinal progenitor cultures by the 
addition of exogenous growth factors from the BMP or TGFβ/activin family between 
days 20-40 of differentiation (Meyer et al., 2011, Eiraku et al., 2011).  We hoped to 
replicate this result in our cultures with the addition of 100ng/ml of Activin A from 
days 20-40 in dorsomorphin induced Shef6, but this was not effective in stimulating 
pigmentation. The fact that activin A treatment alone was also ineffective at 
increasing RPE yields in control samples suggests that cells at this time point were 
not correctly primed to respond to activin A treatment in this culture system at this 
concentration.   A very recent study has reported that supplementing feeder-free 
cultures with significantly lower concentrations of activin A at much earlier time 
point (10ng/ml, day 0-28) restores pigmentation levels to that of MEFs co-culture 
(Hongisto et al., 2012). It would be interesting to determine whether earlier activin A 
stimulation could restore pigmentation in our dorsomorphin induced Shef6 cultures. 
 
There have been some conflicting reports regarding the efficacy of activin A 
treatment for RPE differentiation. One study reported that the molecule has little 
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impact on RPE yield unless cells had first been primed by the addition of NIC 
(Idelson et al. 2009). In another report, however, the same concentration of activin A 
was shown to significantly enhance RPE differentiation in optic vesicle-like 
structures (Meyer et al., 2011). Large differences have also been found in activin A 
responsiveness between the H7 and H9 cell lines with the latter responding 
dramatically to 100ng/ml activin A (a reported 98% pigmented cells generated) and 
the former being responsive only to its inhibition with SB431542 (Zhu et al., 2013).   
Another report found activin A treatment alone to have little impact of MitF gene 
expression (Buchholz et al., 2013). More recently, additional factors have proven to 
induce RPE differentiation in neuroretinal primed cultures. Wnt agonists 
(CHIR99021, or Wnt3a-expressing L cells) have been shown to have a dramatic 
affect on directing RPE differentiation from HESC derived optic vesicle-like 
structures (Nakano et al., 2012). Turning the problem on its head, it would be 
interesting to experiment with molecules that interfere with the FGF signalling 
cascade. This pathway is know to stimulate neural retina (Martínez-Morales et al., 
2004) and its inhibition (using FGF inhibitor SU5402) has been shown to act on the 
reciprocal relationship between MitF and Chx10, swinging the balance in favour of 
MitF and subsequent RPE differentiation (Meyer et al., 2009, Buchholz et al., 2013).  
 
It is likely that, as is the case in drawing comparisons between almost all HESC 
differentiation protocols, the enormous variability between cell lines and their 
hypersensitivity to variations in methods, both for their maintenance and 
differentiation, mean that extensive screening of growth factor and small molecule 
combinations, timings of application and concentrations will be required for every 
cell line and differentiation protocol.   Here we have demonstrated a method for 
reproducibly generating high RPE yields from a previously resistant cell line, in a 
simple, one-step method employing small molecules and feeder-free culture. In 
addition we have shown how a short neural induction step can induce neuroretinal 
differentiation in previously RPE favouring conditions.    
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 5.6 Conclusion 
 
Having investigated how cell line and passage number, MEF feeders vs. feeder-free 
culturing, single cell dissociation and cell seeding density impact on HESC-RPE 
differentiation, we sought to investigate if RPE yields could be improved by 
directing early differentiation using small molecules that interfere with key signalling 
pathways involved in HESC differentiation and development of the human eye. 
 
The study was restricted to looking at early cell fate decisions, specifically 
neuroectodermal conversion, hypothesising that early intervention is likely to have 
the greatest impact. Small molecules were used rather than recombinant growth 
factors, upon the reasoning that they are more stable, less costly, suffer from less 
batch to batch variability and are potentially better able to penetrate thick cell masses 
than recombinant growth factors (Allsopp et al., 2010). We have shown that 
neuroectodermal differentiation can be efficiently enhanced in a feeder-free system 
in two cells lines using ten days of treatment with a single small molecule BMP / 
activin inhibitor, dorsomorphin, presumably via a mechanism of dual SMAD 
inhibition.  In addition, we have shown that enhancing neuroectoderm conversion 
leads to a robust increase in RPE yields in feeder-free conditions, in the otherwise 
low yielding Shef3. In feeder-free, density optimised, monolayer culture, 
dorsomorphin treatment enhanced RPE yields five fold, which is comparable the 
improvements seen by the addition of growth factors by others. In the usually high 
RPE yielding cell line Shef6 however, the same neural induction step enhanced 
neuroretinal differentiation – at the expense of RPE differentiation. This method 
could be widely applied to generating RPE or neural retina from poorly performing 
cells lines, and to extend the useful life span of HESC cells, making them productive 
even at high passages.  Future work could focus on the use of small molecules to 
manipulate differentiation during the in vitro equivalent of the patterning of the optic 
vesicle stage, when the identity of the neural retina and RPE are specified and 
consolidated. 
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Chapter 6: Summary, Discussion and Future Work 
  
 
6.1 Summary of findings 
 
 
In the course of this work, several different lines of investigation have identified 
parameters that can be varied to improve the RPE yield and conversion efficiency. 
The results from the experimental work are summarised in the table below, expressed 
as average RPE foci yields per cm2 in each cell line from experiments carried out at 
‘normal’ seeding density (1:2 split ratio or 35,000/cm2). 
 
 
 
Shef6: Condition (Passage number) Average RPE Foci 
/cm2 
Fold Change Relative 
to MEFs co-culture 
Shef6, MEFs co-culture (p40-60) 8.7 ± 1.2/cm2 (N=9) 1 
Shef6, MEFs co-culture (p60-85) 0.2± 0.1/cm2 (N=3) 0.02 
Shef6, Matrigel + Conditioned Media (p50-70) 13.0 ± 6.1/cm2 (N=2) 1.5 
Shef6, Matrigel + MteSR1 (p50-70) 15. 9 ± 1.1/cm2 (N=2) 1.8 
SC Shef6 Matrigel + Conditioned Media (p50-70) 35-50  /cm2 (N=4) * 4.0-5.7 
SC Shef6 Matrigel + mTeSR1  (p50-70) 48.2 ± 4.6 /cm2 (N=6) 5.5 
 
Shef3: Condition (Passage number) Average RPE Foci 
/cm2 
Fold Change Relative 
to MEFs co-culture 
Shef3, MEFs co-culture (p40-60) 4.1 ± 1.3 /cm2 (N=7) 1 
Shef3, MEFs co-culture (p60-85) 0.2 ± 0.1 /cm2 (N=7) 0.04 
Shef3, Matrigel + Conditioned Media (p40-50) 0.35 ± 0.27/cm2 (N= 3) 0.08 
SC Shef3 Matrigel + MTeSR1 ( p60-80) 6.7 ± 1.3/cm2 (N=6) 1.6 
SC Shef3 Matrigel + mTeSR1+ Dorsomorphin 
(p60-80) 
17.7± 3.3/cm2 (N=6) 4.3 
Table 7.1 Summary of differentiation yields. 
 
* homogenous pigmented coverage, single foci indistinguishable, SC = single cell dissociation and 
seeding. 
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Both cell lines Shef3 and Shef6 demonstrated increased RPE yields following single 
cell dissociation and seeding onto Matrigel + mTeSR1 media.  
 
Shef6 produced an average of 8.4 ± 1.8 foci/cm2 (N=6, p48-70) in traditional MEFs 
co-culture, following clump passaging. The cell line responded well to transferral to 
matrigel in feeder-free medium generating an average of 13-16 foc/cm2 (N=4). Our 
single cell dissociation protocol increased the yield further with wells generating on 
average 48.2 ± 4.6 pigmented foci/cm2 (N=6, p 50-70) in defined, feeder-free 
conditions.  The addition of a dorsomorphin induction step significantly reduced 
pigmentation in Shef6, instead yielding Chx10 +ve cells resembling neural retinal 
progenitors.  
 
Shef3 produced on average 2.3 ± 2.1 /cm2 (N=7, p40-80), and despite reduced yields 
following feeder-free differentiation in conditioned media following clump 
passaging, saw an increased yield in matrigel +mTeSR1 following single cell 
dissociation up to 6.7 ± 1.3/cm2 (N=6, p60-80), which was then further increased by 
the addition of a dorsomorphin induction step up to 17.7 ± 3.3/cm2 (p60-80). 
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6.2 Process characterisation and feeder-free differentiation 
 
 
In this study, HESC-RPE differentiation, using traditional HESC-MEFs co-culture, 
was carried out in two cell lines, Shef6 and Shef3. A novel method for non-
destructive, semi-automated measurement of HESC-RPE differentiation rates was 
created using a flat bed scanner and a simple program developed in using an open-
source software package, ImageJ.  This system enabled automated analysis of images 
of whole flasks and wells of differentiating HESC. The program quickly and reliably 
distinguished pigmented cells from non-pigmented background and used these 
measurements to count the number of individual HESC-RPE differentiation events 
(number of foci) and the overall % surface pigmentation.  Morphological and 
immunocytochemical analysis of these pigmented cells confirmed their universal 
HESC-RPE identity. In addition to image analysis, quantitative gene expression for 
RPE markers (Pmel17, Bestrophin, CRALBP, Tyrosinase, MitF, Otx2) were used 
throughout this project as a measure of relative target cell yields in the various 
differentiation conditions.  
 
Detection of pigmented cells by image analysis allowed the real time assessment of 
pigmented cell yields without interfering with the progress of differentiation. Data 
was collected over a 30-80 day time span, revealing important differences in the 
differentiation rates between the two cell lines. It was found that Shef3 cells 
consistently produced pigmented foci faster than Shef6, but that Shef6 continued to 
accumulate pigmented foci over a longer stretch of time. As a result Shef6 had a 
significantly greater overall yield. This experiment emphasised the heterogeneous 
differentiation rates between distinctive HESC lines, and helped to define a suitable 
time scale over which to carry out further long term differentiation studies (usually 
50 days). These results may help to explain large ranges in the reported time required 
for pigmentation in other studies (table 1.1), with different cell lines responding 
differently to the same conditions. In terms of industrial HESC-RPE manufacture, it 
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would be advantageous to determine the rate of differentiation for each individual 
cell lines, such that the optimal RPE harvesting time can be determined.  
 
In using a flat bed scanner to record pigmentation, culture vessels were removed 
from the incubator for under a minute, much less time than is required for manual 
counting (Idelson et al., 2009, Kokkinaki et al., 2011, Vaajassaro et al., 2011, 
Hongisto et al., 2012,) or microscopic imaging of individual pigmented foci 
(Rowlands et al., 2012). This is important as the drop in temperature resulting from 
prolonged time out of the incubator has been shown to cause a drop in the media pH, 
affecting both cell proliferation and differentiation (Veraitch et al., 2008).  
 
The specially designed T25 mounting device reduced the influence of ambient 
lighting and helped to standardize image acquisition, thereby reducing the 
requirement for further processing and allowing for comparison of images acquired 
over the time span of the project. Data was collected on the changes in RPE yields 
with increasing passage number over the span of the project.  A significant drop-off 
in differentiated cell yield over time in culture was observed in both cell lines: on 
average, cells produced 9 foci per cm2 at passage 40-50, but only 0.2 per cm2 at 
passage 70-90.  HESC are heralded for their purportedly infinite expansion capacity 
(Hoffman et al., 2005), and although subtle changes in HESC behaviour over time in 
culture have been noted (Baker et al., 2007), this drop-off in differentiated RPE cell 
yield has not previously been reported and will be an important consideration in the 
design of any manufacturing processes using HESC.    
 
Interestingly, later in this study it was found that the usually low yielding, high 
passage Shef3 cells could be coaxed into more efficient differentiation. Passage 60-
80 Shef3 could produce on average ~18 RPE foci/cm2 when subjected to a 
dorsomorphin induction step. This suggests that cells become resistant to 
differentiation with prolonged time in culture, rather than loosing their pluripotency 
altogether.  
 
The use of feeder cells, murine or human, is undesirable in the manufacture of cells 
for cell therapy. Not only do they pose a risk in the potential transmission of 
pathogens and present an additional regulatory burden, but they also add significant 
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logistical complications to culturing practices and compromise reproducibility and 
standardization (Akopian et al., 2010, Chin et al., 2007). In this study, the ability of 
HESC to generate RPE in commercially available feeder-free systems was assessed. 
HESC-RPE with pigmentation, classical morphology and RPE marker expression 
were observed in feeder-free conditions in both cell lines.  During the course of this 
project, feeder-free derivation has been demonstrated by others (Vaajassari et al., 
2011, Rowland et al., 2012, Buchholz et al., 2013, Sridhar et al., 2013). To our 
knowledge, there has been only one other recent comparison of differentiated cell 
yields between feeder cell co-culture and feeder-free differentiation protocols 
(Rowland et al., 2012). Significantly reduced RPE yields were observed in our study 
on matrigel in feeder cell free conditions following clump passaging in Shef3. 
Similarly, another group has reported differentiation of H9 cells generated ~50% 
fewer pigmented foci/cm2 on Matrigel relative to hs27 human feeders (Rowland et al., 
2012).   
 
In addition to being a highly supportive environment for HESC growth and 
differentiation, MEFs secrete growth factors that are implicated in in-vivo eye 
development such as activin A and IGF1 (Hongisto et al., 2012, Gerber et al., 2007, 
Bendall et al., 2009), which have been proposed to contribute to the relatively high 
rate of RPE derivation in standard HESC culture conditions (Vugler et al., 2008).  
The results of this study may reflect the absence/reduced quantity of these RPE 
inductive factors in feeder-free culture. Apart from the impact on cell fate decisions, 
the effect of feeder-free culture on cell growth rates may be of equal importance in 
determining differentiated cell yields (Tavakoli et al., 2009). In this study it was 
shown that neither Shef6 nor Shef3 could produce RPE in continuous, adherent 
differentiation on matrigel in the absence of an expansion step in which the cells 
reached confluence, indicating the importance of high local cell density. 
 
In these, circumstances, where an undefined and complex culturing practice produces 
the highest product yields, the construction of a financial and bioprocessing 
modelling tool would be beneficial (Placzek et al., 2009). This could enable 
comparisons of the raw material/labour requirements vs. the relative process 
efficiency to determine the most cost-effective strategy.  
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 One surprising finding of this study was that unlike Shef3, when Shef6 were 
subjected to feeder-free culture, they underwent significantly more efficient RPE 
differentiation. This difference may stem from the divergent growth factor 
requirements and endogenous signalling levels in the two cell lines. It may also be a 
reflection of the relative adaptability of the two cell lines. Significantly reduced cell 
proliferation rates were observed in Shef3 when cells were transferred to the feeder-
free culture relative to Shef6. These finding underline the necessity to carry out 
screening and optimisation studies for every new HESC or IPSC line. 
 
6.3 Seeding density and process efficiency 
 
One aim of this study was to quantify the RPE foci generated per quantity of HESC 
within a given time and volume of raw material, in various different differentiation 
conditions. 
 
The number of individual HESC colonies seeded into each flask could be quickly 
established using the flat bed scanner, mounting device and Image J. This 
information was used to calculate the number of RPE foci derived per HESC colony 
over a number of differentiation runs and hence to establish the HESC-to-RPE 
conversion efficiency. Importantly the conversion efficiency was shown to vary 
significantly with seeding density (from 0.22 to 0.88 RPE foci/HESC colony). Not 
only did the higher density flasks produce more RPE, more rapidly, but the 
proportion of HESC colonies that generated RPE actually increased.  This is the first 
study to our knowledge reporting this relationship in HESC-RPE differentiation and 
is in line with findings in other HESC differentiation protocols suggesting that high 
density cultures are conducive to anterior neuroectoderm differentiation (Chambers 
et al., 2009).  An ideal HESC-RPE manufacturing process should generate the largest 
number of RPE foci, using the smallest amount of lab space, time, manual labour and 
raw materials (including HESC). Given that the same quantity of media, incubator 
space and manual labour was used for both low and high density flasks, there are 
clearly significant cost savings to be made by optimising seeding density. 
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These density optimisation experiments were repeated using a single cell dissociation 
protocol covering a larger range of densities. Single cell dissociation in HESC is 
usually avoided due to reportedly low viability (Watanabe et al., 2007).   In this 
study it was shown that survival, proliferation and differentiation of both Shef6 and 
Shef3 following single cell dissociation is possible following a gentle enzymatic 
treatment and seeding at relatively high densities. It was observed that only very low 
density conditions (8500 cells/cm2) were not permissive to cell survival.  Using this 
new approach it was shown that the trend for increased process efficiency with 
increased HESC density reached a peak at 35,000 HESC/cm2, above which, RPE 
yields per HESC cell were compromised.  Establishing the optimum seeding density 
for large scale manufacturing will require the modelling of raw material and 
processing costs against the changing differentiation efficiencies reported here. 
 
6.4 Dorsomorphin induced neuroectoderm conversion 
 
We hypothesised that the low RPE differentiation yields seen in Shef3 could be 
improved by prompting neuroectodermal conversion with small molecules. Small 
molecules which interfere with key signalling pathways are powerful tools in stem 
cell research. Compared to growth factors they are less vulnerable to degradation in 
culture, are significantly cheaper and suffer from less batch to batch variability 
(Allsopp et al., 2010), properties which make them excellent tools for industrial 
application.  Early treatment with the BMP/Activin/Nodal inhibitor dorsomorphin 
selectively upregulated neuroectoderm gene expression and simultaneously 
suppressed mesoderm, endoderm and trophectoderm expression, in both cell lines.  
In feeder-free, density optimised and defined differentiation conditions, the 
dorsomorphin induction step consistently enhanced Shef3 RPE yields.  The Shef3–
RPE cells derived from these cultures displayed typical pigmented cobblestone 
morphology and stained positively for classical RPE markers.  
 
The ability to induce high RPE yields from otherwise recalcitrant cell lines may 
become important with the advent of IPSC technology, where the idea of patient-
specific cell lines for personalised cell therapies is being proposed. In this scenario 
there would be a need for strategies to induce RPE differentiation in feeder-free, 
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clinically appropriate differentiation conditions regardless of the cell line’s innate 
propensity for RPE differentiation (Boulting et al., 2011, Buchholz et al., 2009). 
 
Shef6 consistently generated higher RPE yields than Shef3. When Shef6 were 
subjected to the same early dorsomorphin treatment however, pigmentation and RPE 
gene expression were suppressed and an upregulation in neural retinal marker Chx10 
was observed. The reason for this disparity between cell lines requires further 
investigation; the neuroectoderm conversion may be too efficient in Shef6 in the 
presence of dorsomorphin and in the absence of MEFs or non neuroepithelial cells 
which secrete growth factors that mimic the environment of the extraocular 
mesenchyme, RPE differentiation is not induced (Hongisto et al., 2012, Meyer et al., 
2011).   
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6.5 Future work 
 
Despite the significant improvements in yield and reproducibility using the new 
protocols developed here, sources of variability clearly remain. We can only presume 
that the varying differentiation states of the seeded HESC are behind this variability. 
Although a protocol was developed to differentiate cells in density controlled, 
feeder-free conditions, they were expanded by traditional clump passaging in MEFs 
feeder co-culture and thus subject to the variations in environment that go with this 
method.  It may prove to be beneficial to expand cells in feeder-free conditions for 
several passages prior to differentiation. Currently the high costs of mTeSR1 and 
other defined media formulations would make this challenging in a standard 
laboratory environment. .  
 
Although the numbers of individual foci generated per HESC cell/ HESC colony and 
the % pigmented surface area were determined, a protocol that generated a 
suspension of single cells from differentiated flasks at day 50 without suffering 
significant cell losses was not established, due to the time available. As a result, the 
actual number of pigmented cells generated was not determined in this study.  This 
did not interfere with our ability to compare differentiation efficiencies between 
protocols, as was the aim of this study, but it could hamper further process 
development. Thus, if given more time or resources we would focus the next part of 
the study on developing scalable and clinically appropriate methods to separate the 
pigmented foci from the non-pigmented background and in characterising the 
expansion capacity of the isolated foci. In a very recent study a strategy of clonal 
propagation and serial passaging claims to enrich for RPE cells generating up to 99% 
pigmented RPE cells, simply by repeated passaging (Maruottie et al., 2013). This is a 
promising strategy in terms of its scalability, however the limited proliferation 
capacity of HESC-RPE is well documented and thus the maintenance of RPE 
identity would need to be verified. The exact identity of the heterogeneous 
population of non-pigmented cells which co-emerge with RPE in standard HESC 
culture is unclear and presumably subject to the same level of sensitivity to culture 
conditions. Other studies have identified non-pigmented co-emerging cells as having 
characteristics of early forebrain derivatives (Meyer et al. 2011).  From a validation 
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and safety perspective, it will be important to verify that these cells are removed 
prior to clinical implantation.   
 
During the course of this project, loss of experiments due to cell sheet peeling and 
contamination was a significant problem.  Transferring these protocols to dedicated 
clean room facilities would most likely reduce such occurrences. The protocol that 
we describe here is more amenable to automation that traditional current best 
practice methods. Whilst clump passaging is challenging to automate, HESC 
maintenance in a fully automated robotic platform using single cell passaging has 
been demonstrated (Thomas et al., 2008). In addition, flow rate controlled feeding 
could reduce losses due to disturbances of the cell sheet.   The prolonged time 
required to generate pigmented cells (see table 1.1, median time to pigment = 28 
days), combined with the daily media exchange requirement makes for a labour 
intensive and therefore expensive process. Automated cell feeding could lead to 
significant improvement in processing efficiencies. Incorporating automated cell 
culture into an imaging system for recording pigmentation could lead to the 
development of a high throughput screening platform, enabling rapid assessment of 
the optimal differentiation conditions for each cell line.    
 
In a very recent report, pigmented RPE cells were generated from the H9 cell line in 
the significantly reduced time frame of 14 days, by the addition of several growth 
factors and small molecules (Buchholz et al., 2013, see table 1.1), thus proving that 
in vitro RPE differentiation need not follow the same time course as seen in vivo.  
This development, if applicable to multiple cell lines is a step forward that could lead 
to significant cost savings. 
 
The expansion capacity of HESC make them ideal source for large scale production, 
but they present a number of unique challenges e.g. the long time scales required for 
RPE generation, karyotypic instability, the complexity of culturing methods, 
spontaneous differentiation, reliance on expensive recombinant growth factors and 
serum. In addition the use of HESC for commercial therapies is an ethical concern 
for some. The discovery and rapid developments in IPSC technology is likely to 
provide a less contentious alternative source of RPE in the future (Buchholz et al., 
2009, Carr et al., 2009). In terms of manufacturing it is worth noting that IPSC 
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currently have similarly complex cell culturing requirements, on top of which the 
efficiency of their derivation from somatic cells is very poor (e.g. less than 0.001%, 
Hasegawa et al., 2010). Alternative methods for generating RPE may include 
somatic cell conversion strategies, which promise more rapid fibroblast-RPE 
conversion by bypassing the pluripotency stage (Zhang et al., 2013).  
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 6.6 Conclusion 
 
Since the serendipitous discovery in 2002 by Kawasaki and colleagues of Pax6 
pigmented foci spontaneously appearing in cultures of primate ES cells (Kawasaki et 
al., 2002), RPE have been derived from a number of HESC and IPSC lines (table 
1.1) . Until recently, there has been surprisingly little research focused on improving 
RPE differentiation yields using scalable and reproducible differentiation methods.  
A diverse range of protocols generate RPE from HESC and IPSC, including 
differentiating cells on a monolayer, growing them as suspended aggregates, 
directing differentiation with growth factors and small molecules or by spontaneous 
differentiation. Although the eventual number of RPE cells required per therapy is 
likely to be small (estimated at ~100,000 cells per therapy (Carr et al., 2013)), the 
cost and complexity of HESC culturing, coupled with the long time scales required 
for cells to differentiate, will mean that the HESC-RPE conversion efficiency is 
likely to be a key driver in the economic feasibility of any potential therapies.   In 
this project the relative conversion efficiency of the HESC-RPE differentiation 
process was analysed and evaluated following a number of process changes aimed at 
improving the scalability, reproducibility and target cell yield. Several critical 
parameters were identified that could help develop a robust, scalable and cost-
effective strategy for wide-scale HESC-RPE manufacturing. It is hoped that these 
process improvements will become widely adopted and will have the predicted 
beneficial effects on reducing the costs of RPE generation. Reduced manufacturing 
costs will ultimately increase the availability of RPE implantation as a therapy to 
ameliorate common and incurable forms of blindness. 
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Appendix :  Validating changes to HESC-RPE 
differentiation process 
 
 
 
 
 
 
 
 
A.1 Introduction 
 
This chapter has been included to meet the requirements of the Validation II module 
of the EngD programme; in it the key validation issues relating to the research 
presented in this thesis will be outlined and discussed.  Clinical approval for the use 
of HESC-derived RPE at the London Project to cure Blindness has recently been 
granted, demonstrating that the regulatory and validation requirements have been met 
using the current process for HESC-RPE manufacture. Thus this chapter concerns 
the regulatory requirements incurred by changes to the manufacturing procedure and 
critically assesses their potential value in a scaled up manufacturing process. 
 
The objective of this research has been to understand and improve the efficiency of 
the current processes for manufacturing RPE from HESC for the treatment of AMD.  
The finished product of the RPE manufacturing procedure is a 3mm by 6mm 
polyester patch seeded with approximately 100,000 pigmented RPE cells derived 
from the Shef1 cell line (Carr et al., 2013). The procedure currently used at The 
London Project to generate and expand HESC-RPE is sufficient to produce material 
for small scale animal studies; however significant challenges may arise in designing 
and validating a more economical, scaled up process. At present the quantity of 
material produced per batch is highly variable, and the key process parameters that 
cause this variability are not fully understood.  It was the aim of this thesis to 
investigate some of the sources of variability in the process and their respective 
impact on RPE derivation, with a view to optimising HESC-RPE manufacture.  
These improvements in manufacturing procedures ultimately aim to reduce the cost 
of goods (COG) which can be achieved via several mechanisms: 
 
1. Improving the over all HESC-RPE differentiation efficiency 
2. Reducing the cost and/or quantity of raw materials required 
3. Reducing the time and physical lab space required to create the final product 
4. Reducing the manual labour requirement 
5. Reducing the regulatory burden  
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 The outcomes of this study as well as the recent work of others have identified 
several process parameters which have a significant impact on HESC-RPE 
differentiation yield and over all process efficiency:  
 
 Cell line characteristics 
 Differentiation method (Embryoid body, continuous adherent culture, single 
cell seeding etc.) 
 Feeder cell co-culture vs. feeder-free differentiation 
 The substrate used for  RPE differentiation and expansion phases 
 Addition/withdrawal of growth factors and/or small molecules from the 
growth and differentiation medium 
 Separation and enrichment of pigmented RPE cells from contaminating non-
pigmented cells. 
 
Adjusting these parameters, whilst improving differentiation efficiency and reducing 
processing costs, will have significant validation and regulatory implications the 
nature of which are discussed in this chapter. 
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A.2 Validation Issues 
 
 
In order to validate any changes to the HESC-RPE manufacturing procedure, the 
goal will be to create a set of specifications that, when met, ensure the product is 
equivalent to that generated using current processes, in terms of both safety and 
efficacy. These criteria should be used to test the manufacturing processes and ensure 
that all processes are kept within pre-determined windows of operation. When 
adhered to, these process validation criteria should help to minimise batch-batch 
variability in the product. Planning the IQ, OQ and PQ will only be possible once the 
process has been further defined, developed and optimised.  This will involve 
establishing process robustness, determining the windows of operation, and testing 
the operating extremes. The following summarises the key validation issues that are 
likely to arise as changes to the manufacturing procedure are implemented. 
 
 
A.2.1 Additional pluripotent cell line characterisation 
 
Although early clinical studies using HESC derived RPE currently make use of only 
one cell line (Schwartz et al., 2012, Carr et al., 2013), if early clinical studies prove 
successful, patient specific IPSC derived RPE or HESC derived, HLA matched cell 
therapies may be required which will demand the use of multiple cell lines 
(Carpenter et al., 2009).  When validating new cell lines for clinical use an important 
property to assess is karyotypic stability.  HESC cells in culture will occasionally 
undergo random chromosomal rearrangements, which may cause them to become 
more abundant in culture than cells with normal karyology (Baker et al., 2007).  This 
may affect the propensity of the cells to differentiate into the desired phenotype and 
could pose a safety risk (e.g. by giving the cells cancerous properties) (Blum et al., 
2008). The rate at which these events occur may vary considerably between cell lines.  
In order to account for this, a percentage of the growing cells must be regularly 
karyotyped for validation purposes. It may be necessary to undergo this testing at the 
beginning of expansion, and at the end of the expansion phase.  Karyotypic changes 
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occur during cell division and accumulate during prolonged growth periods (Baker et 
al., 2007); differentiated HESC-RPE cells undergo few cell divisions when spatially 
constricted. If the cells prove to be normal after expansion therefore, they will not 
undergo any further karyotypic changes prior to administration. Karyotypically 
normal cells can be banked by cryopreservation in vials which can be defrosted and 
expanded as required in a defined number of passages. If all culturing conditions are 
kept constant and the cells are not put under any undue stress, this should reduce the 
probability of karyotypically abnormal cells becoming abundant in culture. 
 
In this study we have demonstrated innate variability in the differentiation rates of 
different cell lines. This will be an important consideration in the validation of new 
cell lines. Of particular concern is the rate at which cells depart from the pluripotent 
state as the transplantation of pluripotent cells may pose a significant risk to patients 
(Lu et al., 2009).  With current protocols, Shef1 derived RPE are cultured for 
prolonged periods of time following their initial emergence in culture (5-6 weeks) 
which partly serves to reduce the risk of pluripotent cells remaining; the required 
time to negate this possibility in new cells lines will have to be assessed and 
validated.  
 
 Another finding of this study was that different cell lines produced significantly 
different RPE yields over the same time period in culture. This could indicate 
differences in the relative proportions of contaminating cell types between different 
cell lines.  It may be necessary to apply additional testing confirming the absence of 
non-RPE cell types in the mechanically isolated pigmented foci. This should include 
testing for pigmented cell types than are not RPE such as neural crest derived 
melanocytes; although these cells do not appear in standard culture conditions in 
Shef1 nor Shef6/3, they may arise in as yet uncharacterised cell lines each with 
distinct innate differentiation preferences. 
 
If multiple cell lines are going to be used for tailor made HLA matched HESC-RPE 
or IPSC-RPE therapies, a plethora of sample segregation protocols will have to be 
implemented. These will include issues surrounding lot segregation, area clearance, 
material tracking and lot paperwork review and approval (Mason et al., 2007). 
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 A.2.2 Feeder-free derivation and Raw Materials 
 
A number of the materials currently used to derive and grow HESC cells are animal 
derived (table 6.1). These present a validation challenge in terms of controlling batch 
to batch variability and, for regulatory purposes, demonstrating the absence of animal 
derived pathogens/immunogenic components.  Human foreskin fibroblasts (HFFs) 
are now used is place of MEFs in the preparation of Shef1 RPE for clinical trials, 
which reduces the risk of xenogeneic contamination. Never the less significant 
logistical and validation challenges remain in the use of an additional feeder cell line 
including the necessity of proving batch to batch equivalence in the feeder cells. 
Validating the use of these materials is likely to require the regular sampling and 
associated paperwork at significant cost. 
 
 
Material Xenogenic component 
Mouse embryonic fibroblast layer Derived from CF1 mice 
Knockout serum replacement Contains bovine serum albumin 
Gelatine Derived from Porcine Skin 
  
    Table A.1.Xenogeneic materials in standard HESC culture 
 
In this study we have demonstrated feeder cell free HESC differentiation using 
defined media mTeSR1 and matrigel matrix which is derived from the Englebreth-
Holm-Swarm sarcoma. New xeno-free, human-derived, good manufacturing 
practice- compliant medias and matrices have since become commercially developed 
(Table 2.)  Assuming HESC-RPE can be successfully derived in these new 
medias/matrices (as is the case with mTeSR1 and Matrigel), switching to feeder-free 
differentiation will significantly reduce the regulatory burden as well as simplifying 
cell culturing logistics.  It will be necessary to batch test new matrices and media to 
demonstrate lot-lot equivalence and sterility. 
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Current component Feeder-free alternative Source 
TeSR2 media  Stemcell technologies, 
Vancouver, Canada 
StemPro media, Invitrogen, Paisley, UK 
NutriStem Media* Stemgent, MA, USA 
CELLstart matrix, Invitrogen, Paisley, UK 
MEFs or HFFs,  
DMEM/ 20% KOSR 
Synthemax* matrix Corning, NY, USA 
 
   Table A.2  Xeno-free materials developed for HESC culture with potential use in ‘feeder-free’ 
HESC-RPE differentiation. (* These materials have very recently been used for completely 
Xenogeneic component free retinal differentiation of IPSCs, see discussion (Sridhar et al., 2013)). 
 
In this study we have demonstrated the phenotypic equivalence of feeder cell free 
derived RPE, in terms of morphology and marker expression.  For industrial 
validation of this new technique however it will be necessary to carry out a more 
comprehensive set of characterisation experiments to determine equivalence of the 
finished product (see section 7.2.5). 
 
A.2.3 Differentiation yield assessment by image analysis 
 
In this study we have demonstrated how differences in culture conditions (density, 
cell line, feeder-free differentiation etc.) can alter the rates of RPE emergence. This 
is an important area for process optimisation and could lead to significant cost and 
efficiency savings. In order to monitor the differentiation rates we have developed a 
semi automated image capture and analysis system.  This has the potential to be 
incorporated into a cGMP environment so that on-line monitoring of the 
differentiation progress can be achieved.  In addition to the potential cost and 
efficiency savings, monitoring the timing of foci emergence may have important 
implications on product consistency. It has been well documented that HESC derived 
RPE have limited proliferative capacity, gradually de-differentiating and eventually 
irreversibly de-pigmenting and adopting mesenchymal characteristics. Thus it is 
desirable from a validation perspective to isolate the emerging RPE at a defined time 
point following their emergence in culture.  In addition to undertaking the required 
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cleaning procedures and associated documentation to make the scanning device 
cGMP compliant, the image recognition capacity should be validated in relation to 
biological assays. Individual foci detected by the image analysis should be isolated 
and global gene expression analysis used to assess their relative differentiation states. 
 
 
A.2.4 Cell separation 
 
In the current process pigmented RPE cells are separated from a mixed background 
of cells (both undifferentiated stem cells and various other differentiated phenotypes) 
via a process of manual dissection using microsurgical blades. Pigmented regions are 
identified by the operator and the surrounding non-pigmented cells are dissected 
away from it.  The pigmented foci are then plated onto matrigel for further expansion. 
This manual separation is not very amenable to validation since the quality of cell 
separation is highly dependent on the operator.   
 
Differences in RPE differentiation yield may also affect the suitability of pigmented 
foci isolation procedures at the end of the differentiation. For example whilst one 
operator may be able to comfortably isolate the 100 or so foci that typically arise in 
one cell line, another cell line producing 300-400 will require additional time in the 
cGMP facility, additional operators and potentially a entirely new foci isolation 
strategy. These changes will have to be validated and incorporated into the 
manufacturing plan when new cell lines are included.  
 
There is potential to use fluorescence activated cell sorting (FACS) or magnetic 
activated cell sorting (MACS) to isolate the desired cell type. However after 3 weeks 
of differentiation, cells are entangled in a tough extra-cellular matrix, this presents 
significant problems in making the single cell suspension necessary for FACS and 
could lead to large product losses. Should further optimisation of the enzymatic 
dissociation render this method more efficient, its accuracy and reliability would 
have to be validated as well as any enzymes used included in the list of raw materials 
to be approved for clinical use. FACS based selection has the advantage that cells 
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could be sorted on the basis of pigmentation, avoiding the need to include and 
validate the use of primary and secondary antibodies in the manufacturing. An 
alternative separation technique could employ semi-automated laser-assisted micro 
dissection (Terstegge et al., 2009). In this case image recognition software and laser 
micro-dissection would have to be proven to meet acceptable standards of accuracy 
and reliability.  
 
A.2.5 Characterization of HESC RPE 
 
The ultimate goal of a validation strategy is to ensure that the finished product will 
reliably be both safe and efficacious.  As we have seen in this study, alterations in 
differentiation methods and materials can have a dramatic effect on the RPE 
differentiation yield; our characterisation studies however suggest when isolated and 
re-plated the expanded RPE cells have very similar characteristics irrelevant of how 
they were derived. For clinical use however a very comprehensive set of assays will 
be required to ensure product equivalence. Having established equivalence, batch 
release criteria should be drawn up. When met these criteria should confirm the 
identity of the cell population as fully differentiated and functional RPE. In the 
current process pigmented cells are manually isolated from the differentiating Shef1 
HESC before being plated onto CELLstart for expansion over 5-6 weeks. During this 
time the cells de-differentiate and re-differentiate as they proliferate and over time 
express an increasing number of markers typical of native human RPE cells. This 
process of maturation can be monitored by way of gene expression and proteomic 
analysis.  Validation might involve taking samples from dissociated HESC-RPE 
which have been identified as ‘mature’ by analysis of morphology or level of 
pigmentation. These samples could then be analysed by way of quantitative PCR 
(QPCR) and western blot analysis.  In this instance the release criteria for a batch 
could be the fold increase in expression of ‘mature’ RPE genes such as RPE65, 
CRALBP, Bestrophin, PEDF and Tyrosinase and the concurrent fold decrease in 
expression of stem cell associated genes such as Oct4, Nanog and Sox2. QPCR is a 
particularly useful technique in that many genes can be analysed concurrently on a 
96 well plate using very small quantities of sample. This analysis could be confirmed 
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by western blotting; comparing the expression of RPE related genes in the HESC-
RPE line to that of an established RPE cell line or foetal RPE. In addition to QPCR, 
assessing levels of pigmentation by image analysis is a good technique for assessing 
cell confluence and relative maturation. The presence of mature RPE specific 
proteins such as PMEL17 could also be assessed by immunocytochemistry 
performed on patches from a particular batch. The specific quantities which 
determine the lot release criteria could be established by relation to functional assays 
such as phagocytosis assays which tests the cells ability to phagocytose fluorescently 
labelled rod and cone outer segments (Carr et al., 2009), assays to measure PEDF 
and VEGF secretion (Maminishkis et al., 2006) and studies in rodent models.  These 
gene expression and proteomic assays would have to be performed on samples from 
each batch.   Image analysis is a non-destructive monitoring technique and could be 
performed on each individual patch. 
 
A.2.6 Storage and handling  
 
Although not within the scope of this thesis, storage and transportation will be a key 
validation issue in the large scale production of HESC-RPE. If the RPE cells are to 
be manufactured at a centralised facility prior to transportation, the storage and 
handling during transfer must be carefully planned. This might include a process of 
freezing the cells in which case cell viability after thawing must be accounted for.  
The temperature of the transportation vessel must be monitored and kept within pre-
determined limits e.g. 1-2 degrees Celsius for live cells and 2-5 degrees for 
cryopreserved cells. 
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A.3 Key Regulatory Issues 
 
Human embryonic stem cell based therapies are very much in their infancy with only 
two therapies granted approval to enter clinical trials in the US and UK. It will be 
necessary to define with the regulatory authorities a reasonable set of regulations 
with which a HESC derived product must adhere.  
 
The regulatory issues applicable to HESC-RPE will concern the safety and efficacy 
of the cell product. In terms of safety, immunogenicity and tumorigenicity will be 
primary concerns.  In terms of efficacy, designing clinical trials that will prove that 
HESC-RPE can ameliorate the effects of macular degeneration to an extent that 
justifies the risk and cost to the patient will be the aim. In addition establishing the 
potency of the cells and regulating/optimising the dose will be a primary concern. 
 
 
Immunogenicity:  
 
This HESC-RPE therapy for AMD would be allogeneic i.e. cells derived from one 
donor will be implanted into all patients. This has obvious implications in 
immunogenicity of the implanted cells. It is often stated that the eye is an ‘immune-
privileged site’ owing to the blood-retinal barrier separating the retina; however this 
barrier can be compromised in diseased retinas (Da Cruz et al., 2007). It has been 
proposed that a course of anti-inflammatory, immunosuppressive drugs could be 
prescribed after the initial surgery and then stopped after the implantation site has 
healed (Schwartz et al., 2012).  
 
Aside from the potential immunogenicity of the transplanted cells themselves, 
regulators will require proof that no contaminating agents (viruses, bacteria, 
mycoplasma) have been incorporated into the product during the processing which 
may proliferate inside a host or illicit an immune response.   This concerns the HESC, 
the mouse embryonic feeder layer and any animal derived media components such as 
serum replacement. This will be of particular concern when products are bovine 
derived. All cell handling must be carried out in state of the art clean room facilities 
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to avoid contamination.  This should include the use of fully validated ISO class 5 
bio safety cabinets in a fully validated ISO class 7 clean room under environmental 
control. In addition regular testing during processing should be used to confirm the 
absence of contamination in cells and materials. 
 
Teratoma formation: 
 
One of the primary concerns regarding HESC based therapies is the ability of HESC 
cells to form teratomas in vitro. These are benign tumours consisting of a mix of 
unwanted cells.  They form when undifferentiated stem cells are administered into a 
live animal or when cells have acquired a karyotypic change that affords them a 
growth advantage and tumorigenic characteristics. The chance of teratoma formation 
increases in proportion with the specific number of undifferentiated cells 
administered (Blum et al., 2008). It will be essential to regulate the removal of 
undifferentiated cells from the product, and to demonstrate the absence of 
tumorigenesis during early pre-clinical trials, in order to satisfy regulators. 
 
HESC spiking studies could be performed throughout the differentiation process to 
assess the survival of any undifferentiated cells. Undifferentiated cells can be 
detected by way of antibody staining owing to the specific antigens residing on an 
undifferentiated cell’s surface.  An alternative might be the use of antibodies which 
specifically bind to and induce apoptosis of undifferentiated HESC. The potential 
toxicity of this type of molecule however means that safety data would have to be 
gathered and an effective method for its removal established.  
 
Clinical trial design: 
 
There is currently no viable treatment for dry macular degeneration and patients 
usually become legally blind within 10 years of the onset of notable visual 
impairment. In designing an appropriately controlled clinical trial for a HESC-RPE 
therapy, it will be necessary to consider the nature of the disease and of this potential 
treatment.  HESC-RPE would be administered to patients preferably with early stage 
AMD on a 2 by 3mm polyester patch. The hope is that the HESC-RPE will prevent 
further degeneration of vision, but it is unlikely to restore vision that has already 
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been lost. Therefore a clinical trial would have to monitor the decline or otherwise in 
visual acuity of HESC-RPE transplanted patients over the duration of at least 10 
years.  The trial design will be challenging as the disease progresses differently in 
different patients and it would be unethical to implant an empty graft into the control 
group. However, the disease is common, and there is no alternative cure; meaning 
that finding sufficient volunteers to assemble age-matched and disease phenotype-
matched controls should be possible. It is relatively easy to monitor the state of the 
retina using Fundus photography. This is helpful for physiological examination of 
the disease progress once the cells have been administered. Methods for examination 
would have to be standardised to guarantee the acquisition of comparable data 
between patients. 
 
 
A.4 Conclusion 
 
The current processes for deriving HESC-RPE for early clinical trials can generate 
sufficient material for small scale studies. Subsequent advancements in techniques 
for HESC maintenance and differentiation have the potential to improve upon the 
efficiency of RPE manufacture substantially, which could lead to reduced processing 
and product costs. This can be achieved by improving differentiation yield, reducing 
the raw material costs and reducing the labour and time requirements. The results 
chapters of this thesis have demonstrated how small changes to cell processing can 
dramatically affect the RPE yield, although the identity of the final product appears 
unchanged.  In order to gain regulatory approval for any cell processing changes, a 
set of assays which comprehensively prove RPE product equivalence will be 
required. These assays should focus on survival and functionality, particularly 
pigmentation, growth factor secretion and phagocytosis.  Of particular concern to the 
regulator will be proving the absence of undifferentiated HESC and adventitious 
agents such as viruses and mycoplasma. 
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Fig 2.1. Epson V750 flat bed scanner and custom made flask mounting block 
designed to fit one T25 flask in a fixed position. (A) The mounting block is finished 
with matt black walls and a matt white lid was designed to ensure a light background with 
which the pigmented foci would contrast (B).An example of the image acquired using the 
scanner and mounting block, with pigmented foci clearly visible against a background of 
non-pigmented cells.
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Figure 2.2 Image J ‘find edges’ function detects pigmented areas in images acquired 
from the EPSON V700 scanner. Shadows from the edges and top necessitate the use of 
Image J’s ‘find edges’ function to detect pigmented foci in at the top (i) and side edges of 
the flask. (A) A Threshold applied to whole flask highlights areas in shadow (i) due to the 
shape of the T25 flask as well as pigmented foci (ii). (B) The find edges function applied to 
the same flask (Shef6, day 45) detects pigmented cells in the previously shadowed region. 
Scale bar = 10mm, 5mm.
(i)
(ii)
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Figure 2.3. White flecks are digitally removed prior to applying ‘find edges’ 
function. Samples of scans of Shef6 cells containing pigmented foci, before (top) and 
after (bottom) removing bright outliers and applying find edges and threshold 
functions.  Top Panel:  Red circles highlight areas where white dust has been left on 
flask surface, these are picked up by find edges function and included when a threshold 
is applied.  Bottom panel:  Bright flecks are removed using ‘remove outliers’ function 
with the radius set to 30 pixels and the threshold set to 15. The white flecks are 
removed and no longer picked up when the threshold is applied as seen by the empty 
red circles in the last column. The pigmented regions are still picked up as seen by the 
remaining black areas in the last column.
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Figure 2.4  Comparing auto-counting method to manual counts. (A). A typical scan of 
Shef6 at day 50 containing pigmented RPE foci. (B) Manually selecting and counting 
pigmented foci using the ImageJ cell counter function determines 118 individual foci in the 
flask. (C) Auto-count using ‘find edges’ function, thresholding at 45 and including particles 
>18 pixels in size  returns 118 particles in the same flask, scale bar =10mm (D-F) Close up 
sections of the flasks above, containing with manual and auto-counts labelled, each returning 
17 particles, scale bar = 5mm. (G) The combined functions were then assimilated into an 
ImageJ Macro. The ‘autocount macro’ generates a value for the total number of pigmented 
foci above a specified size and pigment intensity threshold.  (H) A total of 8 flasks with 
varying degrees of pigmentation were counted three times on three separate occasions using 
both manual counting and auto-counting methods applying the macro. Error bars were reduced 
using the auto-counting macro. For smaller foci numbers, manual counting over estimated the 
number of foci relative to auto-counting, for larger foci numbers manual counting 
underestimated the numbers relative to auto-counting.
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Figure 2.5 Percent pigmented area. Percent pigmented area was used as an alternative to foci 
numbers to compare relative yields in six well plates where yields were particularly high and 
individual foci could not be easily distinguished. (A). Scanned images of a typical well at day 
50 containing 14.7% pigmented surface area, a circular area as close to the edge of the well as 
possible was selected, without incorporating side shadows, scale bar = 10mm (B) Enlarged 
area of the well in A, scale bar = 5mm. 8 bit images were thresholded at 120/255, selecting 
only pigmented areas and excluding background. The area fraction darker than 120 was then 
selected, and the % coverage was calculated in image J ‘analyse particles’ function.
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Fig 2.6 Visualisation of HESC colonies at day 6. Examples of scanned image of a flask 
with the lid removed from the mounting device allowing visualisation of individual HESC 
colonies at day 6. Colonies were counted using Plugins>analyze>cell counter function. 
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Figure 2.7 Confluence vs. Cell number correlation curve (A) A threshold was 
applied to the scanned images enabling an approximation of the % confluence. (B) Six 
flasks of shef6 HESC were scanned at day 6 before dissociating into single cells and 
counting. The results were used to construct a calibration curve that allowed for the 
approximate determination of cell seeding density.
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Fig 3.1 HESC-RPE Differentiation using the continuous adherent MEFs co-culture 
method. The ‘continuous adherent’ method of differentiation involves plating 
undifferentiated pluripotent HESC onto mitotically inactivated MEF feeders (‘MEFs’). 
During the HESC expansion phase (first 10 days) cells grow to confluence in expansion 
medium containing 20% KOSR and 4ng/ml bFGF, during this period 
immunocytochemistry (ICC) and real-time quantitative PCR (QPCR) is carried out to 
monitor the expression of pluripotency markers over time. After 10 days the medium is 
switched to ‘differentiation medium’ containing 20% KOSR but no bFGF.  During 
differentiation, acquisition of neuroectoderm, eye field and finally pigmented RPE 
characteristics are monitored with ICC, QPCR, standard reverse transcriptase PCR (RT- 
PCR) and Image analysis.  From day fifty onwards, pigmented foci are large enough to 
be mechanically extracted. Isolated pigmented foci are then re-plated onto Matrigel 
coated plates and fed with a-MEM based RPE medium for 20-30 days. Pigmented RPE 
monolayers are characterised by immunocytochemisty for RPE markers. Scale bars (left 
to right) 500µm,  10mm, 200µm.
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Figure 3.2 HESC morphology. Phase-contrast photographs showing the varying 
morphology of pluripotent and differentiating shef3 and 6 on MEFs feeders. If colonies 
are left to expand without passaging their morphology begins to change indicating the 
loss of pluripotency and beginning of differentiation,  (A-C) Typical Shef6 colonies at 
day 5 (A) and day 10 (B)  and day 15 (C) post passaging.. (D-E) Shef3 at day 5 (D), day 
10 (E) and day 15 (F) post passaging .Scale bar = 500µm
A 
.
D 
.
C 
.
B 
.
E 
.
F 
.
Sh
ef
6
Sh
ef
3
Day 5 Day 10 Day 15
500µm
113
Figure 3.3 Pluripotency marker expression at day 5. The majority of HESC colonies 
are round, tightly compacted and stain positively for pluripotency markers Oct4 and 
tra160.(A)Shef6 passage 50 (B) Shef3 passage 50. Scale bar = 500µm.
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Figure 3.4 Heterogeneous HESC cultures contain some differentiating colonies at 
day 5. Immunocytochemistry using pluripotency markers (Oct4, tra160, tra181) 
demonstrates the loss of pluripotency marker expression in spontaneously 
differentiating colonies of Shef6 and Shef3. (A) Oct4 expression down regulated at one 
edge of a large Shef6 colony. (B) Oct4 down regulation in a small Shef3 colony at day 
5. (C) Tra160 expression is reduced in the centre of a large Shef6 colony. (D) Tra181 is 
down regulated in the centres of two large Shef3 colonies. (E) SSEA1, a marker of 
early differentiation in HESC is expressed in the centre of a differentiating colony of 
Shef6. (F) SSEA1 is expressed across one edge of a differentiating Shef3 colony. (G-H) 
Isotype controls antibodies (mouse, rabbit)  + Alexa 488 secondary. Scale bars = 
500µm.
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Figure 3.5 Karyotypic Analysis of Shef6 and Shef3 cell lines. Karyotypic analysis 
using standard G banding was carried out regularly (TDL genetics, Whitfield street, 
London). (A) G banded chromosomes of Shef3 at passage 103. In the majority of cases 
Shef3 had a normal 46 XY karyotype. On one occasion a subpopulation of TRISOMY 5 
cells was detected.  (B) G banded Shef6 chromosomes at passage 62 showing a normal 
46 XX karyotype. On one occasion a TRISOMY 5 and TRISOMY 17 sub population of 
cells were also detected in Shef6. 
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Figure 3.6 Spontaneous differentiation of HESC in MEFS co-culture. (A) Scanned 
images of whole flasks show how individual colonies expand over time to fill a T25 
culture flask. (B-E) Bright field images show the changes in cell morphology that 
accompany early, spontaneous differentiation after prolonged culture on MEFs and 
withdrawal of bFGF at day 10, scale bar = 500µm. (F-I) Immunofluorescence images of 
OCT4 and DAPI over the time course of early differentiation show the progressive loss of 
Oct4 immunoreactivity. (J) QPCR for HESC markers (OCT4, NANOG, TDGF) show a 
gradual decrease in expression over the first 15 days of differentiation post seeding. Bars 
represent the normalised fold change in gene expression relative to day 3. 
OCT4DAPI
J.
Day 3 Day 10 Day 15 Day 20
20 mm
119
Figure 3.7 Spontaneous differentiation yields thickened ridges containing Pax6 and 
Otx2 positive neuroepithelial rosettes. (A-H) Bright field and immunofluorescence 
images taken at day 20 of continuous adherent differentiation on MEFs. Thickened, 
multilayered clumps of cells containing rosette structures are Pax6 and Otx2 positive, 
scale bar = 100µm. (G-H) The clumps and ridges are found in abundance across the 
flasks as seen in 4x magnification images, scale bar = 500µm. (I) QPCR time course 
over 25 days in shef6 bars show the expression of Pax6 and Otx2 at each day relative to 
day 5. (K) RT-PCR at days 5,10,20,30 and 50 of differentiation in Shef3 shows the 
expression of Otx2 and Pax6 relative to the house keeping gene TBP as well as no 
reverse transcriptase (NRT) and no template controls (NTC). Pax6 primers amplify both 
the larger +5a (arrow) and smaller -5a Pax6 isoforms, the former of which is more 
critical to retina formation (Azuma et al., 2005). 
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Figure 3.8 Pigmented foci being to appear  between days 25 and 32 post HESC 
seeding. (A,B) Scanned images of Shef6 and Shef3 flasks at day 40 showing the 
pigmented foci, scale bar = 10mm. (C-E) QPCR time course of gene expression in whole 
flasks over 50 days of Shef6 differentiation from HESC demonstrates the relative fold 
increases in expression RPE/Pigmentation genes Tyrosinase (C), PMEL17 (D) and 
MitF(E). (F) RT-PCR time course of Shef3 differentiation showing a similar pattern of 
Tyrosinase and Pmel17 up regulation over time. An increase in MitF expression is 
detected earlier in Shef3 at day 10.(NTC = no template control, TBP = house keeping 
gene, NRT= no reverse transcriptase control).
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Figure 3.9 Kinetics of RPE accumulation over time. The numbers of individual foci 
were determined from scanned images of flasks taken at several time points using the 
image J macro (see chapter 2 methods) over 84 days (Shef3, N=3) or 58 days (Shef6 
N=3) of HESC-RPE differentiation. Error bars = SEM. In both cell lines numbers of foci 
accumulated rapidly from days 30-50 in Shef3 at a rate of 0.27 ±
 
0.02 foci/cm2/day and 
in Shef6 at 0.53±0.03 foci/cm2/day. Two way ANOVA revealed a significant effect of 
time (F(4,20) = 47.5, p<0.001), Cell line (F(1,20) = 18.4, p<0.001) and a significant 
interaction (F(4,20) = 14.31 p<0.001 ), indicating that the cell line effect increased with 
time in culture. At days 50 and 58 there were significantly greater numbers of pigmented 
foci in Shef6 relative to Shef3 (**p<0.01 unpaired student’s t-test).
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Figure 3.10 RPE yield is compromised at high passage numbers. (A) Representative 
scanned areas of typical flasks of Shef3 (top panel) and Shef6 (lower panel) at day 50 at 
low (p40-50), medium (p50-60) and high (p70-90) passage numbers illustrating 
difference in typical foci numbers. (B) Scatter graph of number of foci per cm2 at day 
50 vs. starter HESC culture passage number. Average (p40-50 Shef6+Shef3)= 9.3±1.0 
foci/cm2, (p50-60 Shef6+Shef3)= 3.0±1.0 foci/ cm2, (p70-90 Shef6+Shef3) =0.23±0.08 
foci/cm2). Two way ANOVA revealed a significant effect of passage number (F(2,10)= 
70.9, p<0.01 ) and cell line (F(1,10) = 5.8, p<0.05 ) but no significant interaction 
(F(2,10)=2.02, p=0.23 ).
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Figure 3.11 Pigmented foci adopt a range of sizes and morphologies. Scan of a whole 
T25 flask at day 60 containing several pigmented foci with the corresponding 4x and 10x 
bright field microscope images of individual foci labelled (A-E). In some areas, a 
pigmented monolayer of cells ‘fan out’ from a central focus (A), in other areas foci are 
small and discrete (C). Differences are likely due to local spatial constraints and 
asynchronous differentiation. Scale bars (large) = 200µm, (small) = 500 µm.
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Figure 3.12 Manually isolated foci adhere to Matrigel coated plates and proliferate 
forming monolayers of pigmented cells with ‘cobblestone morphology’. Bright field 
microscope images taken at 4x magnification. Four pigmented foci were manually 
extracted from typical day 60 cultures using microsurgical blades and re-plated onto 
Matrigel coated plates in aMEM- RPE medium.  By day 3 the foci had adhered to the 
coated plates and cells had begun to proliferate away from the attached foci. By day 18 
heavily pigmented cells were visible, though a contaminating cell type with neuronal 
projections was visible in one well (Foci 3, arrow). By day 35 extensive monolayers of 
heavily pigmented cells with classical, polygonal RPE morphology had formed around 
each foci but the total area occupied by pigmented cells was variable. Scale bars = 500µm
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Figure 3.13 Contaminating, non pigmented cell types were occasionally visible in the 
manually extracted foci. Microscope images of an expanding foci at day 9 and day 35 at 
4x (A,C) and 20x (B,D) magnification. (A) In addition to the usual cells with a 
cobblestone, pigmented phenotype, a cluster of non pigmented cells from which neuronal 
projections were visible was observed (enlarged image B). By day 35 these cells  had 
receded and the area was overtaken by expanding RPE (C,D).
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Figure 3.15 Proliferating RPE de-pigment, adopt an elongated morphology and 
down regulate RPE marker expression. (A,B) Scanned images showing typical wells 
containing expanding pigmented foci (day 35) scale bar = 10mm. The attached 
pigmented foci are clearly visible (arrows) and are surrounded by an expanding 
monolayer of RPE with the intensity of pigment decreasing with distance from the 
central foci. (C) Microscope images stitched together showing changes in cell 
morphology and pigmentation with distance from the adherent foci. Cells close to the 
central foci are pigmented and have typical cobblestone morphology, whereas at the 
proliferating edge cells are de-pigmented and have a more elongated morphology, scale 
bar =200µm. (D,E) Brightfield and immunocytochemisty at the leading edge. (D) ZO1 
expression indicates the presence of tight junctions across the expanding RPE but a 
clear change in morphology towards a more elongated phenotype at the leading edge. 
(E) Bestrophin is only expressed in the compacted, heavily pigmented cells close to the 
central foci. DAPI nuclear staining is obscured in heavily pigmented cells, scale bar = 
200µm
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Figure 3.16.  Pax6 up regulation and cell growth rates in Shef6 and Shef3 in feeder- 
free differentiation. (A) QPCR showing relative fold up regulation in Pax6 from days 5- 
15 in Shef6 and Shef3 cells taken from a range of passages (passage numbers 50-80). 
Cells were split three ways and allowed to expand and differentiate in three separate 
systems: 1. On low attachment plates as embryoid bodies (EBs) in HESC media +bFGF 
2. On Matrigel in MTeSR1 media 3.In MEFs co-culture and HESC media +bFGF. After 
10 days expansion and 5 days in differentiation media (-bFGF), cells were harvested for 
QPCR.  The graph shows the average relative up regulation in Pax6 expression from 
days 5- 15. In Shef6 there were statistically significant differences between the 
differentiation methods (one way ANOVA, F(2,6)=37.6, p<0.01), but not in Shef3. In the 
EB method Shef6 up regulation was significantly higher in Shef6 than Shef3. In contrast 
, in MEFs co-culture differentiation, Pax6 up regulation was significantly higher in Shef3 
(* P<0.05 student’s t-test error bars =SEM). (B) Shef3 and Shef6 cell growth rates were 
measured over 7 days in feeder-free Matrigel+mTeSR1 conditions.  There was a 
significant difference between cell lines (2 way ANOVA) with shef6 cell numbers 
significantly greater than Shef3 at days 3, 5 and 7 (* P<0.05, N=4, Student’s unpaired t- 
test).
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Figure 3.17.  Shef3 expanding in MEFs and feeder free conditions . (A). 4x phase 
contrast images of typical Shef3 cultures at day 3 and day 10 in three differentiation 
conditions;  on Matrigel in HESC media, on Matrigel in MEFs conditioned media, and in 
MEFs co-culture. MEFs conditioned (CM) media maintains undifferentiated HESC 
morphology similar to that seen in MEFs co-culture although colonies tended to expand to 
larger sizes. Cells grown on Matrigel in standard HESC media rapidly differentiated 
adopting non HESC-like morphologies. Scale bar = 500µm. (B) Similar to differentiation 
by the embryoid body method (Fig 3.16), Pax6 expression is significantly higher at day 10 
in cells grown on Matrigel with standard HESC media (one way ANOVA, F (2,6)= 150, 
P<0.05) this reflects the rapid differentiation of HESC in the absence of MEFS or MEFS 
conditioned medium regardless of whether cells are differentiating as floating EBs or 
adhered to Matrigel.
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Figure 3.18  Time course of gene expression over 50 days Shef3 differentiation in 
MEFs co-culture and in feeder cell free conditions. RNA was harvested at 5 times 
points from Shef3 differentiating in  three conditions; on Matrigel in HESC medium 
(+bFGF), on Matrigel in MEFS conditioned media (CM) or in MEFS co-culture, bFGF 
containing media (or CM) was replaced with –bFGF differentiation media from day 10 
onwards. In the absence of MEFs or MEFs conditioned medium, genes critical to RPE 
formation ( Pax6, Otx2, MitF, Tyrosinase, Pmel17) are down regulated over time. In the 
presence of MEFs CM (middle row) the temporal gene expression pattern is similar to 
that seen in HESC differentiating in MEFs co-culture (bottom row). 
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Figure 3.19 RPE yields in Feeder free culture.  RPE foci numbers were counted using the 
auto-count macro (see methods) from scans of flasks taken at day 50 (N=3 passage numbers 
45-48). (A) Shef3 produced significantly greater RPE yields when differentiated in MEFs co- 
culture relative to the other conditions (one way ANOVA, F(2,6) = 76.8, p< 0.05, student’s 
paired t-test, **p<0.001). Cells seeded onto Matrigel in standard HESC media had poor 
survival and produced very few RPE per cm2, when seeded onto Matrigel with MEFs 
conditioned media the yield improved slightly but not significantly.  (B) QPCR analysis 
following 50 days of Shef3 differentiation. There were significant differences in Tyrosinase 
and Pmel17 expression at day 50 (One way ANOVA, F(2,6)= 26.5, p<0.01, F(2,6)= 33.7, 
p<0.01 respectively) with the expression of both genes significantly higher in MEFs co-culture 
(student’s paired t-test, **P<0.01). The differences in expression between Matrigel + CM and 
matrigel only were not significant. Error bars = SEM.(C) Bright field images of emerging 
pigmented foci in day 50 cultures of Shef3 in feeder-free Matrigel+CM and MEFs co-culture 
differentiation. (D) ‘Feeder free’ Matrigel+CM derived foci were mechanically isolated and 
re-plated. Typical cobblestone RPE monolayers formed with pigmented cells that were 
positive for RPE markers Bestrophin and CRALBP, scale bar = 50µm.
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Figure 3.20 Shef6 expanding in feeder-free conditions. (A) Bright field microscope 
images at day 2 and day 8 showing Shef6 colony morphology in different conditions.  
Typical HESC morphology as seen in standard MEFs co-culture  is apparent when cells 
are seeded on Matrigel+ conditioned media, or mTeSR1 media. In absence of MEFs, 
MEFs-CM or mTeSR1 however, when cells are grown in standard HESC media +bFGF, 
distinctive changes in cell morphology are apparent by day 8 (bottom left panel), scale 
bar = 200µm (B) Growth curves of Shef6 expanding on Matrigel in MEFs-CM and in 
defined mTeSR1 media over 8 days in culture. There were statistically significant 
differences in cell numbers between cells lines which increased over time ( 2 way 
ANOVA, F(2,18) =  47.7, p<0.001) ), specifically there were more cells in the MEFs- 
CM condition at day 3 but more cells in mTeSR1 by day 8 (unpaired, student’s, t-test 
N=4,  * P<0.01), possibly reflecting a period of adaptation to mTeSR1 media. Error bars 
= SEM.
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Figure 3.21 Shef6 RPE yield in feeder-free culture. (A) The average number of 
pigmented foci /cm2 in Shef6 cells at day 50, following differentiation in four 
conditions (N=2 passage numbers 42, 54). In Matrigel + standard HESC media, 
Matrigel + MEFs conditioned media, Matrigel + mTeSR1 media and in MEFs co- 
culture, error bars = SEM. Areas taken from scanned images of flasks at day 50. (B) 
QPCR analysis reveals differences in Tyrosinase and Pmel17 expression at day 50, 
following expansion in the different feeder-free conditions.
5mm
A.   SHEF6 Day 50 Foci Yield
B.   QPCR Day 50
148
200µm
10mm
200µm
2mm 200µm
50µm
Matrigel + mTeSR
Matrigel + CM
Figure 3.22 Variation in cell sheet coverage and thickness at day 50 dependent on 
expansion medium.  Scanned images of flasks at day 50 showing opaque white areas 
covered with thick cell sheets, and dark, translucent areas with little cellular material. 
(A) Shef6 expanded in CM had formed a patchy cell sheet at day 50. (B,C) Large areas 
with sparse cell coverage were visible. (D,E) large areas of expanding pigmented RPE 
were also visible (F-H) Shef6 cells that were expanded in mTeSR1 media formed a 
thick multi-layered sheet in which abundant pigmented foci were embedded. Scale bars 
(left to right) = 10mm, 2mm, 200µm.
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Figure 3.23 Shef6 feeder-free derived RPE. Pigmented foci were isolated at day 50 
from Matrigel + mTeSR1 flasks and plated onto Matrigel for expansion. After three 
weeks, sheets of pigmented cells with classical cobblestone, RPE morphology were 
expanding away from the adhered pigmented foci. Pigmented cells were positive for RPE 
markers CRALBP, Bestrophin and MitF. Scale bars = 200µm and 50µm (insert).
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Figure 4.1 Mechanically passaged colonies tend to aggregate at high density leading 
to an uneven distribution. A. T25 containing areas of low and high colony density. B. 
Bright field and fluorescence images taken in areas of different local cell density. Colonies 
in lower density areas proliferated and maintained Oct4 expression and undifferentiated 
morphology by day 10 whereas highly confluent areas of the same flask (lower panel) 
began to differentiate and loose Oct4 expression. Scale bar = 500µm
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Figure 4.2  Uneven colony distribution leads to an uneven distribution of 
pigmentation at day 50. Vertical sections of scanned T25 flasks of differentiating cells 
taken at days 2,15 and 50. Areas of high seeding density have produced pigmented RPE 
(white circles). Areas with low seeding density have produced no pigment and appear to 
be devoid of surviving cells at day 50 (red circles).  Scale bar = 10mm
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Fig 4.3  Time course of differentiation at different seeding densities. Higher seeding 
density consistently produced a greater RPE yield over 3 passages (p44-47) (A) Close 
ups of the scanned images at day 50 at the different seeding densities. Scanning with a 
white background (left panel) clearly shows the pigmented cells. Removing the white 
backing before scanning (right panel) shows the density of the cell sheet with 
multilayered thick areas appearing opaque white. Scale bar =  5mm. (B) Average number 
of Foci per T25 flask from days 40-50 analysed using the auto-counts method (chapter 2) 
from scanned images of flasks seeded at three different densities (split ratios low density 
1:4, medium density 1:2 and high density 2:1). Two way ANOVA revealed a significant 
effect of density (F(2,28) = 19.4, p<0.001) , time (F(3,28) = 49.1,  P<0.001) and a 
significant interaction (F(6,28) = 14.1, p<0.001) . At all time points, high density seeded 
flasks has significantly greater foci numbers than low or medium density seeded flasks 
(** p < 0.001, student’s unpaired t-test, ). Error bars =SEM.(C-E) Individual graphs from 
each experimental run, passage numbers 44, 45 and 47.
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Fig 4.4 HESC seeding density effects the expression of RPE pigmentation genes at 
day 50. QPCR analysis of Tyrosinase (A) and PMEL17 (B) expression at three densities 
across three passages (p44, 45 and 47).  Bars represent the fold change in expression 
relative to the lowest density (1:4) within each experimental run.  Relative gene 
expression follows the pattern of relative pigmentation. All QPCR expression data was 
normalised to the mean expression of house keeping genes POL, MAN and GNB 
(chapter 2 methods). 
0
0.5
1
1.5
2
2.5
3
3.5
p44 p45 p47
Passage Number
R
el
at
iv
e 
Fo
ld
 C
ha
ng
e
Low Density 1:4
Medium Density 1: 2
High Density 2:1
0
0.5
1
1.5
2
2.5
p44 p45 p47
Passage Number
Re
la
tiv
e 
Fo
ld
 C
ha
ng
e
Low Density 1:4
Medium Density 1: 2
High Density 2:1
A.
B.
PMEL17
Tyrosinase
173
Figure 4.5 Number of RPE foci per HESC colony vs. seeding density. The total 
number of foci at day 50 was divided by the total number of HESC colonies seeded as 
determined at day 7. This indicates the differentiation efficiency and clearly shows a 
correlation between the number of colonies seeded per flask (seeding density) and the 
differentiation efficiency (RPE foci formed per HESC colony). R squared value = 0.9126.
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Seeding Density vs. Pax6 expression at  Day 15
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Figure 4.6. Seeding density affects early differentiation. (A) Photomicrographs at 
day 3 showing dissociated cells surviving and proliferating after seeding  at a range of 
densities (upper panel). At day 15 thick ridges had formed between ‘holes’ of less 
compacted cells, these were more pronounced at higher densities (50-100k/cm2), scale 
bar= 500µm. (B)  Immunocytochemistry showing the presence of Pax6 positive 
neuroepithelial rosettes on these thickened ridges, scale bar = 200µm. (C) QPCR 
analysis at day 15, bars represent the fold increase in Pax6 expression relative to the 
17K/cm2 condition, normalised to three house keeping genes (Error bars = SEM, N=3).. 
One way ANOVA revealed a significant difference in Pax6 expression with seeding 
density (F(3,8) = 4.5, *p<0.05).
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Figure 4.7.  Time course of gene expression during early differentiation. QPCR 
analysis of gene expression of cells differentiating following seeding at three different 
plating densities (50,25 and 17K/cm2). Cells were harvested at 5 time points up to day 35 
of differentiation.  Lines represent the normalised fold change in gene expression relative 
to the day 0 starter cultures. (A) Oct4 expression decreases over time in culture as the 
cells differentiate, the rate of down regulation is reduced at low density (17K /cm2) and 
similar in the 25 and 50 K/cm2 condition. (B) Rx expression increases as cells 
differentiate and adopt an eye field fate. The peak in Rx expression occurs later at high 
density (50K/cm2) compared to medium density (25K/cm2).
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Figure 4.8.  Pigmented RPE morphology at 17K and 100K/cm2 seeding densities. 
Photomicrographs and immunohistochemistry at day 50 in wells seeded with 17 and 
100k/cm2 HESC. In wells that were seeded with 100K/cm2, Otx2 positive pigmented 
cells appear as contiguous flattened sheets (middle panel). At 17K/cm2 Otx2 positive 
pigmented cells appear in small, slightly raised and compacted foci in which the highly 
concentrated pigment partially obscures the fluorescence signal (top panel).
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Fig 4.9 Seeding density and rate of pigmentation following conditioned media 
expansion. Panels show scanned images of the wells seeded at different densities (17k- 
100k /cm2) showing the increase in pigmentation over time from days 33-50. Graphs 
show % surface pigmentation at days 35 (blue) and 50 (red) as assessed in Image J (See 
Chapter 2, materials and methods. (A) Scans and % pigmentation data from run 1, using 
passage 60 Shef6. (B) Scans and % pigmentation data from experimental run 2, using 
passage 68 shef6. (C)  QPCR analysis of RNA extracted at day 50 of differentiation 
from passage 60 Shef6. Each bar represents the normalised expression of an RPE 
marker (Tyrosinase, Pmel17, Otx2, MitF, Bestrophin, CRALBP) at day 50 relative to its 
expression at day 50 in the lowest seeding density condition (17k/cm2).
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C. Shef6 Passage 52 –mTeSR1 Expansion
17
50
70
100
Day
33          35          40         50 
0
1
2
3
4
17 50 70 100
Day 35
Day 50
S
ee
di
ng
 D
en
si
ty
 x
10
^3
 /c
m
2
Day
33          35          40         50 
17
25
35
50
70
100
S
ee
di
ng
 D
en
si
ty
 x
10
^3
 /c
m
2
D. Shef6 Passage 68 –mTeSR1 Expansion
0.0
0.2
0.4
0.6
0.8
17 25 35 50 70 100
Day 35
P
ig
m
en
te
d 
 a
re
a 
(%
) 
Seeding Density x10^3 /cm2
P
ig
m
en
te
d 
 a
re
a 
(%
) 
Seeding Density x10^3 /cm2
190
E.
Day 50 Gene Expression
(MTeSR1 Expansion)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
17 50 70 100
Seeding Density x10^3 /cm2
N
or
m
al
iz
ed
 F
ol
d 
C
ha
ng
e 
re
la
tiv
e 
to
 1
7K
Tyrosinase
PMEL17
Otx2
MitF
Bestrophin
CRALBP
Figure 4.10 Seeding density and rate of pigmentation following mTeSR1 expansion. 
Panels show scanned images of the wells seeded at different densities (17k-100k /cm2) 
from days 33-50 using cells at passage 50(A), and 51 (B), 62 (C) and 68 (D). Red 
crosses indicate wells lost before day 50 to contamination (C). Graphs show % surface 
pigmentation analysis in Image J at days 35 (blue) and 50 (red). In (D) day 50 
measurements could not be taken due to cell sheet peeling. QPCR analysis of RNA 
extracted at day 50 of differentiation from passage 50 Shef6. Each bar represents the 
normalised expression of an RPE marker (Tyrosinase, Pmel17, Otx2, MitF, Bestrophin, 
CRALBP) at day 50 relative to its expression at day 50 in the lowest seeding density 
condition (17k/cm2).
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Figure 4.11 Average fold change in pigmentation.  The % pigmentation data from all 
6 feeder-free single cell dissociation experiments were collated. Bars represent the fold 
change in % pigmentation relative to % pigmentation in the 17K/cm2 condition in each 
of the 6 runs. (Error bars = SEM, N=4-6). One way ANOVA revealed a significant 
difference in fold increases in pigmentation with seeding density (F(4,17)=3.0, 
p<0.05),. Post hoc t-tests found that the fold changes at 35K/cm2 were significantly 
higher than those at 100 K/cm2 , * = P<0.05 (student’s unpaired t-test).
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Fig 4.12.  RPE Differentiation Efficiency per HESC cell.  Scatter plot showing the 
changes in HESC conversion efficiency with increasing cell seeding density for each 
experimental run. Each dot  represents the total pigmented cell area in a well at day 50 
(mm2) divided by the number of cells seeded (in thousands) versus number of cells seeded 
(x10^3/cm2). In each run, the peak efficiency occurs at a seeding density between 17- 
35,000 cells/cm2, with higher densities giving reduced efficiency. NB. wells that were 
lost before day 50 are not included (mTeSR1 passage 68, mTESR1 passage 52 (70-100K 
wells)).
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Figure 5.1  Small molecule inhibitors enhance neuroectoderm differentiation in 
Shef3.  Immunocytochemistry for Pax6 and Oct4 following ten days of differentiation 
in the presence of small molecules. (A-D) Control samples (DMSO only), some neural 
rosettes are visible (A, arrows) but many are not Pax6 positive at this time point (B), 
Oct4 is not detectable . (E-H) BMP/activin inhibitor dorsomorphin (DM) 1µm only, 
Pax6 positive cells are now abundant though not arranged in rosette like structures. 
Some Pax6 –ve cells remain in hole like structures (F, arrow). Oct4 is again not detected 
(G,H). (I-L) 1µm dorsomorphin + activin/nodal inhibitor SB431542 10 µm, a similar 
picture to dorsomorphin only with Pax6 positive sheets interspersed with Pax6-ve holes 
(J). (M-P) 1µm Dorsomorphin + 10 µm SB431542 + FGF/ERK inhibitor PD0325901 
1µm Pax6 positive cells appeared in more tightly compacted islands surrounded by 
larger Pax6 negative holes (M,N), again Oct4 was not detected (O,P).
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Figure 5.2  Small molecule inhibitors control neuroectoderm differentiation in 
Shef6.  Immunocytochemistry for pax6 and Oct4 following ten days of differentiation in 
the presence of small molecules. (A-D) Control samples (DMSO only). Pax6 positive 
neural rosettes were abundant on thick ridges in day 15 control samples (B, arrows), 
Oct4 was not detected (C,D). (E-H) BMP/activin inhibitor dorsomorphin 1µm only.  
Neural rosettes were no longer visible but contiguous sheets of Pax6 positive cells had 
formed (F), a faint Oct4 signal was also detected (H). (I-L) 1µm dorsomorphin + 
activin/nodal inhibitor SB431542 10 µm. A highly compacted contiguous sheet of Pax6 
positive cells similar to the Dorsomorphin only condition had formed (J), Oct4 was not 
detected (L). (M-P) 1µm Dorsomorphin + 10 µm SB431542 + FGF/ERK inhibitor 
PD0325901 1µm. Pax6 positive cells appeared only on thickened islands, similar to the 
control condition (N), Oct4 was not detected.
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Figure 5.3 Dorsomorphin (DM) suppresses the down regulation of pluripotency 
gene expression. .(A) QPCR showing the expression of pluripotency genes Oct4, 
Nanog and TDGF in Shef6 at day 15 relative to HESC. All pluripotency genes are down 
regulated at day 15 of differentiation relative to HESC in both dorsomorphin and 
control wells. (B) QPCR showing the expression of pluripotency genes at day 15 in 
dorsomorphin treated relative to control wells in Shef6 and Shef3. In the presence of 
dorsomorphin the expression of Nanog and TDGF is higher in Shef6 than in control 
Shef3.  There were no significant differences between Dorsomorphin and control 
samples in Shef3 however. There was a significant difference in the day 15 TDGF and 
Nanog expression relative to controls between the two cell lines (p<0.05, N=3, student’s 
unpaired t-test ).
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Figure 5.4 Dorsomorphin enhances neuroectoderm and suppresses mesoderm, 
endoderm and trophectoderm gene expression relative to untreated controls. 
Normalised relative expression of markers of mesoderm (Brachyury, AFP), endoderm 
(Sox17, Gata6) and trophectoderm (CDX2) following 10 days of differentiation in the 
presence of dorsomorphin relative to DMSO control wells (shef3-light bars, Shef6-dark 
bars). One way ANOVA demonstrated a significant difference between the expression 
of markers of the different germ layers (neuroectoderm, mesoderm, endoderm and 
trophectoderm) in both cell lines Shef6 (F(3,26)=13.3, p<0.001) and Shef3 (F( 23,3) = 
10.5, p< 0.001). Post hoc analysis  (unpaired student’s t-test) revealed a significant up 
regulation in neuroectoderm marker expression (Six3, Lhx2, Pax6, Nestin) relative to 
dorsomorphin induced changes in the other germ layers in both cell lines (**p<0.001), 
suggesting that dorsomorphin had a specific affect of up regulating neuroectoderm gene 
expression.. There was a significantly greater down regulation of 
mesoderm/endoderm/trophectoderm markers in Shef3 relative to Shef6 (one way 
ANOVA F(1,28) = 3.8 p<0.05, but no overall difference between the cell lines in the 
upregulation of neuroectoderm markers.
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Fig 5.5 Dorsomorphin (DM) enhances neuroectoderm differentiation at a range of 
seeding densities. (A) Bright field images of cells seeded over a range of densities and 
differentiated in 1µm dorsomorphin or control media, control wells contain distinctive 
circular holes of flattened, non-compacted cells (labelled H) surrounded by thickened 
ridges (labelled R). (B) The non-compacted holes found in control wells are 
immunonegative for Nestin, compacted cells in DM+ cultures are Nestin positive. (C) 
QPCR showing relative expression of Pax6 at day 15 (DM/Control) over a range of 
densities. The relative fold increase in Pax6 expression declined slightly with increasing 
seeding density but not significantly. Bars represent average normalised fold increase in 
dorsomorphin treated over control wells at the same density in two separate passages 
(N=2). 
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Figure 5.6 Time course analysis of neuroectoderm and eye field transcription 
factor gene expression. QPCR analysis shows the change in mRNA levels of eye field 
transcription factors Six3 and Lhx2, expressed relative to undifferentiated HESC in 
cells induced with dorsomorphin (thick black line), and cells from the same starter 
culture treated with DMSO only (thin line). Experiments were carried out in shef6 (A) 
and Shef3 (B).
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Figure 5.7 Dorsomorphin enhances RPE yield in Shef3 MEFs co-culture. (A) 
Scanned images of Shef3 flasks at passage 56 following 50 days of differentiation with 
(DM+) or without (control) a ten day dorsomorphin induction step. (B) Phase contrast 
image of expanding pigmented cells, derived from dorsomorphin induced flasks. 
Dorsomorphin derived pigmented cells have typical RPE morphology. (C) Pigmented 
foci yields per cm2, assessed using the auto-count method at day 50 in dorsomorphin 
treated (DM+) and control flasks over a range of passage numbers. The average fold 
increase dorsomorphin/control was 4.1±0.4 (N=3).
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Figure 5.8 Dorsomorphin robustly enhances RPE differentiation efficiency in shef3. 
(A) Representative scanned images of 6 well plates at day 50 in control and dorsomorphin 
treated wells from passage numbers (P) 61, 70 and 80. (B) Enlarged areas from of 
dorsmorphin and DMSO control wells demonstrating a significant increase in pigmented 
cell yield. (C) Average % pigmented area and number of foci per cm2 in control and 
dorsomorphin wells (error bars = SEM, N=6). Dorsomrophin induced a statistically 
significant increase in % pigmentation the (ANOVA F(1,10) = 8.0) and in the number of  
foci/cm2 (F(1,10)=9.6), **p<0.01, N=6. The average fold increase pigmented area 
dorsomorphin/controls = 5.0 ± 0.7. (D) Bright field and immunofluorescence images of 
expanding RPE taken from dorsomorphin treated wells at day 50. Pigmented cells have 
typical RPE morphology and express RPE markers Otx2, ZO1, MitF and Pax6. (E) QPCR 
at day 50 in 4 separate experiments shows the up regulation in RPE associated genes 
Pmel17, MitF, Otx2 and Pax6 relative to controls (N=4, * p<0.05, student’s paired t-test).
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Figure 5.9 Dorsomorphin and RPE yield in Shef6 MEFs co-culture. (A) Scanned 
images of Shef6 flasks at passage 56 following 50 days of differentiation with (DM+) 
or without (control) a ten day dorsomorphin induction step. (B) Phase contrast image of 
expanding pigmented cells, derived from dorsomorphin induced flasks. Dorsomorphin 
derived pigmented cells have typical RPE morphology. (C) Pigmented foci yields per 
cm2 in Shef6, assessed using auto-count method (chapter 2, methods) at day 50 in 
dorsomorphin treated (DM+) and control flasks over a range of passage numbers (p47- 
56). The difference between control and DM+ flasks was not significant. The average 
fold increase was 1.3 ± 0.1 (N=3). 
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Figure 5.10 Dorsomorphin and RPE differentiation efficiency in Shef6. (A) Scanned 
images of 6 well plates at day 50 showing typical DMSO control and dorsomorphin 
treated wells from passage numbers (P) 55, 57 and 69. (B) Microscope images day 50 
taken at 4x and 40x magnification. Control wells contain pigmented foci with 
cobblestone RPE morphology whereas dorsomorphin treated wells contain non 
pigmented cells with a disordered morphology, scale bars = 500µm (upper) and 50µm 
(lower). (C) Average % pigmented area and number of foci per cm2 in control and 
dorsomorphin treated wells at day 50. Error bars = SEM, N=6, (ANOVA F(1,10)= 8.2, 
** p<0.01). (D) QPCR analysis on day 50 samples from 3 separate experiments showing 
the relative down regulation in expression of RPE associated genes Tyrosinase, Pmel17, 
MitF, Otx2, but a relative increase in RPE/neural retina gene Pax6 (Error bars = SEM, 
N=3). One way ANOVA revealed a statistically significant difference in the 
dorsomorphin induced expression of RPE genes (MitF, Pmel17, Otx2) in Shef6 vs. Shef3 
(F(1,19) = 5.5 p<0.01).
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Figure 5.11 Chx10 and MitF expression at day 50 in Shef6 and Shef3. (A) 
Immunocytochemistry in Shef6–RPE shows the mutually exclusive expression of MitF and 
Chx10. (B-C) QPCR showing the relative expression of Chx10 and MitF in day 50 samples 
of dorsomorphin treated and control shef6 (N=3) and shef3 (N=4). The difference between 
dorsomorphin induced Chx10 augmentation in Shef6 and Shef3 was significant (ANOVA 
F(1,5) = 15.0, p<0.05 ). MitF expression was up regulated in dorsomorphin treated Shef3 
and down regulated in dorsomorphin-treated Shef6 relative to control wells. The difference 
in dorsomorphin induced expression was significant ANOVA F(1,5) = 2.4, p<0.05 ). (D) 
Bright field images at low and high magnification show the presence of pigmented RPE 
cells in control wells, and their absence in dorsomorphin treated wells. (E) The non 
pigmented cells found in dorsomorphin treated wells stained positively for neural retinal 
marker Chx10. 
Chx10
BFBF
Control DM+
Chx10
DAPI DAPI
2mm
50 µm
D.
E.
50 µm
BFBF
235
Figure 5.12 100ng/ml activin A supplemented from days 20-40 has no impact on 
pigmented cell yield in DM or control wells. (A-D) Scanned and enlarged images of 
typical wells depicting pigmentation at day 50 in control (A), activin only (B), 
dorsomorphin only (C) and dorsomorphin + activin A (D) treated wells at day 50. (E) 
Graph shows the average % pigmentation at day 50 in the four conditions (N=3). Activin 
A had no significant impact on pigmentation in dorsomorphin induced or control wells.
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